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 Science never solves a problem without creating ten more. 
 George Bernard Shaw 
 3  Introduction 
 
1. Introduction 
The human genome consists of three billion base pairs along forty-six DNA 
molecules contained in twenty-three pairs of chromosomes.1 DNA is a linear 
polymer that is composed of four different building blocks, the nucleotides. It is in 
the sequence of the nucleotides in the polymers where the genetic information 
carried by chromosomes is located. Each nucleotide is composed of three parts: 
(1) a nitrogenous base known as purine (adenine (A) and guanine (G)) or 
pyrimidine (cytosine (C) and thymine (T)); (2) a sugar, deoxyribose; and (3) a 
phosphate group. The order of bases along the DNA molecules is known as the 
DNA sequence.1 
 
 
Chart 1  Schematic representation of Adenine, Guanine, Cytosine and Thymine. 
The structure, stability and reactivity of the double-helix DNA is affected by the 
binding to divalent metal cations.2 These interactions have been investigated by 
a variety of spectroscopic techniques. These studies indicated that alkaline earth 
metal ions interact mainly with the DNA phosphates, stabilizing the double helix 
by reducing the overall electrostatic repulsion, while a destabilization of the DNA 
duplex can be induced by transition metal ions that preferentially bind to the 
bases.2 Metal ions, in the form of appended complexes, have been used to 
introduce site-specific redox- and photo-active centers in DNA and address 
questions regarding charge transport. 
 
Depending on the type of metal ion (main group or transition metal; charge; d-
electron configuration; hardness or softness), its binding preference (phosphate 
oxygens; heterocyclic part; site of heterocycle; mono or multi-functional), and 
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other ligands already bound to the metal ion, the net effect on the nucleic acid 
(duplex) at higher metallation levels may lead to strong thermal stabilization or 
pronounced destabilization due to the disruption of an ordered structure.3 
 
The best understood metal-ion interactions with DNA are those involving the 
platinum drugs e.g., Cisplatin. Cisplatin is one of a number of platinum 
coordination complexes with antitumour activity. The potential of this compound 
as an antitumour agent was recognized through an observation made by Barnett 
Rosenberg and co-workers. This accidental discovery initiated a series of 
investigations and studies into the effects of platinum compounds and cell 
division.4 
 
In 1970, further studies performed by Rosenberg and his colleagues revealed 
that these compounds displayed significant antitumour activity and demonstrated 
that diamminedichloroplatinum(II), specifically the cis isomer, was extremely 
effective against sarcoma 180 and L1210 leukemia in mice.4 
 
The efficacy of the platinum complex as an anticancer agent has now been 
established in a variety of animal tumor models and in human cancer. The 
anticancer properties of cisplatin stem from the relative ease of substitution of the 
chlorine ligands with the nucleophilic species like nucleic acid bases of a DNA 
strand. Before cisplatin binds to such nucleophiles, it is usually converted to the 
active form by aquation. The conversion occurs intracellularly as the lower 
chloride concentrations permit it. The resulting electrophile can bind to a variety 
of macromolecules having nucleophilic groups, which include DNA. It is now 
widely accepted that DNA is the primary target of cisplatin. This function is 
believed to be the largest contribution to its cytotoxicity.4 
 
Cisplatin forms covalent bonds with nucleophilic sites on guanine present in all 
DNA. As cisplatin is a bifunctional agent, it is able to bind to two sites in a DNA 
strand. This results in the formation of inter- and intra- chain cross-linkings which 
interferes with cellular transcription and replication. Regulatory mechanisms 
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detect the abnormal DNA and so activate a chain of responses to try and correct 
it. This, ultimately, causes cell death (apoptosis).4 
 
Multiple hydrogen bonding has been found to be the driving force in the 
molecular recognition process in metal nucleobase complexes.5 The interaction 
of nucleic acid bases with metal cations has a strong effect on the structures and 
properties of nucleic acids. The replacement of the protons involved in hydrogen 
bonding between the nucleobases by the metal entities has led to the synthesis 
of the compounds which are relevant in biology and medicine.6-12 Novel 
molecular architectures for nucleobases and metal entities that include    
triplets,13-15 tetrads,11,12,16-19 hexagons,20,21 molecular boxes18,22 and self-
assembled nucleobase aggregates,23-25 have been synthesized that exploit the 
right angles formed by the metal-N(1) and metal-N(7) purine bases. Theoretical 
studies have been carried out at different levels to explore the effect of metals on 
the formation of nucleobase pairs and trimers.14,26-36 
 
The dimerization of Pt(II)-coordinated Guanine-Cytosine base pairs yields a 
metalated GCGC base tetrad.11,12 The crystal structure of this platinum-modified 
base tetrad reveals a unique multicenter hydrogen bonding pattern around 
guanine O(6) that is strongly affected by the presence of the platinum.12 The 
influence of the metals on the neighboring hydrogen bonds is crucial in building a 
stable molecular assembly from metal coordinated nucleobases. This compound 
contains an unprecedented hydrogen bonding pattern between deprotonated 
guanine and neutral cytosine that involves cytosine H(5) and guanine N(1). Such 
a hydrogen bonding pattern could be very important in DNA chemistry as it 
expands the possible hydrogen bonding patterns in DNA base pairing 
interactions. 
 
The tautomeric form of nucleobases determines their interactions with other 
nucleobases,37-40 and their ability to be incorporated into stable nucleic acid 
structures.37-41 Thus, the occurrence of spontaneous mutations in the DNA has 
been related to the presence of minor tautomers of the nucleobases. Minor 
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tautomeric forms have been found experimentally in DNAs containing modified 
nucleobases, such as isoguanosine,42 which exists in both enol and keto 
tautomeric forms, and N4-methoxycytosine, which is found in the mutagenic imino 
form in different DNA structures.43-46 Mutagenicity induced by the occurrence of 
minor tautomeric forms has also been investigated in halo derivatives of   
uracil.47-49 
 
Metal binding to a certain site of the heterocyclic nucleobase may cause a shift of 
a weakly acidic proton to another site, thereby generating a metal complex of a 
nucleobase tautomer structure normally present in a concentration too low to be 
detected experimentally. A series of such complexes with PtII and PtIV have been 
prepared, isolated and in some cases characterized by X-ray crystallography. 
The imino tautomers of cytosine and adenine have been found in model 
nucleobases in the presence of metals.3,50 
 
The existence of tautomeric equilibria in nucleobases under physiological 
conditions has many biotechnological applications. These molecules might 
display multiple recognition patterns depending on the complementary base. A 
direct biotechnological application of the relationship between tautomerism and 
recognition patterns is in the design of compounds which are able to stabilize 
anomalous forms of DNAs. 
 
The base-pair formation is neither prevented nor diminished when metal 
coordinates to a nucleobase donor atom remote from its hydrogen bonding site.51 
On the contrary, the base-pair formation is reinforced. Studies have established 
that G/C Watson-Crick pairing is strengthened due to the metallation either at N7 
of the guanine or N(1) of the cytosine.51 
 
These findings led to the pursuit of the idea of synthesizing the artificial 
oligonucleotide analogs that consist of a backbone of metal ions Pt2+ and bridging 
ligands.51 These cationic complexes are expected to show a high affinity towards 
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the polyanions DNA and RNA. Therefore, they might be useful as antigene52,53 
and antisense54,55 reagents.  
 
1.1 Antigene and Antisense Technology 
The majority of genes are expressed as the proteins they encode. The process 
occurs in two steps:  
• Transcription = DNA → RNA  
• Translation = RNA → protein 
The concept of antisense-mediated gene inhibition, first introduced by 
Stephenson and Zamecnik in 1978,54 has now emerged as a potentially powerful 
alternative to conventional cancer chemotherapy. The term "antisense" refers to 
the fact that the nucleic acid synthesized is complementary to the coding (i.e., 
"sense") genetic sequence of the target gene. 
 
The gene expression may be interrupted at either of the two stages. The first is 
transcription, the stage at which a gene's code is transferred to a messenger 
RNA (mRNA) that leaves the cell nucleus. One idea is to engineer an antisense 
strand which is capable of interacting with a specific strand of the DNA double 
helix, thereby creating a triplex (a triple-strand helix) within a gene or in one of its 
control elements. This in turn may prevent the gene's code from being read. 
Hence, this is known as antigene technology.52,53 
 
The other interruptible stage is translation, where the unpaired nucleotides of the 
mRNA are read by transfer RNA (tRNA) anticodons as the ribosome proceeds to 
encode the protein. If an antisense strand can hybridize with a specific mRNA, 
the resulting duplex may prevent translation. This is known as antisense 
technology.54,55 Antisense constructs hybridize in an antiparallel orientation to the 
sense mRNA through Watson-Crick base-pairing. This may occur because  
• the ribosome cannot gain access to the nucleotides in the mRNA or  
• duplex RNA is quickly degraded by ribonucleases in the cell 
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1.2 Aim of the Project 
Synthetic oligonucleotides have shown an immense promise and have been 
extremely useful in gene activation and repression strategies over the past 20 
years. However, several factors have limited their potential, namely the 
susceptibility to nuclease digestion. A modified oligonucleotide, peptide nucleic 
acid or PNA,56 was developed which displayed high affinity and specificity of 
binding to DNA and RNA and showed great resistance to both nucleases and 
proteases.57 
 
PNAs are nucleic acid analogs in which the phosphodiester backbone has been 
replaced with a polyamide backbone.56 The backbone contains no phosphate 
groups and hence, is not charged. Consequently, there is very little repulsion 
when the PNA hybridizes to its target nucleic acid sequence, leading to a more 
stable complex.57 A further increase in the affinity can be achieved by modifying 
the backbone in such a way that it is positively charged.58 It was indeed the case 
when the phosphodiester backbone was replaced with a guanidine residue.59-62  
 
Our ongoing research51,63,64 in this area is focused on the synthesis of artificial 
oligonucleotide analogs (Chart 2) that consist of a backbone of metal ions and  
 
 
                                 = nucleobase 
Chart 2  Schematic view of the strategy for the synthesis of cationic di- (n = 0), tri- (n = 1), 
and oligonucleotides (n ≥ 2) with a Pt2+ backbone. (Adopted from ref. 62) 
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bridging ligands, with the nucleobases bound to the metal centers either through 
N1 (unsubstituted pyrimidine bases), via N9 (unsubstituted purine bases) or N7 
(N9-substituted purine bases) sites. These cationic oligonucleotides are expected 
to be kinetically robust. Moreover, the nucleobases attached to the metal centers 
are forced in a more or less coplanar orientation and the hydrogen bonding 
properties are usually maintained. The cationic oligonucleotides can function as 
antisense54,55 and antigene52,53 reagents due to their ability to bind both DNA and 
RNA targets with high specificity and affinity. 
 
The ligands of choice for the present work were common and rare nucleobases 
such as isocytosine, guanine, 9-ethylguanine and 7-methylguanine. These 
ligands were studied with regard to the effects of metallation on hydrogen 
bonding properties and tautomerism. 
 
As it turned out, the planned fixation of a suitable metal entity to a particular site 
of a nucleobase or to a particular tautomer of a nucleobase in most cases is 
anything but trivial. Understanding factors which determine the reactivity of 
individual nucleobase tautomers toward metal species eventually proved to be 
essential. 
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2. Results and Discussions 
2.1 Complex Formation of Isocytosine Tautomers with PdII and 
PtII 
2.1.1 Introduction 
Isocytosine (ICH, 2-aminopyrimidin-4-(3H)-one) is a structural isomer of cytosine 
(C) and exists as two major tautomers (Chart 3), 1a and 1b. A third, minor 
tautomer (not shown) adopts an enol structure. 
 
 
Chart 3  Two tautomeric forms of ICH. 
Although not a natural nucleobase like cytosine, nucleosides of isocytosine have 
been reported to exhibit interesting pharmaceutical properties,65,66 and the C(5)-
glycosidic derivative pseudoisocytidine (ΨIC) has proven a valuable tool for 
molecular biology studies (Chart 4), e.g. for DNA triplex formation67 and 
mechanistic studies of RNA catalysis.68 
 
 
Chart 4  Cytosine and C(5)-glycosidic derivative pseudoisocytidine ΨIC. 
Moreover, the potential usefulness of isocytosine as a hydrogen bonding partner 
of the likewise non-natural isoguanine in oligonucleotides has been a point of 
interest.67,69-76 Our focus on isocytosine originates from its potential metal binding 
   12 Results and Discussions
properties and our general interest in metal complexes of ligands existing as 
different tautomers.77-81 Metal complex formation with isocytosine has previously 
been studied by other groups,82-85 and there are examples of X-ray structurally 
characterized metal compounds with O(4)84 or N(3)85 coordination. Various 
substituted isocytosine derivatives (substituents at N(1), N(2), C(5) positions) 
have likewise been studied.86 
 
2.1.2 Aim of the Project 
At the outset of our work, we were intrigued by the potential of isocytosine to form 
inert metal complexes of tautomer 1b, hence metal compounds with N(1) 
coordination. Brüning et al. have previously observed that with cytosine the minor 
tautomer could be complexed by metal ions to an extent that exceeded its 
occurrence in solution by far.77,78 Moreover, examples of both linkage isomers 
(metal at N(1) or N(3)) were isolated on a preparative scale and characterized by 
X-ray crystal structure analysis. In its deprotonated form, the isocytosine 
tautomer 1a provides, in principle, the ability of recognizing guanine nucleobases 
in a way different from that of cytosine (Chart 5), namely in a reversed 
Watson-Crick manner. 
 
Chart 5  Pairing patterns between guanine, cytosine, isocytosine, metalated cytosine and 
metalated isocytosine. 
Similarly, a N(1) metalated isocytosine anion can interact with guanine in this 
fashion, unlike N(1) metalated cytosinate, which pairs according to 
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Watson-Crick.51 These considerations can be extended to pairing motifs between 
cytosine and neutral, protonated, or metalated isocytosine (Chart 6) and 
contrasted with the situation in hemiprotonated cytosine pairs ("i-motif").87 
 
Chart 6  Pairing motifs between cytosine and neutral, protonated or hemiprotonated 
cytosine pairs. 
Our particular interest in this ligand was the metal binding behavior of tautomer 
1b and specifically the attachment of a PtII entity to the N(1) position. This way 
we wanted to generate platinated nucleobase analogs (Chart 7) which, when 
incorporated into a suitable backbone,51,88 might give rise to artificial, cationic 
oligonucleotide analogs with the ability to recognize natural nucleobases via 
hydrogen bond formation. 
 
 
Chart 7  N(1)-platinated forms of isocytosine (neutral ligand left; anionic ligand right). 
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2.1.3 Tautomerism of Isocytosine 
Isocytosine crystallizes in two tautomeric forms: 1,4-dihydro-2-amino-4-oxo-
pyrimidine (keto-N(1)H, 1a) and 3,4-dihydro-2-amino-4-oxo-pyrimidine 
(keto-N(3)H, 1b), in an exact 1:1 ratio.89,90 The tautomers are hydrogen bonded 
to each other in a manner similar to that of the guanine and cytosine pair in 
DNA.91 A number of electronic spectroscopic studies92-97 have been carried out to 
study the tautomerism of isocytosine. These studies reveal that the ratio of the 
two tautomers present in solution is solvent and temperature dependent. In 
ethanol and diethyl ether, keto-N(3)H form 1b predominates over keto-N(1)H 
form 1a, while in aqueous solution the two forms are present (Chart 8) in almost 
1:1 ratio.93,94,96 
 
 
Chart 8  Tautomerism of ICH in solution (1a, 1b) and hydrogen bonded adduct 1a – 1b in 
the solid state. 
Temperature-dependent solution studies94 indicate that in aqueous solution, with 
the rise in temperature, keto-N(1)H tautomer 1a becomes more stable as 
compared to keto-N(3)H tautomer 1b. Morita and Nagakura93 have also 
determined the energy differences and entropy changes between the two (keto-
N(1)H vs. keto-N(3)H) forms to be 1.3 kcal/mol and 4.7 cal/mol K, respectively, 
on the basis of the temperature-dependence of the absorption spectra of the 
molecules. 
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Several quantum-mechanical computational studies98-100 have been carried out 
on different tautomers of isocytosine. In the gas phase, the keto-N(3)H tautomer 
1b is more stable than the keto-N(1)H tautomer 1a. From the calculated and 
experimental data, it was found that in a solid argon matrix98 isocytosine is 
present as a mixture of both enol and keto-N(3)H 1b tautomeric forms with the 
enol form being dominant. 
 
Our calculations on two tautomers (keto-N(1)H and keto-N(3)H) in gas phase are 
in agreement with the calculations carried out earlier.98,99 The energy difference 
between keto-N(3)H form 1b and the keto-N(1)H form 1a using Lanl2dz and 
6-31+G* basis sets101-103 is -8.4 and -11.0 kcal/mol, respectively. 
 
2.1.4 Solution Studies of Isocytosine 
Brown and Teitei96 reported pKa values of 4.0 and 9.59, which were obtained by 
means of ultraviolet spectroscopy. In the course of the present work, pKa values 
of isocytosine were determined using pH dependent (Figure 1) 1H NMR 
spectroscopic measurements. The pKa for the protonated ICH2+ was found to be 
4.07 ± 0.01, and for the neutral ICH 9.47 ± 0.03. Chart 9 depicts the two 
acid-base equilibria. 
 
 
Figure 1  pD dependence (δ, ppm) of H5 and H6 resonances of ICH in D2O. 
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Chart 9  Acid-base equilibria 
Raman spectra of isocytosine were recorded in the solid state as well as in 
different solvent mixtures of DMF and H2O. For the solid isocytosine (Figure 2), in 
the spectral range 400 – 1700 cm-1, there was a series of characteristic twin 
bands104 due to complex ring bending (798 cm-1, 785 cm-1) and stretching modes 
of the ring (1232 cm-1, 1210 cm-1) for the two tautomers. The band at 798 cm-1 for 
the deformation mode can be assigned to the keto-N(1)H tautomer 1a of 
isocytosine [ref. section 2.2]. The band at 785 cm-1 is subsequently assigned to 
the keto-N(3)H tautomer 1b of isocytosine. 
 
 
Figure 2  A section of a solid state Raman spectrum of ICH. 
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Similarly, the band at 1232 cm-1 is assigned to the stretching mode of the keto-
N(1)H tautomer 1a of isocytosine and correspondingly, the other band at 
1210 cm-1 to the keto-N(3)H tautomer 1b. There are also twin bands at 791  cm-1 
and 787 cm-1 for isocytosine in pure DMF but there is only one band observed at 
1214 cm-1, which is strongly asymmetric, however. In water, there is a broad 
band at 791 cm-1 and another one at 1232 cm-1, which possibly is due to two 
species present, although there is no clear separation of individual peaks. As 
DMF is successively diluted with water, there is a shift to higher wavenumbers, 
i.e. from 789 cm-1 to 791 cm-1 and from 1214 cm-1 to 1232 cm-1, yet there is no 
separation of individual peaks as is the case for isocytosine in the solid state and 
in pure DMF. 
 
2.1.5 Reactions of (dien)PdII with Isocytosine 
In order to study the metal binding to isocytosine and to identify the various 
binding sites, the reactions were carried out on the NMR scale. 1:1, 1:3 and 3:1 
mixtures of isocytosine and [(dien)Pd(D2O)](NO3)2 were prepared and reactions 
were carried out without pH* adjustment at the start of the reaction. The samples 
were kept at 40 ˚C for few hours until no further changes were detected in the 
1H NMR spectra. A typical spectrum (Figure 3) consists of four sets of aromatic 
H5 and H6 resonances (doublets each, 3J ~ 6.7 – 7.3 Hz) sets. 
 
5.86.06.26.46.66.87.07.27.47.67.8
H6
H5
A
A
B
B
C CD
D
ppm  
Figure 3  1H NMR spectrum (D2O, pH* 4.0, isocytosine resonances only) of reaction mixture 
(1:1) of [(dien)Pd(D2O)]2+and isocytosine after few hours at 40 ˚C. Assignment 
of resonances (A)–(D) was made on the basis of their pD dependence. A, B, C, 
D are assigned to N(1), N(3), N(1)N(3) and free ICH, respectively. 
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Typically, 1:1 reaction mixtures were treated with acid and/or base over a wide 
pH* range and 1H NMR spectra were recorded. The four sets of resonances 
(A) - (D) were assigned based on pD dependent (Figures 4 and 5) 1H NMR 
spectroscopic measurements.  
 
Resonances (C) are due to the dinuclear species, [(dienPd)2(IC-N1,N3)]3+ as this 
set of resonances is insensitive to pD. An intense set of resonances (B) is 
assigned to the N(3) linkage isomer, [(dien)Pd(ICH-N3)]2+/[(dien)Pd(IC-N3)]+, 
pKa 6.50 ± 0.01, by comparison with the spectrum of the isolated compound, the 
structure of which has been established through X-ray crystallography (see 
below). The set of resonances furthest downfield (A) is assigned to the N(1) 
linkage isomer, [(dien)Pd(ICH-N1)]2+/[(dien)Pd(IC-N1)]+, pKa 6.20 ± 0.01. Finally, 
the set of resonances (D) belongs to free isocytosine, ICH2+/ICH, 
pKa 4.07 ± 0.01. 
 
 
 
Figure 4  pD dependence (δ, ppm) of H5 proton for [(dien)Pd(ICH-N1)]2+ (N1), [(dien)Pd(ICH-
N3)]2+ (N3), [(dienPd)2(IC-N1,N3)]3+ (N1,N3) and free isocytosine (ICH) in D2O. 
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Figure 5  pD dependence (δ, ppm) of H6 proton for [(dien)Pd(ICH-N1)]2+ (N1), [(dien)Pd(ICH-
N3)]2+ (N3), [(dienPd)2(IC-N1,N3)]3+ (N1,N3) and free isocytosine (ICH) in D2O. 
 
2.1.6 Characterization of [(dien)PdBr]Br (1) 
In order to study (dien)PdII binding to isocytosine, (1) was prepared analogously 
to [(dien)PtI]I.105 Yellow crystals were isolated and characterized by X-ray 
crystallography. A view of [(dien)PdBr]Br is given in Figure 6. 
 
 
Figure 6  View of [(dien)PdBr]Br (1) with atom numbering scheme. 
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Table 1  Selected distances (Å) and angles (º) for [(dien)PdBr]Br (1) 
[(dien)PdBr]Br (1) 
Pd(1)-Br(1) 2.4303(7) Pd(1)-N(2) 2.013(4) 
Pd(1)-N(1) 2.036(4) Pd(1)-N(3) 2.049(4) 
    
N(2)-Pd(1)-Br(1) 173.7(2) C(1)-N(1)-Pd(1) 108.1(4) 
N(1)-Pd(1)-Br(1) 96.37(2) C(3)-N(2)-Pd(1) 108.3(4) 
N(3)-Pd(1)-Br(1) 96.4(2) C(2)-N(2)-Pd(1) 108.2(3) 
N(2)-Pd(1)-N(3) 83.9(2) C(4)-N(3)-Pd(1) 108.5(3) 
N(1)-Pd(1)-N(3) 165.8(2)   
 
Selected bond lengths and angles for [(dien)PdBr]Br are given in Table 1. Bond 
distances and bond angles within the diethylenetriamine are normal and agree 
with the previously reported values. The Pd-N distances range from 
2.013(4) - 2.049(4) Å and are likewise normal. The dien ligand has a 
characteristic sting-ray geometry106 with the central methylene groups C(2) and 
C(3) of the dien ligand above the PdN3Br plane. Deviations of carbon atoms of 
the dien ligand from the least-squares planes formed by the PdN3Br plane are 
0.15(1) Å (C1), -0.40(1) Å (C2), -0.40(1) Å (C3) and 0.16(1) Å (C4). The bromide 
anion is involved in numerous hydrogen bonding interactions with the NH2 and 
NH groups of dien, N(1)-H···Br(2), 3.584(5) Å, N(1)-H···Br(2), 3.512(5) Å, N(3)-
H···Br(2), 3.509(4) Å, N(3)-H···Br(2), 3.482(4) Å and N(2)-H···Br(2), 3.373(4) Å. 
 
2.1.7 Characterization of [(dien)Pd(ICH-N3)](NO3)2 (2) 
The reaction of (dien)PdII with isocytosine was carried out on a preparative scale 
and the solution was kept for crystallization at room temperature. The yellow 
crystals were isolated and the characterization of the compound was achieved by 
X-ray analysis as well as IR, Raman and NMR spectroscopy. 1H NMR spectra 
were recorded in D2O and it was found that there was an immediate equilibration 
of the compound in solution to give four sets of resonances (A) – (D), (refer 
Figure 3) with set (B) dominating. 
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A view of the molecular cation of [(dien)Pd(ICH-N3)](NO3)2 (2) is given in 
Figure 7. Pd is bonded through the N(3) position of the isocytosine (Pd-N(3), 
2.029(3) Å). Distances and angles within the ICH ligand are not unusual. 
 
 
Figure 7  View of cation of [(dien)Pd(ICH-N3)](NO3)2 (2) with atom numbering scheme. 
Angles about the Pd deviate markedly from ideal square-planar (e.g. N(1e)-Pd-
N(2e), 84.8(2)˚; N(1e)-Pd-N(3e), 167.8(2)˚), as expected. The dien chelate 
adopts the characteristic sting-ray geometry106 with the methylene groups C(2e) 
and C(3e) above the PdN4 plane. The ICH plane forms an angle of 73.2(1)˚ with 
the Pd coordination plane. A comparison of the external angles at N(3) 
(Pd-N(3)-C(4), 114.5(3)˚; Pd-N(3)-C(2), 125.2(3)˚) shows these to be unequal. 
Consequently, O(4) is closer to Pd as compared to N(2). N(1)H, N(2)H2, and O(4) 
of the ICH ligand are involved in numerous hydrogen bonding interactions. For 
example, the proton at N(1) is “chelated” by two oxygen atoms of a nitrate anion, 
whereas the two protons of N(2) form hydrogen bonds to oxygens of two different 
nitrate anions. O(4), on the other hand, is bonded to a proton of the amino group 
N(3e) of the dien ligand. None of these contacts (2.9 – 3.1 Å) between heavy 
atoms is particularly short. 
 
2.1.8 Reactions of (dien)PtII with Isocytosine 
Analogous NMR scale reactions (Figure 8) were also performed with 
[(dien)Pt(D2O)](NO3)2 and isocytosine. The reaction conditions were similar 
except that the completion of the reactions took two days in the case of Pt. 
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Figure 8  1H NMR spectrum (D2O, pH* 1.3, isocytosine resonances only) of reaction mixture 
(1:1) of [(dien)Pt(D2O)]2+ and isocytosine after 2 days at 40 ˚C. Assignment of 
resonances (A’), (B’), (D’) was made on the basis of their pD dependence. A’, 
B’ and D’ are due to the N(1), N(3) and free ICH, respectively. 
Later, pD dependent 1H NMR spectroscopic measurements (Figures 9 and 10) 
were carried out. Depending on the pD of the solution, there were three or four 
sets of resonances observed. As explained above, resonances (A’) – (D’) were 
assigned on the basis of their pD dependence. The species distribution was 
similar to that in the (dien)PdII/ICH system. Relevant pKa values are 6.39 ± 0.03 
for [(dien)Pt(ICH-N3)]2+ and 5.97 ± 0.03 for [(dien)Pt(ICH-N1)]2+. 
 
Figure 9  pD dependence (δ, ppm) of H5 proton for [(dien)Pt(ICH-N1)]2+ (N1),  
          [(dien)Pt(ICH-N3)]2+ (N3), [(dienPt)2(IC-N1,N3)]3+ (N1,N3) and free 
isocytosine (ICH) in D2O. 
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Figure 10  pD dependence (δ, ppm) of H6 proton for [(dien)Pt(ICH-N1)]2+ (N1),  
        [(dien)Pt(ICH-N3)]2+ (N3), [(dienPt)2(IC-N1,N3)]3+ (N1,N3) and free 
isocytosine (ICH) in D2O. 
 
2.1.9 Characterization of [(dienM)2(IC-N1,N3)](ClO4)3 (M = PtII, 3 or PdII, 4) 
1:3 mixtures of isocytosine and [(dien)M(D2O)]2+ were kept at 40 ˚C for a few 
hours. Initially, a typical spectrum at pD 4.6 consisted of four sets of aromatic 
H(5) and H(6) isocytosine resonances (doublets each, 3J ~ 6.7 – 7.3 Hz). The 
most intense set of resonances was due to the N(3) linkage isomer and 
correspondingly, the other sets of resonances belonged to the free ligand, N(1) 
linkage isomer and N(1),N(3) dinuclear species. pD’s of the samples were 
subsequently adjusted to 7.6 and [(dien)M(D2O)]2+ solutions were successively 
added to the reaction mixtures. This was repeated until only a single set of 
resonances due to 3 or 4 was observed.  
 
Both 3 and 4 display 1H NMR resonances, which are insensitive to pD over a 
wide range. However, at pD 1.2, 4 decomposes in the solution to give ICH and 
(dien)PdII, whereas 3 is converted into [(dien)Pt(ICH-N1)]2+ (5a) 
(ref. section 2.1.10). 
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Views of the molecular cations 3 and 4 are shown in Figures 11 and 12. Selected 
bond lengths and angles for 3 and 4 are given in Table 2. Pd and Pt have the 
expected square-planar coordination geometries. 
 
 
Figure 11  View of cation of [(dienPt)2(IC-N1,N3)](ClO4)3 (3) with atom numbering scheme. 
 
Figure 12  View of cation of [(dienPd)2(IC-N1,N3)](ClO4)3 (4) with atom numbering scheme. 
As can be seen, metals are bonded through N(1) and N(3) positions of the IC; 
M(1)-N(1) has the distances ranging from 2.026(6) to 2.034(3) Å and M(2)-N(3) 
from 2.037(3) to 2.039(6) Å for Pd and Pt, respectively. Distances and angles 
within the IC ligand are not unusual.  
 
Angles about Pd and Pt deviate markedly from ideal square-planar (e.g. N(1a)-
M(1)-N(2a), 84.6(2) to 84.9(2)˚; N(1a)-M(1)-N(3a), 167.8(2) to 176.6(2)˚; N(1b)-
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M(2)-N(2b), 84.9(2) to 85.2(2)˚; N(1b)-M(2)-N(3b), 168.4(2) to 169.1(3)˚ for Pd 
and Pt, respectively). The M-N(dien) distances range from 1.999(4) Å in M(1)-
N(2a) or M(2)-N(2b) to 2.039(4) Å in M(1)-N(3a) or M(2)-N(3b), and are likewise 
normal. The dien ligands, "a" and "b", adopt the characteristic sting-ray 
geometries106 with the central methylene groups C(2) and C(3) of the two dien 
ligands pointing in the same direction, yet in opposite directions for "a" and "b". 
 
Deviations of carbon atoms of the two dien ligands from the least-squares planes 
formed by the PtN4 plane are -0.52(1) Å (C2a), -0.36(1) Å (C3a), -0.02(1) Å (C1a) 
and 0.29(1) Å (C4a) as well as 0.50(1) Å (C2b), 0.62(1) Å (C3b), -0.003(1) Å 
(C4b), and -0.15(1) Å (C1b). Thus, the two halves of the dien ligands undergo 
marked distortions from the case of a symmetrical distribution of the two carbon 
atoms of an ethylenediamine ring.106 
 
For the corresponding Pd compound, these values are rather similar. IC planes 
form angles of approximately 86˚ and 74˚ with the respective Pd(1)/Pt(1) and 
Pd(2)/Pt(2) coordination planes. The external angles at N(1) and N(3) (M(1)-N(1)-
C(6), 120-121˚; M(1)-N(1)-C(2), 120-122˚; M(2)-N(3)-C(4), 118-119˚; M(2)-N(3)-
C(2), 120-121˚) are quite similar. 
 
The water molecules, dien ligands, perchlorate anions, N(2)H2 and O(4) of the IC 
ligand are involved in numerous intramolecular and intermolecular short contacts. 
For example, the protons at N1(a/b), N2(a/b) and N3(a/b) of dien ligands are 
hydrogen bonded to various oxygen atoms of different perchlorate anions, water 
molecules and O(4) of the IC ligand, whereas the two protons of N(2) in IC form 
hydrogen bonds to oxygen of a perchlorate anion and a water molecule. 
 
A motif is also present in the solid structure, where O(4) of the IC ligand forms 
hydrogen bonds to protons at N(1) of dien ligands of two different molecules. 
None of these contacts (2.9 – 3.1 Å) between heavy atoms is particularly short. 
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Table 2  Selected distances (Å) and angles (º) for 3, 4 
 3 4 
M(1)···M(2) 5.90(2) 5.89(2) 
M(1)-N(1) 2.034(3) 2.026(6) 
M(1)-N(1a) 2.042(3) 2.039(5) 
M(1)-N(2a) 1.999(3) 2.006(8) 
M(1)-N(3a) 2.034(3) 2.033(5) 
M(2)-N(3) 2.037(3) 2.039(6) 
M(2)-N(1b) 2.032(3) 2.037(5) 
M(2)-N(2b) 1.999(4) 2.009(8) 
M(2)-N(3b) 2.048(3) 2.049(5) 
   
M(1)N4/ICHa 86.9(1) 86.2(2) 
M(2)N4/ICHa 74.6(1) 74.8(2) 
C(2)-N(1)-C(6) 116.6(4) 116.1(6) 
C(2)-N(3)-C(4) 120.3(4) 120.6(6) 
N(1)-C(2)-N(3) 123.9(3) 124.0(4) 
aDihedral angle between M coordination plane (M-N4) and IC 
 
2.1.10 Characterization of [(dien)Pt(ICH-N1)]2+ (5a) and [(dien)PtCl]+ (5b) 
In the course of these studies, it was noticed that in acidic medium the dinuclear 
complex 3 could be converted into the mononuclear complex [(dien)Pt(ICH-N1)]2+ 
(5a), which contains the desired tautomer 1b bonded to Pt via the N(1) position.  
 
The time course of the reaction was followed by 1H NMR spectroscopy. The 
stacked plot of the downfield regions in the 1H NMR spectra is shown in 
Figure 13. A small proton-deuterium coupling was also observed for the H5 
proton of isocytosine which undergoes a partial exchange with the 2D. 
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Figure 13  Stacked plot of the downfield regions in the 1H NMR spectra (200 MHz, D2O, 
pH* 1.0, isocytosine resonances only). The set of resonances A is due to 
[(dienPt)2(IC-N1,N3)]3+ and set B is assigned to the [(dien)Pt(ICH-N1)]2+ on the 
basis of their pD-dependent shifts. 
 
Unfortunately, our attempts to isolate 5a have failed so far. We propose that 
removal of the (dien)PtII entity from N(3) of 3 follows a way which Lippert et al. 
have shown to take place with N(3) platinated 1-methyluracil and 
1-methylthymine model nucleobases.107-109 According to it (Chart 10), protonation 
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of the exocyclic O(4) oxygen atom labilizes the Pt-N(3) bond to such an extent 
that it breaks. The enol tautomer formed initially converts then quickly into the 
oxo tautomer 5a. 
 
 
Chart 10  Proposed removal of the (dien)PtII entity from N(3) of 3. 
Crystallization during the course of the work described above yielded a sample 
suitable for X-ray analysis. Unfortunately, the analysis revealed the structure 5b 
(Figure 14) instead of 5a. Table 3 provides a few selected structural details of the 
compound 5b. 
 
Figure 14  View of cations of [(dien)PtCl]ClO4 (5b) with atom numbering scheme. 
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The geometry of the (dien)PtII entity is not unusual and compares well with the 
published data,106 including the deviations of angles at the Pt from 90˚. Out of the 
eight CH2 groups, the four central methylene groups C(2c) and C(3c), C(2d) and 
C(3d) are on the same side of the Pt(1)N4 and Pt(2)N4 planes, respectively. 
 
Bond distances and bond angles within the diethylenetriamine are normal and 
agree with the previously reported values. The molecular ions, [(dien)PtCl]+, are 
arranged in a head-tail orientation in the crystal such that the Cl groups can 
participate in various intermolecular and intramolecular hydrogen bonding 
interactions, viz. N(2c)-H···Cl(4), 3.27(2) Å, N(1c)-H···Cl(3), 3.35(2) Å and N(3d)-
H···Cl(4), 3.39(2) Å. The perchlorate anions form several hydrogen bonds to the 
dien-NH2 and dien-NH groups. None of these contacts (3.1 – 3.4 Å) between 
heavy atoms are particularly short. 
 
Table 3  Selected distances (Å) and angles (º) for [(dien)PtCl]ClO4 (5b) 
[(dien)PtCl]ClO4 (5b) 
Pt(1)-Cl(3) 2.301(4) Pt(2)-Cl(4) 2.307(4) 
Pt(1)-N(1c) 2.04(2) Pt(2)-N(1d) 2.03(2) 
Pt(1)-N(2c) 2.00(2) Pt(2)-N(2d) 2.01(2) 
Pt(1)-N(3c) 2.05(2) Pt(2)-N(3d) 2.05(2) 
    
Cl(3)-Pt(1)-N(1c) 95.5(3) Cl(4)-Pt(2)-N(1d) 95.4(4) 
Cl(3)-Pt(1)-N(2c) 179.4(4) Cl(4)-Pt(2)-N(2d) 177.4(4) 
Cl(3)-Pt(1)-N(3c) 95.3(3) Cl(4)-Pt(2)-N(3d) 96.0(3) 
N(1c)-Pt(1)-N(2c) 85.0(4) N(1d)-Pt(2)-N(2d) 83.3(5) 
N(1c)-Pt(1)-N(3c) 168.4(4) N(1d)-Pt(2)-N(3d) 167.6(5) 
N(2c)-Pt(1)-N(3c) 84.2(5) N(2d)-Pt(2)-N(3d) 84.2(5) 
 
2.1.11 Reactions of trans-(NH3)2PtII with Isocytosine 
In an attempt to obtain metal complexes containing the N(1) linkage isomers of 
isocytosine, several reactions at different ratios Pt:ICH (1:1; 1:3; 3:1 etc.) were 
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performed with trans-[(NH3)2Pt(D2O)2]2+ and isocytosine and followed by 1H NMR 
spectroscopy. 
 
Unfortunately, due to the large number of resonances (ca. 12 sets of doublets) it 
was not possible to interpret the complicated spectra (Figure 15) obtained after 
the reaction. However, it was clearly evident that there was always a 
predominance of N(3) linkage isomers (H5 resonances in the range 
5.6 - 6.2 ppm) over N(1) linkage isomers (H6 resonances, 7.4 – 8.2 ppm), if 
chemical shifts of the (dien)PtII linkage isomers were taken as a reference. 
 
6.006.507.007.508.00
H6
H5
ppm  
Figure 15  1H NMR spectrum (D2O, pH* 2.3, isocytosine resonances only) of reaction 
mixture (1:1) of trans-[(NH3)2Pt(D2O)2]2+ and isocytosine after two days at 
40 ˚C. 
2.1.12 Reactions of cis-(NH3)2PtII with Isocytosine 
Several reactions at different ratios Pt:ICH (1:1; 1:3; 3:1 etc.) were carried out 
with cis-[(NH3)2PtCl2] and isocytosine at room temperature and at 40 ˚C. The 
reactions were followed by 1H NMR spectroscopy. 
 
For the reactions performed at 40 ˚C, complicated spectra were obtained (ca. 10 
sets of doublets) which were difficult to interpret. In contrast, the 1H NMR spectra 
(Figure 16) for the reaction at room temperature, exhibited three sets of doublets. 
A set of resonances (C) was assigned to free isocytosine on the basis of the 
pD-dependence carried out earlier. The most intense set of resonances (B) was 
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assigned to N(3) linkage isomer (H5 resonances at 5.90 ppm; H6 resonances at 
7.49 ppm), if chemical shifts of the (dien)PtII linkage isomer were taken as a 
reference. Correspondingly, the set of resonances (A) might be due to N(1) 
linkage isomer (H5 resonances at 5.87 ppm; H6 resonances at 7.87 ppm). 
However, it was not possible to isolate and separate the different products. 
 
6.006.507.007.50
H6
H5
C
B
A
A
C
B
ppm  
Figure 16  1H NMR spectrum (D2O, pH* 5.3, isocytosine resonances only) of reaction mixture 
(3:1) of cis-[(NH3)2PtCl2] and isocytosine after five days at room temperature. The 
set of resonances A is assigned to N(1) linkage isomer, B is due to the N(3) 
linkage isomer and finally, C is the free ligand. 
 
2.1.13 Other Attempts to obtain N(1) Linkage Isomers 
Attempts to prepare and isolate N(1) linkage isomers of isocytosine using 
different metal species, such as K2PdCl4, K2PtCl4, cis-[(NH3)2Pt(1-MeC)Cl]Cl, 
trans-[(NH3)2Pt(1-MeC)Cl]Cl, trans-[(NH3)2Pt(9-RGH-N7)Cl]Cl and 
trans-[(NH3)2Pt(1-MeT)Cl] (with 1-MeC = 1-methylcytosine, 9-RGH = 9-methyl- or 
9-ethylguanine, 1-MeT = 1-methylthymine), or different solvents (ethanol, DMF, 
acetone) were likewise unsuccessful. It was found that there was always a 
predominance of N(3) linkage isomers over N(1) isomers. N(1) linkage isomers 
were formed only in small amounts. 
 
2.1.14 Theoretical Calculations 
Molecular geometries of a variety of compounds have been computed in an 
attempt to better understand the apparent preference of PtII and PdII electrophiles 
for the N(3) site of ICH. Figure 17 provides views of optimized structures of the 
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N(1) and N(3) linkage isomers of [(NH3)3Pt(ICH)]2+, trans-[(NH3)2PtCl(ICH)]+, and 
cis-[(NH3)2PtCl(ICH)]+.  
 
Figure 17  Optimized computed structures of N(1) and N(3) linkage isomers of 
[(NH3)3Pt(ICH)]2+, trans-[(NH3)2PtCl(ICH)]+ and cis-[(NH3)2PtCl(ICH)]+. 
 
Calculations of relative energies of N(1) and N(3) linkage isomers in the case of 
(NH3)3PtII reveal a preference of the PtII entity for N(3) (ΔE = 12.2 kcal/mol). The 
comparison between the two geometries shows that in the N(1) linkage isomer 
the heterocycle is perpendicular to the PtN4 plane. The lack of any hydrogen 
bonding between the two trans-positioned NH3 groups at the Pt and the exocyclic 
amino group of ICH and the inability of O(4) to interact with any of the other 
 33  Results and Discussions 
 
ligands of Pt is consistent with this finding. On the other hand, in the N(3) linkage 
isomer the isocytosine ring forms an angle of ca. 55˚ with the PtN4 plane due to 
the possibility of intramolecular hydrogen bonding between O(4) of ICH and one 
of the NH3 ligands of Pt (O···N, 2.79 Å). 
 
The computations furthermore suggest weak hydrogen bonding between a 
second NH3 and the exocyclic amino group N(2)H2 (N···N, 3.27 Å), which has 
undergone some pyramidalization. This finding is consistent with results of recent 
ab initio calculations which suggest that contrary to long-time beliefs that 
nucleobase-NH2 groups are perfectly planar, exocyclic amino groups can be 
partially sp3 hybridized110 with the ability to function as a hydrogen bonding 
acceptor in nucleic acid structures.111 
 
The situation with the two linkage isomers of trans-[(NH3)2PtCl(ICH)]+ closely 
parallels that of [(NH3)3Pt(ICH)]2+. In the N(1) linkage isomer, the ICH ring is 
perpendicular to the PtN3Cl plane, while it is tilted (56.9˚) in the case of the N(3) 
isomer. The energy difference is 4.2 kcal/mol, again with the N(3) linkage isomer 
being the more stable one.  
 
For the two isomers of cis-[(NH3)2PtCl(ICH)]+, the energy difference is 
6.9 kcal/mol, with the N(3) linkage isomer being again the more stable one. In 
both isomers, the ICH plane is tilted with respect to the PtN3Cl plane by 63.8˚ 
(N(1) isomer) and 55.7˚ (N(3) isomer). It appears that, at least with the N(1) 
isomer, weak hydrogen bonding between N(2)H2 of ICH and the Cl ligand is 
responsible for this feature.  
 
With the N(3) linkage isomer, in addition to such a possibility also hydrogen 
bonding between O(4) of ICH and one NH3 ligand (O···N, 2.75 Å) as well as the 
Cl and one NH3 ligand (Cl···N, 3.01 Å) is possible. It is to be noted that none of 
the intramolecular hydrogen bonds is to be considered particularly strong, simply 
because the angles at the acceptor (e.g. Cl) are not very favorable, e.g. Pt-Cl···H, 
62.8˚, in cis-[(NH3)2PtCl(ICH-N3)]+ (see, however, below). An interesting detail of 
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both isomers of cis-[(NH3)2PtCl(ICH-N3)]+ is the pyramidalization of the amino 
group of ICH, in that it is opposite to that seen in the trans-[(NH3)2PtCl(ICH-N3)]+ 
and [(NH3)3Pt(ICH-N3)]2+. It indeed strongly suggests that there is hydrogen 
bonding between N(2)H2 and Cl. 
 
Calculations were performed (Figure 18) on a series of bis(isocytosine) 
complexes of trans-(NH3)2PtII, which differed in their combinations of binding sites 
(linkage isomers) and their rotameric forms. 
 
 
Figure 18  Optimized computed structures of the three types of bis(isocytosine) 
complexes of trans-(NH3)2PtII with different rotamers. 
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As far as relative energies are concerned, the following picture emerged 
(Figure 19): (i) The head-head form of trans-[(NH3)2Pt(ICH-N1)2]2+ (Ia) is the least 
stable form, and the head-tail rotamer of trans-[(NH3)2Pt(ICH-N3)2]2+ (IIb) is the 
most stable one (ΔE = -35.9 kcal/mol). (ii) The head-tail rotamer (Ib) of 
trans-[(NH3)2Pt(ICH-N1)2]2+ is only slightly more stable than its head-head 
rotamer (-1 kcal/mol), while the second rotamer IIa (head-head) of 
trans-[(NH3)2Pt(ICH-N3)2]2+ is considerably less stable than its head-tail rotamer, 
albeit still the second most stable species (-17.7 kcal/mol). 
 
 
Figure 19  Relative energies of the six bis(isocytosine) complexes of trans-(NH3)2PtII shown 
in Figure 18. 
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There are two rotameric forms of the mixed complex trans-[(NH3)2Pt(ICH-
N3)(ICH-N1)]2+ with O(4) of (ICH-N3) either opposite to N(2)H2 of (ICH-N1) (IIIa) 
or with O(4) of (ICH-N3) opposite to H6 of (ICH-N1) (IIIb). The former is stabilized 
by 14 kcal/mol relative to the least stable form (Ia), and (IIIb) is more stable by 
11.8 kcal/mol.  
 
Taken together, these results again confirm the preference of trans-(NH3)2PtII for 
N(3) binding to ICH. With regard to the most stable compound, the head-tail 
rotamer IIb, it is reminiscent of the head-tail rotamer of trans-[(NH3)2Pt(cytosine-
N3)]2+ which is likewise more stable than its head-head form.27 Although 
internucleobase hydrogen bonding is not possible because of the large 
separation between opposite exocyclic O(4) and N(2)H2 groups, there is a 
possibility for hydrogen bonding between NH3 ligands and the O(4) groups (2.84 
Å), leading to a tilting of the bases with respect to the Pt coordination plane 
(56.9˚), very much as in the minimum energy structure of the bis(cytosine) 
compound (60˚).27 With N(1)-Pt coordination, no such hydrogen bonding is 
possible. 
 
As to the reasons for the preference of the N(3) site of ICH for Pt and Pd 
am(m)ine complexes, we considered a favorable orientation of the dipole 
moment of one of the two tautomers (1a, Chart 3) as a possible explanation, very 
much as previously considered for the preferential binding of metal ions to N(7) of 
guanine nucleobases.112,113 However, the results of these calculations (not 
shown) were inconsistent with the experimental findings and the energy 
calculations. 
 
NBO (Natural Bond Orbital)114-116 calculations were subsequently carried out 
which showed that in the N(3) linkage isomer of [(NH3)3Pt(ICH-N3)]2+ not only 
hydrogen bonds between the NH3 ligand and O(4) of ICH were formed but that in 
addition hydrogen bonding took place between a second NH3 ligand and the 
substantially pyramidalized exocyclic amino group of ICH. In fact, both hydrogen 
bonds stabilize the minimum structure in the same order of magnitude.  
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Table 4  Calculated energies (E), energy differences (ΔE), NBO delocalization energies 
(ΔΕdeloc) for the complex [(NH3)3Pt(ICH-N3)]2+ as a function of angle between 64˚ 
to 89˚. The total delocalization energies (ΔΕ(2)) in column 6 are obtained by 
summing up the single contributions ΔΕ(2) nO → o*NH and ΔΕ(2) nN → o*NH in 
columns 4 and 5. 
   ΔΕdeloc/kJmol-1 
Angle/˚ E/Hartrees ΔΕ/kJmol-1 ΔΕ(2) nO → o*NH ΔΕ(2) nN → o*NH ΔΕ(2) tot 
116 683.318595 0.0 15.19 16.90 32.09 
111 683.318436 0.4177 11.00 12.47 23.47 
106 683.317965 1.6549 7.45 8.91 16.36 
101 683.317352 3.2651 4.06 5.31 9.37 
96 683.316605 5.2272 - 2.34 2.34 
 
NBO delocalization energies ΔΕ(2) nO → o*NH and ΔΕ(2) nN → o*NH were obtained 
(Table 4) by starting out from the minimum structure and by varying the dihedral 
angle between the ICH plane and the PtN4 plane between 64˚ and 89˚. The 
decreasing delocalization energies (Figure 20) can be readily correlated to 
decreasing hydrogen bond strengths and decreasing total energies of the 
structures. 
 
 
Figure 20  Correlation between the total NBO delocalisation energies (ΔΕdeloc) and the 
energy differences for the complex [(NH3)3Pt(ICH-N3)]2+ as a function of angle 
between 64˚ to 89˚. The linear relation suggests that the complex 
[(NH3)3Pt(ICH-N3)]2+ is clearly stabilized by hydrogen bonding. 
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This suggests that the observed preference of the (NH3)3PtII entity for N(3) of ICH 
is primarily caused by favorable intramolecular hydrogen bonding. We assume 
that similar reasons apply to the other complexes. Interestingly, the degree of 
pyramidalization of the exocyclic amino group is largest when the ICH plane is 
substantially tilted with respect to the Pt plane, and lost once the heterocycle 
approaches a perpendicular orientation. We are aware that the inclusion of 
solvent molecules and the consideration of anions may modify the picture, yet the 
experimental findings in aqueous solution are consistent with the picture drawn 
on the basis of the NBO calculations.  
 
The molecular geometries of [(dien)Pd(ICH-N1)]2+, [(dien)Pd(ICH-N3)]2+, 
[(dien)Pt(ICH-N1)]2+, [(dien)Pt(ICH-N3)]2+, [(tmeda)Pt(ICH-N1)]2+ and 
[(tmeda)Pt(ICH-N3)]2+ have also been computed. The N(1) linkage isomers 
(Figure 21) of (dien)MII (M = PdII, PtII) are similar. 
 
 
Figure 21  Optimized computed structures of [(dien)Pd(ICH-N1)]2+ and [(dien)Pt(ICH-N1)]2+. 
The angle between the MN4 plane and the ICH plane is 64.2˚ (M = Pd) and 69.0˚ 
(M = Pt). It is possible only as a result of the intramolecular hydrogen bond, 
which is between the exocyclic amino group N(2)H2 of ICH and one of the two 
amino groups of the dien ligand. As can be seen, the ICH amino group has 
undergone some pyramidalization to be able to act as a H bond acceptor, but the 
hydrogen bond (N(2)H2···NH2(dien) 3.287 Å for Pd and 3.425 Å for Pt compound) 
is not to be considered particularly strong due to a somewhat unfavorable angle 
between the dien-NH2 donor and the acceptor. Nevertheless, this hydrogen bond 
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appears to be responsible for the differences in distortions of the two en halves of 
the dien ligands. Deviations of carbon atoms from the mean-squares planes in 
the Pd complex are -0.89 Å (C10) and -0.25 Å (C11), as opposed to -0.69 Å 
(C13) and -0.15 Å (C14). For the corresponding Pt compound, these values are 
rather similar. 
 
The N(3) linkage isomers (Figure 22) of (dien)MII are likewise very similar. The 
ICH plane is tilted by 58.5˚ (Pd) and 56.0˚ (Pt), respectively, relative to the MN4 
coordination plane. 
 
 
Figure 22  Optimized computed structures of [(dien)Pd(ICH-N3)]2+ and [(dien)Pt(ICH-N3)]2+. 
Both NH2 groups of the dien ligands are involved in hydrogen bond formation 
with O(4) as well as N(2)H2 of ICH. Hydrogen bond lengths are for 
O(4)-NH2(dien) 2.843 Å (Pd) and 2.826 Å (Pt), whereas those involving the 
N(2)H2 of ICH and dien-NH2 are 3.435 Å (Pd) and 3.336 Å (Pt). Again, the 
exocyclic NH2 group of ICH has undergone a marked pyramidalization. The dien 
puckers have the characteristic sting-ray geometries106 with the central 
methylene groups C(2) and C(3) above the MN4 plane. Deviations of carbon 
atoms from the mean-squares planes for the Pd complex are -0.11 Å (C10) and 
0.52 Å (C11), as opposed to 0.53 Å (C13) and -0.06 Å (C14). These deviations 
are comparable to those for the Pt complex. 
 
A comparison of the total energies of the ICH linkage isomers of (dien)MII reveals 
that both for Pd and Pt the N(3) isomers are lower in energy, by 15.97 kcal/mol 
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(Pd) and 15.87 kcal/mol (Pt). These energy differences are larger than those 
found for the linkage isomer complexes of (NH3)3PtII, where the N(3) site was 
preferred by ΔE = 12.2 kcal/mol. The N(3) isomer of (NH3)3PtII adopts a similar 
orientation (dihedral angle 55˚) as seen in [(dien)Pt(ICH-N3)]2+, with a normal 
hydrogen bond of 2.79 Å between NH3 of Pt and O(4) of ICH, and a long contact 
(3.27 Å) between NH3 of Pt and N(2)H2 of ICH. In contrast, in [(NH3)3Pt(ICH-
N1)]2+ the ICH is perpendicular to the PtN4 plane with no hydrogen bonding 
interactions between ICH and the two trans-positioned NH3 ligands at all, unlike 
in [(dien)Pt(ICH-N1)]2+ (see above). We conclude from this difference that the 
hydrogen bond between ICH-N(2)H2 and the dien-NH2 group must be very weak 
and that the preference for N(3) is aided by formation of the hydrogen bond 
involving O(4) of the N(3) linkage isomer. 
 
The calculated structures of the ICH linkage isomers (Figure 23) of 
N, N, N’, N’-tetramethylethylenediamineplatinum(II), (tmeda)PtII, reveal that, in 
neither isomer is there an involvement of any of the exocyclic groups of the ICH 
in intramolecular hydrogen bonding. 
 
 
Figure 23  Optimized computed structures of [(tmeda)Pt(ICH-N1)]2+ and  
[(tmeda)Pt(ICH-N3)]2+. 
The dihedral angles between the ICH and the PtN4 planes are 89.6˚ and 90.0˚ for 
N(1) and N(3) linkage isomers, respectively. Moreover, and consistent with this 
view, is the planarity of N(2)H2 group. The puckers of the two halves of the tmeda 
ligand are nevertheless somewhat distorted. Deviations of carbon atoms from the 
mean-squares plane for the N(1) linkage isomer are -0.92 Å (C26) and -0.46 Å 
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(C17), as opposed to -0.58 Å (C18) and 0.07 Å (C30) whereas, deviations of 
carbon atoms from the mean-squares plane for the N(3) linkage isomer are 
0.15 Å (C26) and -0.50 Å (C17), as opposed to -0.50 Å (C18) and 0.07 Å (C30). 
The energy difference between the two isomers is 11.56 kcal/mol in favor of the 
N(3) isomer. 
 
A comparison of all the three systems, hence of (NH3)3PtII, (dien)PtII, and 
(tmeda)PtII therefore suggests that the higher strength of the Pt-(ICH-N3) bond is 
the major determinating factor in the preference for binding, and that 
intramolecular hydrogen bonding involving O(4) in the N(3) isomer adds to the 
stability, while the contribution of N(2)H2 group to hydrogen bonding is small. 
 
Finally, calculations were also performed on dinuclear complexes 
(Figure 24 and 25) of (dien)MII, namely, [(dienPd)2(IC-N1,N3)]3+ and 
[(dienPt)2(IC-N1,N3)]3+. The structures of the two complexes were found to be 
very similar. 
 
Figure 24  Optimized structure of [(dienPt)2(IC-N1,N3)]3+ with atom numbering scheme. 
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Figure 25  Optimized structure of [(dienPd)2(IC-N1,N3)]3+ with atom numbering scheme. 
There is generally good agreement between the dinuclear compounds of 
(dien)PdII, (dien)PtII and the X-ray structures of 3 and 4, respectively. 
Discrepancies are probably a consequence of crystal packing forces and the 
presence of the counter anions in the solid state structures. 
 
For instance, in the calculated complex, the angle between the Pd(1)N4 plane 
and the isocytosine plane is 62.3˚, yet this angle is 86.9˚ in the solid state 
structure (see Table 2). Similarly, the angle between the Pt(2)N4 plane and the 
isocytosine plane is 63.3˚, which is much smaller than in the X-ray structure. The 
angle between the Pt(1)N4 plane and the isocytosine plane is 82.7˚ and the angle 
between the Pd(2)N4 plane and the isocytosine plane is 70.6˚ which are in the 
same range as in the X-ray characterized complexes 3 and 4, respectively. 
 
The M-N(dien) distances range from 2.07 Å in M(1)-N(2a) or M(2)-N(2b) to 
2.122 Å in M(2)-N(3a) or M(2)-N(3b), and are likewise normal. For Pd and Pt 
complexes, the dien ligands (“a” and “b”) bonded to N(1) and N(3) positions of 
isocytosine have different geometries.  
 
Deviations of carbon atoms of the dien ligand from the mean-squares plane 
formed by the M(1)N4 plane range from -0.11 to -0.30 Å (C1a), -0.65 to -1.04 Å 
(C2a), -0.24 to -0.80 Å (C3a) and -0.89 to -1.41 Å (C4a) and for M(2)N4 plane 
range from 0.30 Å (C1b), 0.81 to 0.87 Å (C2b), 0.34 to 0.39 Å (C3b), and 0.95 to 
1.0 Å (C4b). The angles and bond lengths of the isocytosine ring are normal.  
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The NH2 groups of the dien ligands are involved in hydrogen bond formation with 
O(4). Hydrogen bond lengths are for O(4)-NH2(dien) 2.871 Å (Pd) and 2.806 Å 
(Pt). Only in the case of the Pd complex is there a short contact between N(2)H2 
of isocytosine and (dien)-NH2 (3.341 Å). Again, the exocyclic NH2 group of 
isocytosine has undergone a slight pyramidalization. 
 
2.1.15 Summary 
Isocytosine (ICH) exists in solution as two major tautomers, the keto form with 
N(1) carrying a proton (1a) and the keto form with N(3) being protonated (1b). In 
water, 1a and 1b exist in equilibrium with almost equal amounts of both forms 
present. Reactions with a series of PdII and PtII am(m)ine species such as 
(dien)PdII, (dien)PtII, cis-(NH3)2PtII and trans-(NH3)2PtII reveal, however, a distinct 
preference of these metals for the N(3) site, as determined by 1H NMR 
spectroscopy. Individual species have been identified by the pD dependence of 
the ICH resonances. The pKa values (calculated for H2O) for deprotonation of the 
individual tautomer complexes are 6.5 and 6.4 for the N(3) linkage isomers of 
(dien)PdII and (dien)PtII, respectively, as well as 6.2 and 6.0 for the N(1) linkage 
isomers. With (dien)MII (M = Pt, Pd) preferential coordination of tautomer 1a, 
hence via the N(3) position, is observed.  
 
The crystal structure analysis of [(dien)Pd(ICH-N3)](NO3)2 2 is reported. With an 
excess of (dien)MII also dinuclear species [(dienM)2(IC-N1,N3)]3+ (M = PdII, and 
PtII) form, which were isolated as their ClO4– salts (3, 4) and structurally 
characterized. In strongly acidic medium [(dienPt)2(IC-N1,N3)]3+ is converted to 
[(dien)Pt(ICH-N1)]2+, hence to the PtII complex of tautomer 1b. 
 
Ab initio calculations have been performed for tautomer compounds of 
composition [(NH3)3Pt(ICH)]2+, cis- and trans-[(NH3)2PtCl(ICH)]+, as well as trans-
[(NH3)2Pt(ICH)2]2+. Without exception, N(3) linkage isomers are more stable, in 
agreement with experimental findings. As to the reasons of this binding 
preference, a NBO (Natural Bond Orbital) analysis for [(NH3)3Pt(ICH-N3)]2+ 
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strongly suggests that intramolecular hydrogen bonding between trans-positioned 
NH3 ligands and the two exocyclic groups of the ICH is of prime importance. 
DFT calculations, which were also extended to (tmeda)PtII linkage isomers 
suggest that intramolecular hydrogen bonding between the ICH tautomers and 
the co-ligands at M, while adding to the preference for N(3) coordination, is not 
the major determining factor. Rather it is the inherently stronger Pt-N(3) bond 
which favors complexation of 1a. The calculations furthermore show a marked 
pyramidalization of the NH2 group of ICH in the complex once the heterocyclic 
ligand forms a dihedral angle < 90˚ with the Pt coordination plane. 
 
2.1.16 Discussion 
Applying in particular late transition elements, Lippert et al. have demonstrated in 
a number of cases, that it is possible to isolate and study different metalated 
forms of tautomers. For example, of the unsubstituted nucleobase cytosine, both 
N(3) and N(1) linkage isomers of PtII have been isolated,77,78 very much as in the 
case of uracil anions,18 and with 1-methylcytosine both metal complexes of the 
dominant 4-aminooxo tautomer and the rare 4-iminooxo tautomer50,117 have been 
crystallized. In one case, even both forms coexist in a single PtII complex.118 
Similar examples exist for guanine119 and adenine nucleobases82,120-122 and the 
rare 4-hydroxo-2-oxo tautomer of 1-methyluracil has likewise been isolated as a 
metal-stabilized form.108 The topic of metal tautomer complex formation has 
recently also attracted the interest of theoretical and computational     
chemists,123-125 who clearly confirm the enormous influence metal coordination 
can have. Thus in the case of unsubstituted cytosine, Brüning et al. have 
detected a remarkable promotion of N(1) binding of am(m)ine containing PtII and 
PdII species in relationship to the tautomer distribution disfavoring the N(3)H 
tautomer by far.77,78 The low abundance of PtII and PdII complexes of isocytosine 
with N(1) coordination in solution and our failure to isolate such compounds, 
reflect the same principle; unfortunately to our disadvantage. Our efforts to 
accomplish N(1) coordination of ICH by changing the co-ligands at PtII to some 
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extent126 were likewise not successful. These findings are in qualitative 
agreement with the results of our computational studies which suggest an 
inherently stronger binding of ICH through N(3) for both PtII and PdII. 
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2.2 Isocytosine as a Hydrogen Bonding Partner 
2.2.1 Introduction 
ICH exists as two major tautomers, 1a and 1b which crystallize in a 1:1 ratio89 
(Chart 11) and form a hydrogen bonded adduct90 in the solid state. 
 
 
Chart 11  Two tautomeric forms of ICH in the solid state. 
Our particular interest in this ligand was the metal binding behavior of tautomer 
1b and specifically the attachment of a PtII entity to the N(1) position. As it turned 
out, tautomer 1a is more reactive toward metal ions, leading to preferential 
binding of PtII and PdII electrophiles via the N(3) position.  
 
We have examined the possibility of shifting the equilibrium between 1a and 1b 
by adding a co-hydrogen bonding partner, which exclusively interacts with one of 
the two tautomers. This aspect relates to the more general and in particular 
biologically relevant question of nucleobase tautomerism and mispairing leading 
to mutagenesis. 
 
2.2.2 Aim of the Project 
A number of temperature dependent solution studies94 have been carried out, 
which suggest that ICH exists in solution as a mixture of the two forms 1a and 
1b. However, these studies were not able to distinguish which tautomer 
predominates. It has also been observed that the electronic absorption      
spectra92-97 of ICH change on going from aqueous to nonaqueous solution. 
Therefore, it was postulated that this behavior of ICH might be dependent on the 
change of tautomeric ratio caused by the nature of solvent, the temperature and 
that ICH exists predominately as keto-N(3)H form 1b in ethanol and diethyl ether, 
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while in aqueous solution the two tautomers 1a and 1b coexist in comparable 
amounts. Certain bands in the Raman spectra of ICH also shift to higher 
wavenumbers, i.e. from 789 cm-1 to 791 cm-1 and from 1214 cm-1 to 1232 cm-1, 
as DMF is successively diluted with water, though there was no separation into 
individual peaks as is the case for isocytosine in the solid state and in pure DMF. 
 
In a similar way it has been demonstrated that 2’-deoxy-N(6)-methoxyadenosine 
(mo6A) can undergo amino-imino tautomerism, depending on the hydrogen 
bonding partner added,127,128 and detection of createnine by a designed receptor 
is accompanied by a change in tautomer structure of the receptor.129  
 
In more general terms, it is evident that tautomer equilibria are subject to 
changes in the presence of components capable of interacting with one of the 
two tautomers preferentially.130 Therefore, we were intrigued by the possibility of 
shifting the equilibrium between 1a and 1b by adding a co-hydrogen bonding 
partner, which exclusively interacts with one of the two tautomers. 
 
2.2.3 Characterization of 1b · (1-MeC) · 2H2O (6) 
As pointed out in the introduction (Chart 11), crystallization of ICH from water 
yields a 1:1 distribution of the two tautomers 1a and 1b, which is favorable as a 
consequence of complementary hydrogen bonding between the two tautomers. 
Cocrystallization of ICH with 1-methylcytosine (1-MeC) from H2O solution gave 
crystals of 1b · (1-MeC) · 2H2O (6). A view of the hydrogen-bonded pair is given 
in Figure 26. 
 
The two different heterocycles are readily distinguished due to the presence of a 
methyl group in 1-MeC. In the solid, the 1:1 triply hydrogen-bonded complex 
consists of neutral 1-MeC and ICH bases, bonded in a Watson-Crick fashion. 
ICH is present exclusively as its keto-N(3)H tautomer 1b. In addition to the 
unambiguous location and refinement of the proton at N(3) of ICH, the heavy 
atom geometrical parameters are in accord with this interpretation. 
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Figure 26  View of the hydrogen bonded pair ICH · (1-MeC) · 2H2O (6). ICH is present as 
tautomer 1b. The water molecules are omitted for clarity. 
The exclusive presence of 1b, among others, also firmly established by the large 
value of the endocyclic bond angle at N(3), C(2a)-N(3a)-C(4a), 122.1(2)˚. The 
bond length changes are minimal for 1-MeC131 and ICH.89 Structural details of 
the two heterocycles are listed in Table 5. 
 
Table 5  Selected distances (Å) and angles (º) for 1b · (1-MeC) · 2H2O (6) 
 ICH 1-MeC 
O(4)-C(4) 1.255(3) - 
O(2)-C(2) - 1.248(3) 
N(1)-C(2) 1.345(2) 1.395(3) 
N(1)-C(6) 1.355(3) 1.365(3) 
N(3)-C(2) 1.369(3) 1.352(3) 
N(3)-C(4) 1.379(3) 1.340(2) 
N(4)-C(4) - 1.332(3) 
C(5)-C(6) 1.351(3) 1.416(3) 
   
N(1)-C(2)-N(3) 122.8(2) 119.2(2) 
N(1)-C(6)-C(5) 126.3(2) 121.3(2) 
C(2)-N(1)-C(6) 120.9(2) 120.4(2) 
 49  Results and Discussions 
 
C(2)-N(3)-C(4) 122.1(2) 119.6(2) 
N(2)-C(2)-N(3) 116.7(2) - 
O(2)-C(2)-N(3) - 122.3(2) 
N(3)-C(4)-C(5) 115.5(2) 116.7(2) 
 
The isocytosine moiety and 1-MeC are nearly coplanar (deviation 3.6˚). The 
interbase hydrogen bonding is strong and nearly linear, viz. N(4b)-H···O(4a), 
1.94(2) Å, N(3a)-H···N(3b), 1.861(2) Å and N(2a)-H···O(2b), 1.85(2) Å, 
corresponding to distances of 2.882(3) Å, 2.894(3) Å, and 2.874(3) Å between 
the heavy atoms. In addition to this principal hydrogen bonding pattern, pairs of 
1b and 1-MeC are further linked by hydrogen bonds between N(4B)···O(2BA), 
2.893(3) Å and N(2A)···O(4AB), 2.904(3) Å to produce a tape structure 
(Figure 27). These hydrogen bonds are between identical molecules, hence, 
contacts are between 1-MeC molecules on one hand, and 1b molecules on the 
other. Tapes of 6 extend along the b-axis, with mean stacking distances of 3.50 Å 
and opposite directions between stacked tapes. Additional hydrogen bonding 
involving the water of crystallization also contributes to the overall crystal stability: 
O(2W)-H···O(4A), 2.996(3) Å and O(1W)-H···N(1A), 2.909(3) Å. In addition, there 
is a weak contact between C(6B)-H and O(1W) 3.623(3) Å. 
 
 
Figure 27  Pairs within 1b · (1-MeC) · H2O associate via additional hydrogen bonds to give 
an infinite tape structure. The water molecules are omitted for clarity. 
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A Raman spectrum of ICH · (1-MeC) · 2H2O was recorded in the solid state in the 
spectral range 400 – 1700 cm-1. There are characteristic bands present at 
774 cm-1 and 782 cm-1 as well as at 1264 cm-1 and 1217 cm-1 due to complex ring 
bending and stretching modes of 1-MeC and ICH. A comparison of Raman 
spectra of 1-MeC,132 ICH126 and compound ICH · (1-MeC) · 2H2O suggests that 
the band at 774 cm-1 is due to the ring deformation mode of 1-MeC, while the 
band at 782 cm-1 is assigned to a similar mode of the keto-N(3)H tautomer 1b of 
isocytosine. Similarly, the band at 1264 cm-1 is assigned to the stretching mode 
of 1-MeC and, correspondingly, the other band at 1217 cm-1 to the keto-N(3)H 
tautomer 1b.  
 
2.2.4 Complementary Hydrogen Bond Formation of 1a 
Although it is possible to postulate complementary hydrogen bond formation 
between the ICH tautomer 1a and a guanine nucleobase (Chart 12), we were 
unable to prove such a possibility. 
 
 
Chart 12  Feasible hydrogen bond formation between the Watson-Crick face of guanine 
and the O(4)N(3)N(2) face of tautomer 1a of ICH. 
Attempts to cocrystallize ICH and 9-methylguanine or guanosine did not yield 1:1 
adducts, possibly due to the low solubilities of the guanine components relative to 
ICH in water. However, even 1H NMR spectroscopy in DMSO-d6 did not provide 
any compelling evidence in favor of such a hydrogen bonding pattern. Although a 
concentration-dependence of 1:1 mixtures of ICH and guanosine could be 
obtained, albeit in a narrow concentration range only (10 – 70 mMol/L), the 
downfield shift of NH and NH2 resonances with increasing concentrations were 
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within the range found for self-association of the individual components 
guanosine133 and ICH (data not shown), hence in the order of 0.03 ppm for the 
concentration range mentioned. These 1H NMR studies were hampered by the 
fact that the DMSO-d6 samples were not free of water and contained between 2.5 
and 5 equiv of H2O per guanosine and ICH, with more diluted samples having a 
higher water content. Addition of molecular sieves, while reducing the water 
content and increasing the downfield shifts of the NH2 resonances clearly beyond 
those of self-pairing, at the same time led to coalescence of the two NH protons 
(broad resonance at 10.82 ppm, halfwidth ca. 180 Hz) due to exchange. Lippert 
et al. have observed this phenomenon before and believe that it is due to the 
partial hydrolysis of the zeolite and generation of OH–. 
 
2.2.5 Characterization of [1a · ICH2]NO3 (7) 
Eventually, the goal of selectively crystallizing the keto-N(1)H tautomer 1a was 
achieved in the presence of protonated isocytosine. [1a · ICH2]NO3 (7) was 
isolated as single crystals and studied by X-ray analysis. The structure of 7 
consists of two crystallographically independent entities (I, II) and two nitrate 
anions. Both heterocycles form pairs (Figure 28) with their own, symmetry related 
moieties. 
 
Figure 28  View of one (II) of the two crystallographically independent hydrogen bonded 
pairs present in [1a · ICH2]NO3 (7). Only one position of the disordered proton in 
the central hydrogen bond is shown. 
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This feature is reminiscent of that of [C · CH]2 · [ZnCl4] (C = unsubstituted 
cytosine, CH = cytosinium), where likewise two independent hydrogen bonded 
base pairs between cytosinium and cytosine are formed.134 Each pair is held 
together by three hydrogen bonds (Figure 28) between the respective O(4), N(3), 
and N(2) sites.  
 
The central proton, that between the two N(3) sites, is disordered over two 
positions, both of which have been detected in the electron density map. The 
large values of the endocyclic bond angles at N3(a/b), C2(a/b)-N3(a/b)-C4(a/b), 
ca. 122˚, and N1(a/b), C2(a/b)-N1(a/b)-C6(a/b), ca. 121˚, also indicate that the 
proton is disordered over the central hydrogen bond. Within the two pairs, the two 
isocytosine rings (Table 6) therefore cannot be differentiated into neutral and 
protonated form, and the geometries of the two rings are identical within standard 
deviations.  
 
Table 6  Selected distances (Å) and angles (º) for [1a · ICH2]NO3 and ICH (7) 
 [1a · ICH2]NO3 ICH89 
 a* b* 1a 1b 
O(4)-C(4) 1.237(2) 1.250(2) 1.248(3) 1.246(3) 
N(1)-C(6) 1.363(3) 1.358(3) 1.358(3) 1.350(3) 
N(1)-C(2) 1.345(2) 1.354(3) 1.357(3) 1.330(3) 
N(2)-C(2) 1.314(3) 1.310(3) 1.323(3) 1.324(3) 
N(3)-C(2) 1.342(3) 1.338(2) 1.333(3) 1.369(3) 
N(3)-C(4) 1.381(2) 1.374(3) 1.363(3) 1.375(3) 
C(4)-C(5) 1.437(3) 1.433(3) 1.438(3) 1.422(3) 
C(5)-C(6) 1.330(3) 1.333(3) 1.331(3) 1.356(3) 
     
N(1)-C(2)-N(3) 119.7(2) 119.5(2) 121.8(1) 121.9(1) 
N(1)-C(2)-N(2) 120.7(2) 119.9(2) 118.9(1) 120.3(1) 
N(1)-C(6)-C(5) 121.2(2) 120.9(2) 120.5(1) 125.9(1) 
C(2)-N(1)-C(6) 120.9(2) 121.1(2) 120.2(1) 115.9(1) 
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C(2)-N(3)-C(4) 122.1(2) 121.9(2) 119.4(1) 123.3(1) 
N(2)-C(2)-N(3) 119.6(2) 120.6(2) 119.3(1) 117.8(1) 
O(4)-C(4)-C(5) 123.5(2) 123.1(2) 122.0(1) 126.4(1) 
O(4)-C(4)-N(3) 119.8(2) 119.6(2) 119.3(1) 118.8(1) 
N(3)-C(4)-C(5) 116.7(2) 117.3(2) 118.7(1) 114.8(1) 
C(4)-C(5)-C(6) 119.3(2) 119.3(2) 119.1(1) 118.2(1) 
*Molecules a and b in hemiprotonated ICH. 
Thus, the situation is different from that for neutral isocytosine,89 where the two 
tautomers 1a and 1b are clearly identified on the basis of significant differences 
in a number of bond lengths and internal ring angles. Despite this disorder, there 
can be no doubt, however, that 7 represents the adduct between tautomer 1a 
and the isocytosinium cation (ICH2+). Regardless where the central proton is 
located, it will always generate a pair of 1a and ICH2+ (Chart 13). 
 
 
Chart 13  Hydrogen bonded adduct of 1a and ICH2+ as present in compound [1a · ICH2]NO3. 
H+ transfer does not alter the composition. 
Hydrogen bonding distances within the two crystallographically different pairs are 
(I) [N(3a)···N(3ab)], 2.842(2) Å and (II) [N(3b)···N(3ba)], 2.835(2) Å, (I) 
[N(2a)···O(4ab)], 2.834(2) Å, and (II) [N(2b)···O(4ba)], 3.022(3) Å. In 
hemiprotonated 1-methylcytosine compounds ([(1-MeC)2H]+X−),135-137 the central 
hydrogen bond compares well with that found in [1a · ICH2]NO3, but the outer 
hydrogen bonds (ca. 2.75 Å vs. 2.90 Å) differ markedly, as expected. The same 
should be expected for [1a · ICH2]NO3 in the absence of disorder. 
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Pairs I and II of 1a · ICH2+ are part of a ribbon structure (Figure 29) which forms 
as a consequence of additional hydrogen bonds between pairs I and II. Of pair I, 
C(5)H sites act as donors and O(4) sites as acceptors, whereas of pair II, N(2)H2 
groups act as donors and O(4) sites as acceptors. The four intermolecular 
hydrogen bonds between pairs I and II are then between C(5bb)H (I) and (O4ab) 
(II), 3.196(3) Å as well as O(4bb) (I) and N(2ac)H2 (II), 3.022(3) Å. The hydrogen 
bond between C(5)H and O(4) is reminiscent of similar hydrogen bonds found in 
recent years between nucleobases.138-140 
 
 
Figure 29  Association of the crystallographically independent pairs of I and II and the 
nitrate anions in [1a · ICH2]NO3. In both pairs of 1a and ICH2+ disordered 
protons have been fixed in the idealized positions in the central hydrogen 
bonds. 
As can be also seen from Figure 29, the nitrate anions of [1a · ICH2]NO3 are 
involved in hydrogen bonding as well. The shortest ones are those which involve 
N(1)H (N···O, 2.77(3) to 2.80(2) Å) or NH2 (N···O, 2.99(3) Å) sites. I and II as well 
NO3– form a tape structure with individual tapes forming stacks with ca. 3.3 Å 
stacking distances. There are additional weak short contacts between the nitrate 
oxygen atoms and aromatic hydrogen atoms, i.e. C(5)H···O, 3.507(3) Å and 
C(6)H···O, 3.507(3) Å. 
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2.2.6 Summary 
Isocytosine (ICH) 1 exists in solution in an equilibrium of tautomers 1a and 1b 
with the N(1) position and the N(3) position carrying the acidic proton, 
respectively. In the solid state, both tautomers coexist in a 1:1 ratio. As we show, 
the N(3)H tautomer 1b can selectively be crystallized in the presence of the 
model nucleobase 1-methylcytosine (1-MeC). In 1b · (1-MeC) · 2H2O 6 pairs with 
three hydrogen bonds between the components as well as H bonds between 
identical molecules are formed, leading to an infinite tape structure. On the other 
hand, the N(1)H tautomer 1a cocrystallizes with protonated ICH to give 
[1a · ICH2]NO3 7, again with three hydrogen bonds between the partners, yet the 
acidic proton disordered over the two entities. 
 
2.2.7 Discussion 
External factors are known to affect tautomer equilibria. Apart from factors such 
as aggregation state, solvent and temperature, the presence of hydrogen 
bonding partners or metal coordination can shift tautomer equilibria.127-130 Here, 
we have demonstrated that the two dominant tautomers of isocytosine, the N(1)H 
tautomer 1a and the N(3)H tautomer 1b can be individually crystallized in the 
presence of the isocytosinium cation and neutral 1-methylcytosine, respectively. 
In both compounds, the two partners are involved in triple hydrogen bond 
formation. 
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2.3 1-Methylisocytosine as a Ligand for (dien)MII (M = PtII, PdII) 
2.3.1 Introduction 
Isocytosine bears a structural relationship to the canonic bases (Chart 14) 
cytosine and guanine. Even though ICH is not involved directly as a carrier of the 
genetic code, it is of biological significance, and its medical applications are 
numerous.141 A variety of 2-aminopyrimidin-4-ones display anticancer, antiviral or 
antibacterial properties142-146 or are valuable agrochemicals.147 Platinum 
complexes of isocytosine and its derivatives have attracted considerable 
attention because of their antitumour activity.148  
 
There are a few examples of spectroscopically82-85,126 or crystallographically 
characterized metal complexes of isocytosine derivatives.84,85,126 In the course of 
our studies on isocytosine, we have also synthesized a methyl derivative of 
isocytosine. In the present work, we report the preparation and structural 
characterization of Pt(II) and Pd(II) complexes of 1-MeIC. 
 
 
Chart 14  IIustration of a structural relationship between isocytosine, cytosine and 
guanine. 
 
2.3.2 Aim of the Project 
We were particularly interested in synthesizing the metal complexes of 1-MeIC 
and to observe whether these cationic complexes undergo a significant amount 
of deamination to the corresponding complexes of 1-methyluracilate (1-MeU) 
under alkaline conditions or not. Šponer et al. have previously reported149 facile 
deamination of cytosine for the cationic complexes of 1-methylcytosine and 
1,5-dimethylcytosine (1,5-DiMeC).  
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2.3.3 Synthesis of 1-MeIC (8) 
The methylation of isocytosine (2-aminopyrimidin-4-(3H)-one) was carried out in 
an analogous manner as 1-MeC.150 The trimethylsilyl-protected isocytosine was 
treated with methyl iodide which resulted in methylation at N(1) and N(3). 
Cleavage of the protecting group (O–SiMe3) with 6M acetic acid (Chart 15) 
yielded two isomeric monomethyl derivatives, 1-MeIC and 3-MeIC. The crude 
product was washed with a large amount of water and redissolved in ethanol, 
kept at 4 ˚C for a day. White crystalline product precipitated out of the solution 
which was later purified over the sephadex G25 column with a yield of 60%. The 
product (1-MeIC) was identified by elemental analysis and single-crystal X-ray 
diffraction analysis of fully protonated 1-MeIC. The experimental procedure 
employed here was found to be suitable for preparation of larger quantities than 
those described in literature.151,152 
 
Chart 15  Strategy for the synthesis of 1-methylisocytosine. 
2.3.4 Solution Equilibrium of 1-MeIC 
The nucleobases predominantly exist in amino-oxo tautomeric forms. However, 
in the gas phase and in low-temperature matrices 9-methylguanine and 1-MeC 
also exist in the rare amino-hydroxy tautomeric forms.153 In earlier studies of the 
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IR spectrum of matrix-isolated 1-MeIC some weak bands were observed that 
could not be assigned to the amino-oxo tautomer.154 These bands have been 
assigned (Chart 16) to the imino-oxo tautomeric form of 1-MeIC. 
 
 
Chart 16  Amino-oxo (left) and imino-oxo (right) tautomeric forms of 1-MeIC. 
Brown and Teitei96 have reported pKa values for isocytosine and its derivatives by 
means of ultraviolet spectroscopy, though not for 1-MeIC. Neutral 1-MeIC can be 
protonated (pKa of the protonated 1-MeICH was found to be 4.02 ± 0.04). A 
second deprotonation step for the exocyclic amino group occurs only in strongly 
basic medium (pKa > 14). In the course of the present work, the pKa value of 
1-MeIC was also determined using pH dependent (Figure 30) 1H NMR 
spectroscopic measurements. The samples were treated with acid and/or base 
over a wide pD range and 1H NMR spectra were recorded. 
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Figure 30  pD dependence (δ, ppm) of H5 and H6 resonances of 1-MeIC in D2O. 
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2.3.5 Characterization of [1-MeICH]4(NO3)3(ClO4) (9) 
In order to study the tautomeric equilibria of isocytosine, an attempt was also 
made to isolate hemiprotonated 1-MeIC (ref. section 2.2). However, 
crystallization of 1-MeIC from H2O solution at pH* equal to its pKa value (4.0) 
gave crystals of fully protonated, [1-MeICH]4(NO3)3(ClO4) 9. A view of the 
hydrogen-bonded cations is given in Figure 31. 
 
 
Figure 31  View of the cations of [1-MeICH]4(NO3)3(ClO4) (9). A perchlorate and three nitrate 
anions have been omitted for clarity. 
The structure consists of four crystallographically independent bases (“a”, “b”, “c”, 
“d”), a disordered perchlorate and three nitrate anions. Within the four 
heterocycles, each of the two bases are linked via C(6)H and O(4) bond, viz. 
C(6a)···O(4b), 3.141(4) Å and C(6d)···O(4c) 3.107(5) Å between the rings “a” and 
“b” and “c” and “d”, respectively. In recent years, these C-H···O bonds have been 
well documented for the nucleobases.138-140 
 
The bases are further linked by additional hydrogen bonding interactions. In rings 
“a” and “b”, hydrogen bonding occurs between N(3b)-H···O(4a), 2.831(4) Å and 
N(2b)-H···O(4a), 2.796(4) Å. The rings “c” and “d” are associated by a 
C(5)-H···O(4) bond, C(5c)···O(4d), 3.034(4) Å. From ring “b”, the mean stacking 
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distances for the rings “c” and “d” are ca. 2.83 Å and 3.28 Å, respectively. The 
endocyclic bond angles at N(3), C(2a)-N(3a)-C(4a), 125.1(3)º, 
C(2b)-N(3b)-C(4b), 126.4(3)º, C(2c)-N(3c)-C(4c), 126.1(3)º and 
C(2d)-N(3d)-C(4d) 125.4(3)º, have large values due to the protonation. The 
protons at N(3) sites have been unambiguously located and refined. Structural 
details are listed in Table 7. 
 
Table 7  Selected distances (Å) and angles (º) for [1-MeICH]4(NO3)3(ClO4) (9) 
 [1-MeICH]4(NO3)3(ClO4)  (9) 
 A B C D 
O(4)-C(4) 1.230(4) 1.216(4) 1.213(4) 1.219(4) 
N(1)-C(6) 1.379(4) 1.386(5) 1.386(4) 1.379(5) 
N(1)-C(2) 1.350(4) 1.340(4) 1.352(4) 1.350(4) 
N(1)-C(1) 1.471(5) 1.471(5) 1.469(5) 1.470(5) 
N(2)-C(2) 1.308(4) 1.311(4) 1.307(4) 1.304(5) 
N(3)-C(2) 1.352(4) 1.350(4) 1.339(4) 1.350(4) 
N(3)-C(4) 1.383(4) 1.402(4) 1.401(4) 1.398(4) 
C(4)-C(5) 1.428(4) 1.444(5) 1.440(5) 1.438(6) 
C(5)-C(6) 1.333(5) 1.330(5) 1.330(5) 1.335(5) 
     
N(1)-C(2)-N(3) 118.2(3) 118.4(3) 118.2(3) 119.7(3) 
N(1)-C(2)-N(2) 122.4(3) 122.3(3) 121.5(3) 122.2(3) 
N(1)-C(6)-C(5) 122.4(3) 123.2(4) 122.6(3) 122.7(4) 
C(2)-N(1)-C(6) 119.6(3) 119.1(3) 119.5(3) 119.7(3) 
C(2)-N(3)-C(4) 125.1(3) 126.4(3) 126.1(3) 125.4(3) 
N(2)-C(2)-N(3) 119.4(3) 119.3(3) 120.3(3) 119.7(3) 
O(4)-C(4)-C(5) 126.5(3) 128.0(3) 127.0(3) 127.1(3) 
O(4)-C(4)-N(3) 118.9(3) 119.5(3) 119.7(3) 119.3(3) 
N(3)-C(4)-C(5) 114.6(3) 112.5(3) 113.3(3) 113.6(3) 
C(4)-C(5)-C(6) 120.0(3) 120.3(3) 120.3(3) 120.1(3) 
 
 61  Results and Discussions 
 
Within the crystal, the bases are packed in a ladder like form (Figure 32) where 
the bases resemble the rungs of the ladder. Hydrogen bonding by the anions 
also contributes to the crystal stability. The nitrate anions form a number of 
hydrogen bonds, N(2a)-H···O, 2.867(3) Å, N(2d)-H···O, 2.881(5) Å, N(2d)-H···O, 
2.916(4) Å, N(2d)-H···O, 2.943(4) Å, N(2c)-H···O, 2.998(4) Å and N(3a)-H···O, 
2.737(3) Å. The perchlorate anion is hydrogen bonded to N(3c)-H···O, 2.860(4) Å 
and N(2c)-H···O, 2.998(4) Å. 
 
 
Figure 32  View of the hydrogen bonded bases in [1-MeICH]4(NO3)3(ClO4) (9). The anions 
are also involved in hydrogen bonding (not shown for clarity). 
2.3.6 (dien)Pt2+ and 1-MeIC 
1:1 mixtures of 1-MeIC and [(dien)Pt(D2O)]2+ were kept at 40 ˚C for two days. The 
reaction was carried out without adjustment of pD. Initially, a typical spectrum 
(Figure 33) at pD 3.0 consisted of two sets of aromatic H(5) and H(6) 1-MeIC 
resonances (doublets each, 3J ~ 7.6 – 7.9 Hz). The set of resonances was 
assigned to the N(3) linkage isomer, by comparison with the spectra of the 
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isolated compound (H5 resonances at 5.9 ppm; H6 resonances at 7.5 ppm). 
Furthermore, poorly resolved 195Pt satellites were also present for the H5 proton. 
The coupling constant is 3JPt-H ~ 18.4 Hz. 
 
5.506.006.507.00
H6
H5
ppm
**
H5
Pt satellites
195
Pt satellites
195
 
Figure 33  Section of 1H NMR spectrum (D2O, pH* 3.0, 1-MeIC resonances only) of reaction 
mixture (1:1) [(dien)Pt(D2O)]2+ and 1-MeIC after 2 days at 40 °C. The set of 
resonances has been assigned to the N(3) linkage isomer. An enlarged view of 
H5 proton is also shown and the 195Pt satellites are indicated. 
2.3.7 (dien)Pd2+ and 1-MeIC 
Similar reactions (Figure 34) were also performed with [(dien)Pd(D2O)]2+. For 
Pd(II) reaction kinetics were faster155,156 than the corresponding Pt(II) species. 
Consequently, the reaction was complete in a few hours as compared to two 
days for the Pt(II) species. 
 
6.006.507.007.50
B
C
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C
B
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ppm  
Figure 34  1-MeIC resonances of the sample obtained by reacting (1:1; pH* 1.8) mixtures of 
[(dien)Pd(D2O)]2+ and 1-MeIC in D2O after a few hours at 40 °C. The set of 
resonances A is due to the N(3) linkage isomer, B is assigned to the free 
ligand and C might be due to the migration of PdII entity from N(3) to N(4) 
position. 
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The set of resonances (A) was assigned to N(3) linkage isomer by comparison 
with the spectra of the isolated compound. The chemical shifts of doublets (B) 
were those of free 1-MeIC. The species distribution (Table 8) was similar to that 
in (dien)PtII/1-MeIC system. However, a major difference with the (dien)PtII 
species discussed above is that even at low pD (e.g. pD 2.2) a low intensity set 
of resonances (C) is present. 
 
Table 8  1H NMR chemical shifts (ppm) and 3J values (Hz) of 1-MeIC H5 and H6 doublets 
(D2O, pH* 2.0) of [(dien)Pd(1-MeIC-N3)]2+ (A), (1-MeIC)/(1-MeICH)+ (B), and 
[(dien)Pd(1-MeIC-N4)]2+ (C). 
 H5 H6 3J (H5, H6) 
A 5.89 7.49 7.6 
B 6.07 7.65 7.9 
C 5.93 7.50 7.6 
 
The set of resonances (C) might be due to the migration of (dien)PdII from N(3) to 
N(4). The migration of (dien)PtII has been observed for the 1-MeC system.157 The 
major difference between the two systems is that the signals for the migration 
product are significantly downfield in the 1-MeC. In the 1-MeC system, the 
migration brings the (dien)PtII in the vicinity of H5 proton which results in a 
significant downfield shift. However, in the 1-MeIC system, the metal is far-away 
from the H5 proton to cause any significant downfield shift. This observation is in 
accordance with an earlier report on the kinetics of the (dien)PdII for the cytidine 
system.158 
 
2.3.8 X-ray Crystallographic Studies of 1-MeIC Complexes with (dien)Pd2+ 
(10) and (dien)Pt2+ (11) 
Preparative work with (dien)M2+ (M = Pd or Pt) has yielded complexes of 1-MeIC, 
all of which contain the 1-MeIC base bonded to the metal via N(3). X-ray crystal 
structures (Figures 35 and 36) were obtained for [(dien)Pd(1-MeIC-N3)](ClO4)2 
(10) and [(dien)Pt(1-MeIC-N3)](ClO4)2 (11). The cations of 10 and 11 are rather 
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similar. Selected bond distances and angles of these compounds are listed in 
Table 9. 
 
 
Figure 35  View of the cation of [(dien)Pd(1-MeIC-N3)](ClO4)2 (10) with atom numbering 
scheme. 
 
Figure 36  View of the cation of [(dien)Pt(1-MeIC-N3)](ClO4)2 (11) with atom numbering 
scheme. 
The 1-MeIC plane forms an angle of 73.9˚ and 75.7˚ with Pd and Pt coordination 
planes, respectively. The geometry of the (dien)M2+ (M = Pd or Pt) is not unusual 
and compares well with the published data,106,159,160 including the deviation of 
angles at the metal from 90˚. The distances from the metal (M = Pd or Pt) to the 
central nitrogen atom for the dien ligand are shorter than the distances to the 
peripheral nitrogen atoms. This might be an effect of the 1-MeIC ligand and/or 
the size of the metal atom being incompatible with the linear N(1D)-M-N(3D) 
arrays. Of the four CH2 groups of the dien ligand, the two central ones C(2D) and 
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C(3D) are pointing on the same side of the PdN4 plane, deviations from the PdN4 
plane being 0.20(1) Å C(2D) and 0.35(1) Å C(3D). 
 
Table 9  Selected distances (Å) and angles (º) for [(dien)M(1-MeIC-N3)](ClO4)2 (M = Pd (10) 
and Pt (11)) 
 10  11 
Pd(1)-N(3) 2.036(5) Pt(1)-N(3) 2.045(9) 
Pd(1)-N(1D) 2.026(7) Pt(1)-N(1D) 2.03(2) 
Pd(1)-N(2D) 1.991(8) Pt(1)-N(2D) 1.98(2) 
Pd(1)-N(3D) 2.055(7) Pt(1)-N(3D) 2.05(2) 
N(1D)-Pd(1)-N(2D) 85.7(3) N(1D)-Pt(1)-N(2D) 82.6(5) 
N(1D)-Pd(1)-N(3D) 169.1(3) N(1D)-Pt(1)-N(3D) 166.7(4) 
N(2D)-Pd(1)-N(3D) 84.4(3) N(2D)-Pt(1)-N(3D) 85.9(5) 
N(1D)-Pd(1)-N(3) 95.1(2) N(1D)-Pt(1)-N(3) 96.1(4) 
N(2D)-Pd(1)-N(3) 175.8(3) N(2D)-Pt(1)-N(3) 176.0(4) 
N(3)-Pd(1)-N(3D) 95.1(3) N(3)-Pt(1)-N(3D) 95.8(4) 
Pd(1)-N(3)-C(4) 114.8(5) Pt(1)-N(3)-C(4) 116.4(8) 
Pd(1)-N(3)-C(2) 123.3(4) Pt(1)-N(3)-C(4) 123.1(7) 
N(1)-C(2)-N(3) 121.0(6) N(1)-C(2)-N(3) 123.0(1) 
C(2)-N(3)–C(4) 121.7(6) C(2)-N(3)–C(4) 121.0(2) 
 
In contrast to 10, the two central methylene groups, C(2D) and C(3D), in 11 are 
pointing to the opposite side of the PtN4 plane, deviations from the PtN4 plane 
being -0.53(1) Å C(2D) and -0.46(1) Å C(3D). The external angles at N(3) (M(1)-
N(3)-C(4), 114.8(5)˚ Pd and 116.4(8)˚ Pt; M(1)-N(3)-C(2), 123.3(4)˚ Pd and 
123.1(7)˚ Pt) are not equal. Hence, O(4) is closer to M(1) as compared to N(2). 
Distances and angles within the 1-MeIC ligand are not unusual. The crystal 
packing is similar for 10 and 11. The perchlorate anions are involved in numerous 
hydrogen bonding interactions to the dien, O(4) and N(2)H2 groups of 1-MeIC. 
Additionally, there are a few short contacts between the perchlorate anions and 
the methylene groups of the dien ligand. 
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2.3.9 Theoretical Calculations 
Molecular geometries of [(dien)M(1-MeIC-N3)]2+ (M = Pt or Pd) complexes have 
also been computed in order to get an insight into the gas phase structures of 
these complexes. The views of the optimized structures of the N(3) linkage 
isomers of [(dien)M(1-MeIC)]2+ (M = Pt and Pd) are given in Figure 37. 
 
 
Figure 37  Optimized computed structures of N(3) isomers of [(dien)M(1-MeIC)]2+ 
(M = Pt and Pd) with atom numbering schemes. 
The two N(3) linkage isomers of (dien)MII are very similar. The 1-MeIC plane is 
tilted by 58.3˚ (Pd) and 54.9˚ (Pt) relative to the MN4 coordination plane. This is in 
sharp contrast to the angles obtained between the MN4 coordination and 1-MeIC 
for the X-ray characterized compounds 10 and 11, viz. 73.9˚ (Pd) and 75.7˚ (Pt). 
This discrepancy might be explained if we take into account the presence of 
counter anions as well as crystal packing forces in the solid state structures. Both 
NH2 groups of the dien ligands are involved in hydrogen bond formation with O(4) 
as well as N(2)H2 of 1-MeIC. Though, the latter is rather weak.  
 
Hydrogen bond lengths are for O(4)···NH2(dien), 2.829 Å (Pd) and 2.808 Å (Pt) 
whereas, those involving the N(2)H2 of 1-MeIC and dien-NH2 are 3.456 Å (Pd) 
and 3.344 Å (Pt). The exocyclic NH2 group of 1-MeIC has also undergone 
pyramidalization.110,111,126 In the dien puckers, the central methylene groups 
C(11) and C(13) are below the MN4 plane. Deviations of carbon atoms from the 
mean-squares planes for the Pd complex are 0.06 Å (C10) and -0.54 Å (C11), as 
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opposed to -0.52 Å (C13) and 0.12 Å (C14). These deviations are comparable to 
those for the Pt complex. The M(1)-N(dien) distances range from 2.06 Å in 
M(1)-N(2D) Å to 2.08 – 2.12 Å in M(1)-N(1D) or M(1)-N(3D), and are likewise 
normal. The external angles at N(3), (M(1)-N(3)-C(4) and M(1)-N(3)-C(2) are 
119.0˚ and are equal. Thus, O(4) is at the same distance to M(1) as N(2). The 
distances and angles within the 1-MeIC ring have normal values.  
 
2.3.10 Deamination of [(dien)Pt(1-MeIC-N3)]2+ 
Deamination reactions of N(3) platinated 1-MeIC were carried out essentially in a 
similar manner described by Šponer et al.149 The starting compound, [(dien)Pt(1-
MeIC-N3)]2+, was dissolved in D2O, pD of the sample was adjusted to 12.7 and 
the reaction was followed at ambient temperature over time by 1H NMR 
spectroscopy. A typical 1H NMR spectrum (Figure 38) obtained after five days, 
pD 12.3 consisted of two intense sets of resonances, A’’ and B’’. 
 
ppm 5.506.006.507.007.50
B’’
B’’A’’
A’’
H6 H5
 
Figure 38  Lowfield section of 1H NMR spectrum (D2O, pD 12.3) of [(dien)Pt(1-MeIC-N3)]2+ 
after 5 days. The set of resonances A’’ is due to [(dien)Pt(1-MeIC-N3)]2+ and B’’ 
is assigned to the deamination product [(dien)Pt(1-MeU-N3)]2+. 
Signal set A’’ was due to the starting compound, [(dien)Pt(1-MeIC-N3)]2+ and 
correspondingly, the set of resonances B’’ was assigned to the deamination 
product, [(dien)Pt(1-MeU-N3)]2+, by comparison with a sample obtained from a 
reaction between [(dien)Pt(D2O)]2+ and 1-MeU. 
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2.3.11 Summary 
1-MeIC was synthesized and the pKa value (calculated for H2O) was found to be 
4.02. 1-MeICH+ 9 was isolated and characterized by X-ray crystallography. 
Reactions with (dien)PdII and (dien)PtII were carried out and the crystal structure 
analyses of [(dien)Pd(1-MeIC-N3)](ClO4)2 10 and [(dien)Pt(1-MeIC-N3)](ClO4)2 
11 are reported. Under alkaline conditions, [(dien)Pt(1-MeIC-N3)]2+ undergoes a 
significant amount of deamination to give [(dien)Pt(1-MeU-N3)]2+. 
 
Ab initio calculations have been performed for [(dien)Pd(1-MeIC-N3)]2+ and 
[(dien)Pt(1-MeIC-N3)]2+. The calculations show pyramidalization of the NH2 group 
of 1-MeIC in the complexes when the heterocyclic ligand forms a dihedral 
angle < 90˚ with the Pt and Pd coordination planes. 
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2.4 PtII Complexes of Unsubstituted Guanine 
2.4.1 Introduction 
Guanine (Chart 17) is one of the four main nucleobases present in nucleic acids 
(e.g., DNA and RNA). It is also found in the scales of certain fish, the guano of 
sea-birds, and the liver and pancreas of mammals.161,162 Among vertebrate 
species, the range in guanine content in DNA is quite narrow, 20 – 22%. RNA is 
generally richer in guanine than DNA, the guanine content of transfer and 
ribosomal RNA isolated from a variety of sources varies from about 26 to 34%.163 
 
Chart 17  Schematic representation of guanine. 
 
2.4.1.1 Tautomerism and Acidity 
Of the common nucleic acid components, guanine has the largest number of 
possible tautomeric forms (oxo-hydroxy, amino-imino, N(1)H-N(3)H, N(7)H-
N(9)H).163 Many theoretical studies have been carried out to study tautomeric 
equilibria of guanine and calculations mostly show the existence of four low-
energy tautomers (amino-oxo and amino-hydroxy) with the amino-oxo form 
having hydrogen at N(7) as their most stable gas-phase tautomer.164-168 The 
imino tautomers are shown to be energetically less stable.169 Experimental 
results are in agreement with the theoretical data. 
 
Recently, four tautomeric forms of guanine were detected in the gas phase.170,171 
Additionally, the other tautomeric forms are also present. However, their energies 
as well as the free energies are considerably higher. In the solid state, guanine is 
(Chart 18) protonated at N(1) and N(9) positions.172 However, in solution a 
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tautomeric equilibrium exists with the proton distribution between N(7) and N(9) 
positions.163  
 
 
Chart 18  The two preferred tautomeric forms of guanine. 
The pKa values163 for a number of guanine derivatives are summarized in 
Table 10. The pK1 value is for the protonation of guanine either at O(6) or N(3), 
pK2 is for the deprotonation taking place at N(7) or N(9) positions. Finally, pK3 is 
for the deprotonation of N(1) position. 
 
Table 10  pKa values of guanine derivatives 
Compound pK1 pK2 pK3 
Guanine173 3.0 9.3 12.3 
1-Methylguanine173 3.1 10.5 - 
7-Methylguanine173 3.5 10.0 - 
9-Methylguanine174 2.9 9.8 - 
7,9-Dimethylguanine173 7.2 - - 
 
2.4.2 Aim of the Project 
In recent years, interactions between the transition metals and nucleic acids or 
their constituent bases have been a subject of considerable research. Many 
studies of metal ion interactions with nucleic acids or their constituent bases have 
been complicated by the availability of numerous metal binding sites. Various 
spectroscopic (IR, visible)175,176 and physical methods177 have been employed in 
order to determine the metal binding site(s). 
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The present study was undertaken with the objective of synthesizing (dien)PtII 
complexes of unsubstituted guanine in which the metal binding site(s) could be 
unequivocally established and to investigate the physical properties of these 
complexes which might be useful in assigning the metal binding sites. In 
particular, we wanted to synthesize the metal complexes of guanine with the PtII 
entity attached to the N(9) position. This way we would like to generate platinated 
nucleobase analogs (Chart 19) which, when incorporated into a suitable 
backbone,51,88 might give rise to artificial, cationic oligonucleotide analogs with 
the ability to recognize natural nucleobases via hydrogen bond formation.  
 
 
Chart 19  N(9) platinated form of guanine. 
Metal complex formation with guanine has previously been studied by other 
groups.178-181 For GH2+, there are examples of X-ray characterized Zn182 or Cu183 
compounds with N(9) coordination. 
 
2.4.3 1:1 Complexes of (dien)PtII and Guanine  
The reaction of (dien)PtII with guanine was performed on a preparative scale. 1:1 
mixtures of guanine and [(dien)Pt(H2O)]2+ were stirred at 40 ˚C for a few hours. 
Excess guanine was removed by filtration, the solution was rotary-evaporated to 
dryness and a 1H NMR spectrum of the yellow solid was obtained in D2O. 
 
A typical spectrum (Figure 39) in D2O at pD 7.0, consists of two major aromatic 
H(8) guanine resonances (singlets each). The most intense signal (A) with 
platinum satellites (3JPt-H ~ 20.4 Hz) is due to the N(9) linkage isomer and the 
other resonance (B) was assigned to the N(7),N(9) dinuclear species. The 
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assignment was done by comparison with the spectra of the isolated compounds, 
the structures of which have been established by X-ray crystallography. 
Additionally, there were two minor signals due to the formation of some side 
products. However, it was not possible to identify these side products. 
 
3.04.05.06.08.0ppm 7.0
H8
A
H O2
dien
B
 
Figure 39  A section of 1H NMR spectrum (D2O, pH* 7.0) of (dien)PtII complex of guanine. 
Peak A is assigned to the [(dien)Pt(GH2-N9)]2+ and B is assigned to the 
[(dien)Pt(GH-N7,N9)]3+. 
 
2.4.4 Solution Studies of [(dien)Pt(GH2-N9)]2+ 
pD dependent 1H NMR spectroscopic measurements (Figure 40) for this 
compound63 have been carried out previously. However, in absence of the crystal 
structure, the absolute identification of the compound was not possible. 
 
In the course of the present work, a number of samples were prepared at 
different pD’s. Typically, the crystals were dissolved in D2O, were treated with 
acid and/or base over a wide pH* range and 1H NMR spectra were recorded. 
This was done to ensure that the pD-dependence performed previously 
corresponded to this compound. Relevant pKa values are 6.51 ± 0.01 (H2O) and 
10.53 ± 0.05 (H2O) for the deprotonations of N(7) and N(1) positions, 
respectively. 
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Figure 40  pD dependence (δ, ppm) of H8 resonance for [(dien)Pt(GH2-N9)]2+ in D2O.63 
2.4.5 Characterization of [(dien)Pt(GH2-N9)]2+ (12a), (12b) 
Preparative work has yielded three complexes of guanine, out of which two are 
bonded to the metal via N(9). Views of the molecular cations of [(dien)Pt(GH2-
N9)]Cl(ClO4) 12a and 2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} 12b are illustrated in 
the Figures 41 and 42, respectively. Selected bond distances and angles for 12a 
and 12b are given in Tables 11 and 12, respectively.  
 
 
Figure 41  View of cation of [(dien)Pt(GH2-N9)]Cl(ClO4) (12a) with atom numbering scheme. 
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Figure 42  View of cations of 2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} (12b) with atom 
numbering scheme. 
In 12a and 12b, (dien)PtII entities are coordinated to the guanine base via N(9) 
positions. Each cation exhibits a slightly distorted square-planar geometry with 
the four equatorial coordination sites occupied by the tridentate dien chelate, its 
terminal amino groups in trans positions, and the endocyclic nitrogen atom N(9) 
of the guanine base. The geometries of the (dien)PtII groups in both compounds 
are normal, including the deviations of some of the angles from ideal square-
planar coordination geometry of the Pt due to the strain by the tridentate 
ligand.106,159,160 Angles between the Pt coordination plane and the guanine ligand 
are 12.7˚ (Pt(1), 12a), 25.8˚ (Pt(1), 12b) and 39.3˚ (Pt(2), 12b). 
 
Carbon atoms of the ethylene groups of the dien ligands do not display a uniform 
pattern relative to the PtN4 plane. In 12b, the deviations of carbon atoms from the 
least-squares plane formed by the PtN4 plane are -0.51(1) Å C(2d), -0.60(1) Å 
C(3d), 0.17(1) Å C(1d), -0.01(1)Å C(4d), -0.66(1) Å C(2da), -0.59(1) Å C(3da), 
-0.07(1) Å C(1da), and 0.05(1) Å C(4da). Thus, the two halves of the dien ligands 
undergo marked distortions from the case of a symmetrical distribution of the two 
carbon atoms of an ethylenediamine ring. In 12a, the dien ligand adopts a 
sting-ray geometry106 with the central methylene groups C(2d) and C(3d) pointing 
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in the same direction, yet being below the PtN4 plane. Deviations of carbon 
atoms from the least-squares plane formed by the PtN4 plane are -0.55(1) Å 
C(2d), -0.52(1) Å C(3d) and 0.07(1) Å C(1d) and 0.09 (1) Å C(4d). There are no 
significant differences in bond lengths and bond angles for 12a and 12b. The 
guanine ligands do not display any unusual features. Structural data are well 
within those of related compounds.182,183 
 
Table 11  Selected distances (Å) and angles (º) for [(dien)Pt(GH2-N9)]Cl(ClO4) (12a) 
[(dien)Pt(GH2-N9)]Cl(ClO4) (12a) 
Pt(1)N4/GH 12.7(1) Pt(1)-N(1d) 2.040(6) 
Pt(1)-N(9) 2.058(5) Pt(1)-N(2d) 2.005(5) 
Pt(1)-N(3d) 2.042(6)   
    
N(1d)-Pt(1)-N(3d) 166.3(2) Pt(1)-N(1d)-C(1d) 109.4(4) 
N(1d)-Pt(1)-N(9) 95.7(2) Pt(1)-N(2d)-C(2d) 108.4(4) 
N(2d)-Pt(1)-N(3d) 83.4(2) Pt(1)-N(2d)-C(3d) 109.3(2) 
N(2d)-Pt(1)-N(9) 178.2(2) Pt(1)-N(3d)-C(4d) 109.1(4) 
N(1d)-Pt(1)-N(2d) 83.7(2) Pt(1)-N(9)-C(4) 126.6(4) 
N(3d)-Pt(1)-N(9) 97.3(2) Pt(1)-N(9)-C(8) 126.8(4) 
C(2)-N(3)-C(4) 113.7(5) N(7)-C(8)-N(9) 112.2(6) 
C(2)-N(1)-C(6) 124.1(5) C(4)-N(9)-C(8) 106.2(5) 
C(5)-N(7)-C(8) 107.1(5)   
 
Table 12  Selected distances (Å) and angles (º) for 2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} (12b) 
2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} (12b) 
 “a” “b”  “a” “b” 
PtN4/GH 25.8 (1) 39.3(1) Pt-N(1D) 2.040(9) 2.054(8 
Pt-N(9) 2.032(8) 2.047(9) Pt-N(2D) 2.010(1) 2.022(9)
Pt-N(3D) 2.040(1) 2.035(6)    
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Pt-N(1D)-C(1D) 107.9(8) 108.3(7) Pt-N(2D)-C(3D) 107.8(6) 108.0(7)
Pt-N(2D)-C(2D) 108.6(8) 105.4(8) Pt-N(3D)-C(4D) 109.6(6) 109.4(5)
N(1D)-Pt-N(3D) 167.4(5) 167.3(3) Pt-N(9)-C(4) 127.5(7) 125.0(6)
N(1D)-Pt-N(9) 95.1(4) 95.6(4) Pt-N(9)-C(8) 127.2(7) 129.4(9)
N(2D)-Pt-N(3D) 84.3(4) 83.3(3) N(7)-C(8)-N(9) 111.4(9) 113.0(1)
N(2D)-Pt-N(9) 178.3(4) 176.9(5) C(2)-N(3)-C(4) 113.4(1) 112.5(8)
N(1D)-Pt-N(2D) 83.9(4) 85.0(3) C(2)-N(1)-C(6) 127.0(1) 125.0(1)
N(3D)-Pt-N(9) 96.8(4) 95.8(3) C(5)-N(7)-C(8) 109.0(1) 108.4(9)
   C(4)-N(9)-C(8) 105.2(9) 106.0(1)
Pt denotes Pt(1) in “a” and Pt(2) in “b”. D denotes dien ligand. 
In 12a, the purine bases of the adjacent complexes (Figure 43) are hydrogen 
bonded to each other in a Hoogsteen fashion. The hydrogen bond formation 
occurs between O(6)···N(7), where O(6) of the purine base acts as an acceptor 
while the N(7) site acts as a donor for the O(6a) of the adjacent purine base, the 
distance being 2.722(7) Å between the heavy atoms. 
 
 
Figure 43  In 12a, purine rings of the adjacent complexes are bonded to each other in a 
Hoogsteen fashion. The anions are omitted for clarity. 
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In 12b, the purine bases are linked by additional hydrogen bonding between the 
dien-NH2 and O(6) of guanine base for e.g., N(1)-H···O(6), 2.94(1) Å and N(1)-
H···O(6), 2.84(1) Å. The purine rings of the adjacent complexes stack such that 
the pyrimidine ring of one complex overlays the N(1)-C(6) bond on another 
(Figure 44) at a distance of 3.19 Å to form a ladder structure. A network of 
hydrogen bonding exists between the chloride, dien-NH2 and perchlorates. 
 
 
Figure 44  In 12b, purine rings of the adjacent complexes stack such that the pyrimidine 
ring of one complex overlays the N(1)-C(6) bond on another to form a ladder. 
The anions are omitted for clarity. 
 
2.4.6 Solution Studies of [(dienPt)2(GH-N7,N9)]3+ (13) 
[(dienPt)2(GH-N7,N9)]3+ was prepared by taking a solution of 2 equivalent of 
[(dien)Pt(D2O)]2+ and 1 equivalent of guanine and adjusting the pH* to 10.0. The 
solution was kept at 40 ˚C for a few hours. Excess guanine was removed by 
filtration, the solution was rotary-evaporated to dryness and a 1H NMR spectrum 
of the colorless compound was obtained in D2O. Initially, a typical spectrum at pD 
7.0, consists of an aromatic singlet H(8) guanine resonance at 7.62 ppm. 
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pD dependent 1H NMR spectroscopic measurements (Figure 45) have been 
previously performed for this compound63 and the structure of the compound has 
been speculated upon.  
 
Figure 45  pD dependence (δ, ppm) of H8 resonance for [(dienPt)2(GH-N7,N9)]3+ in D2O.63 
During the course of the present work, it was possible to isolate the compound 
and characterize it by X-ray crystallography. The crystals were dissolved in D2O, 
were treated with acid and/or base over a wide pD range and 1H NMR spectra 
were recorded. This was done to ensure that the pD-dependence performed 
previously corresponded to this compound. Relevant pKa values are 0.52 ± 0.07 
and 8.55 ± 0.06 for the protonated N(3) and deprotonated N(1) positions, 
respectively. 
 
2.4.7 Characterization of [(dienPt)2(GH-N7,N9)](ClO4)3 (13) 
Figure 46 depicts the cation of compound 13. Selected interatomic distances and 
angles are given in Table 13. In 13, two (dien)PtII entities are coordinated to the 
guanine ligand via N(7) and N(9) positions. GH planes form angles of 
approximately 43˚ and 45˚ with the respective Pt(1) and Pt(2) coordination 
planes. 
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Figure 46  View of cation of [(dienPt)2(GH-N7,N9)](ClO4)3 (13) with atom numbering scheme. 
Angles about Pt deviate markedly from ideal square-planar106,159,160 (e.g. N(1da)-
Pt(1)-N(2da), 83.9(5)˚; N(1da)-Pt(1)-N(3da), 166.8(5)˚; N(1db)-Pt(2)-N(2db), 
85.0(6)˚; N(1db)-Pt(2)-N(3db), 168.9(4)˚). The M-N(dien) distances range from 
2.000(1) to 2.010(1) Å in Pt(1)-N(2da) or Pt(2)-N(2db), to 2.010(1) to 2.040(1) Å 
in Pt(1)-N(3da) or Pt(2)-N(3db), and are likewise normal. 
 
Table 13  Selected distances (Å) and angles (º) for [(dienPt)2(GH-N7,N9)](ClO4)3 (13) 
[(dienPt)2(GH-N7,N9)](ClO4)3 (13) 
Pt(1)···Pt(2) 5.983(1) Pt(1)-N(7) 2.020(1) 
Pt(2)-N(9) 2.020(1)   
    
N(2db)-Pt(2)-N(9) 175.7(5) Pt(1)-N(7)-C(8) 126.9(11) 
N(3db)-Pt(2)-N(9) 94.4(4) C(5)-N(7)-C(8) 105.0(1) 
N(1da)-Pt(1)-N(7) 95.4(4) C(2)-N(3)-C(4) 114.4(1) 
N(1db)-Pt(2)-N(9) 96.1(4) N(7)-C(8)-N(9) 118.0(1) 
N(2da)-Pt(1)-N(7) 177.4(4) N(1)-C(2)-N(3) 125.0(1) 
N(3da)-Pt(1)-N(7) 96.5(4) N(3)-C(4)-N(9) 125.7(13) 
Pt(2)-N(9)-C(8) 129.3(9) N(1)-C(6)-C(5) 113.0(1) 
N(7)-C(5)-C(4) 107.0(1) C(4)-N(9)-C(8) 104.4(1) 
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Distances and angles within the GH ligand are not unusual. The geometries of 
the (dien)PtII entities are likewise not unusual and compare well with the 
published data. The dien ligands, "da" and "db", adopt the characteristic sting-ray 
geometries106 with the central methylene groups C(2) and C(3) of the two dien 
ligands pointing to the same side of the PtN4 plane, yet in opposite directions for 
"da" and "db". 
 
Deviations of central methylene groups of the dien ligands from the least-squares 
planes formed by the PtN4 planes are 0.56(2) Å (C2da), 0.56(2) Å (C3da), 
-0.25(2) Å (C2db) and -0.37(2) Å (C3db). The purine rings of the adjacent 
complexes stack such that the pyrimidine ring of one complex overlays the N(1)-
C(6) bond on another at a distance of ca. 3.5 Å. 
 
The dien ligands, perchlorate anions, N(1)H, N(2)H2 and O(6) of the GH ligand 
are involved in numerous intramolecular and intermolecular short contacts. For 
example, the protons at N1d(a/b), N2d(a/b) and N3d(a/b) of dien ligands are 
hydrogen bonded to various oxygen atoms of different perchlorate anions, and 
O(6) of the GH ligand, whereas the N(1)H and N(2)H2 in GH are hydrogen 
bonded to perchlorate anions. None of these contacts (2.9 – 3.1 Å) between 
heavy atoms is particularly short. 
 
2.4.8 Theoretical Calculations 
Molecular geometries of [(dien)Pt(GH2-N7)]2+ and [(dien)Pt(GH2-N9)]2+ 
complexes have been computed in an attempt to better understand the metal 
binding behavior of guanine. Figure 47 provides views of the optimized structures 
of [(dien)Pt(GH2-N7)]2+and [(dien)Pt(GH2-N9)]2+. 
 
Calculations of relative energies of N(7) and N(9) linkage isomers for 
[(dien)Pt(GH2)]2+ reveal a preference of the PtII entity for N(7) site 
(ΔE = 8.4 kcal/mol). The theoretical results are not in agreement with the 
experimental observation. The experimental results reveal a preference of the PtII 
entity for the N(9) site.  
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Figure 47  Optimized computed structures of [(dien)Pt(GH2-N7)]2+ and [(dien)Pt(GH2-N9)]2+ 
with atom numbering schemes. 
The comparison between the two geometries shows that in the N(7) linkage 
isomer the guanine ring forms an angle of ca. 55˚ with the PtN4 coordination 
plane. The NH2 group of the dien ligand is involved in hydrogen bond formation 
with O(6), the hydrogen bond length being O(6)···NH2(dien), 2.768 Å. On the 
other hand, in the N(9) linkage isomer the guanine ring is tilted at an angle of ca. 
36˚ with respect to the Pt coordination plane. The low value of the dihedral angle 
between the PtN4 and guanine planes is consistent with the values obtained for 
the solid state structures, viz. in the range of 12 to 40˚.  
 
Hydrogen bond formation takes place between the (dien)NH2···N(3), 2.911 Å. 
There are no significant differences in the bond lengths and angles in the two 
linkage isomers (e.g. Pt(1)-N(10), 2.077 to 2.078 Å, Pt(1)-N(20), 2.064 to 
2.068 Å, Pt(1)-N(30), 2.118 to 2.122 Å, N(10)-Pt(1)-N(20), 83.8˚ to 84.0˚, N(20)-
Pt(1)-N(30), 83.3˚ to 83.2˚ for N(7) and N(9) linkage isomers, respectively), 
except the Pt(1)-N(7), 2.075 Å and Pt(1)-N(9), 2.063 Å bond lengths. There is 
generally a good agreement between the calculated and the solid state geometry 
of the N(9) linkage isomer. The minor discrepancies might be due to the absence 
of counter anions and the crystal packing forces. 
 
Finally, the calculations were also performed for the dinuclear compound, 
[(dienPt)2(GH-N7,N9)]3+. View of the optimized structure is presented in 
Figure 48. 
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Figure 48  View of the optimized computed structure of [(dienPt)2(GH-N7,N9)]3+ with atom 
numbering schemes. 
The guanine ring forms an angle of ca. 50˚ and 40˚ with the Pt(1)N4 and Pt(2)N4 
coordination planes, respectively. The M-N(dien) distances range from 2.07 Å in 
Pt(1)-N(10) or Pt(2)-N(40) to 2.120 Å in Pt(1)-N(30) or Pt(2)-N(60), and are 
likewise normal. The dien ligands bonded to N(7) and N(9) positions of guanine 
have different geometries.  
 
Deviations of carbon atoms of the dien ligand from the mean-squares planes 
formed by the Pt(1)N4 plane are 0.05 Å (C11), -0.49 Å (C12), -0.84 Å (C13) and -
0.21 Å (C14) and for Pt(2)N4 plane are 0.11 Å (C15), -0.52 Å (C16), -0.55 Å 
(C17) and 0.83 Å (C18). 
 
The angles and bond lengths of the guanine ring are usual. O(6), N(3) and NH2 
groups of the dien ligands are involved in hydrogen bonding. Hydrogen bond 
lengths are O(6)-NH2(dien), 2.784 Å and N(3)-NH2(dien), 2.939 Å. Additionally, 
there might be a weak interaction between N(2)···NH2(dien), 3.541 Å. 
 
In general there is a good agreement between the dinuclear compounds of 
(dien)PtII and the X-ray structure of 13. However, the minor discrepancies are 
probably a consequence of crystal packing forces and the presence of the 
counter anions in the solid state structures. 
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2.4.9 Summary 
Guanine (GH2) exists in solution as two major tautomers, the keto form with N(7) 
carrying a proton (I) and the keto form with N(9) being protonated (II). (dien)PtII 
prefers binding to the N(9) position. The crystal structure analyses of 
[(dien)Pt(GH2-N9)]Cl(ClO4) 12a and 2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} 12b are 
reported. With an excess of (dien)PtII dinuclear species [(dienPt)2(GH-N7,N9)]3+ 
forms, which was isolated as a ClO4– salt 13 and structurally characterized. 
Individual species have been identified by the pD dependence of the guanine 
resonances. pKa values (calculated for H2O) for deprotonation of the N(9) linkage 
isomer are 6.5 and 10.5, as well as 0.5 and 8.6 in the dinuclear complex 
[(dienPt)2(GH-N7,N9)]3+. 
 
Ab initio calculations have been performed for [(dien)Pt(GH2-N7)]2+, 
[(dien)Pt(GH2-N9)]2+ and [(dienPt)2(GH-N7,N9)]3+. The calculations reveal that 
the N(7) linkage isomer is more stable than the N(9) linkage isomer by 
ΔE = 8.4 kcal/mol. The reason of this binding preference might be the 
intramolecular hydrogen bonding between O(6) and the NH2(dien) ligand in the 
N(7) linkage isomer. However, this observation is not in agreement with the 
experimental results. The experimental results reveal a preference of the 
(dien)PtII entity for the N(9) position.  
 
2.4.10 Discussion 
We were able to synthesize (dien)PtII complexes of unsubstituted guanine and to 
a large extent, we successfully identified the various metal binding site(s). 
However, our goal of synthesizing N(9) bound complexes of PtII on a preparative 
scale is still in its infancy. 
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2.5 Synthesis of Cationic Oligonucleotide Analogs using 
9-Ethylguanine (9-EtGH) 
2.5.1 Introduction 
9-ethylguanine (9-EtGH) can exist in 10 different tautomeric forms.184 However, 
at physiological pH, it exists primarily in the keto-amino form (Chart 20). 
 
 
Chart 20  Schematic representation of 9-ethylguanine. 
9-EtGH can undergo protonation at N(7) position (pKs = 3.27) and deprotonation 
occurs at N(1) position (pKs = 9.57).174 In a highly acidic medium, a second 
protonation can occur at N(3) position.185 
 
2.5.2 Aim of the Project 
The objective of the present project was the synthesis of artificial oligonucleotide 
analogs. The synthesis of artificial oligonucleotide analogs can be divided into 
three parts. 
 
(1) Synthesis of Central Building Blocks 
Hegmans et al.186 have previously described a synthetic route (Chart 21) for 
the preparation of trans-[(NH3)Pt(9-EtGH)I2] starting out from cis-[(NH3)2Pt(9-
EtGH-N7)Cl]Cl.187 The use of KI and slightly acidic reaction conditions greatly 
increases the yield of the trans complex, thereby making this reaction useful 
for subsequent preparative work. 
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Chart 21  Synthetic strategy for the preparation of trans-(NH3)Pt(9-EtGH)I2. 
(2) Choice of the Bridging Ligands 
The distance between the Pt2+ centers or the nucleobases should be around 
3.4 Å. Therefore, the bridging ligand can either be short (e.g., hydrazine) or a 
long flexible molecule like ethylenediamine. During the course of the present 
work, the following bridging ligands were used i.e., pyrazine, ethylenediamine 
and 4,4’-bipyridine (Chart 22). 
 
 
Chart 22  The bridging ligands, ethylenediamine, pyrazine, 4,4’-bipyridine (from left 
to right). 
With pyrazine, the distance between the Pt2+ centers is around 7 Å.188 
Therefore, the hydrogen bonding of cationic oligonucleotides can occur only 
with every second nucleobase in DNA or RNA. When 4,4’-bipyridine is used 
as a bridging ligand, the distance between the Pt2+ centers is around 
11.1 Å.189 Hence, the hydrogen bonding is only possible with every third or 
fourth nucleobase in DNA or RNA. 
 
(3) Synthesis of the Terminus 
The terminus of the cationic oligonucleotide is formed by an am(m)ine ligand 
cis to the nucleobase (Nb). Therefore, the ends can be capped by using 
precursor complexes of the type cis-[(NH3)2Pt(Nb)Cl]+ or [(en)Pt(Nb)Cl]+. 
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2.5.3 Synthesis of the Building Blocks 
2.5.3.1 Synthesis of cis-[(NH3)2Pt(9-EtGH-N7)Cl]Cl (14) 
Synthesis of 14 was carried out according to the synthetic procedure reported in 
the literature.187 1:1 mixtures of cis-[(NH3)2PtCl2] and 9-EtGH were kept at 40 ˚C 
for 48 h. The crude product was a mixture of cis-[(NH3)2Pt(9-EtGH-N7)Cl]Cl and 
cis-[(NH3)2Pt(9-EtGH-N7)2]Cl2 complexes. The yellow-white precipitate was 
washed with DMF to get pure compound 14. 
 
During the course of the present work, we have also isolated the 2:1 complex 
(cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2) as an impurity of 1:1 (cis-[(NH3)2Pt(9-EtGH-
N7)Cl]Cl) complex. cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 19 has been characterized 
by X-ray crystallography. A view of the molecular cation is given in Figure 49. 
Selected interatomic distances and angles are listed in Table 14. 
 
 
Figure 49  View of cation of cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 (19) with atom numbering 
scheme. 
As can be seen from Figure 49, the neutral 9-ethylguanine ligands are 
coordinated to Pt through N(7). The two purine bases are oriented in a way that 
the exocyclic oxygens are at the same side of the Pt coordination plane, hence in 
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a head-to-head fashion. The review of the published structures on 
bis(guanine)-cis-diam(m)ineplatinum(II) complexes shows that the two purine 
bases are always in a head-to-tail orientation,190-193 with an exception of only a 
few structures.194,195 In all these cases, Pt is coordinated through N7 of the 
guanine ligand. 
 
Table 14  Selected distances (Å) and angles (º) for cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 (19) 
cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 (19) 
Pt(1)-N(7a)  2.020(7) Pt(1)-N(13) 2.026(6) 
Pt(1)-N(7b) 2.000(1) Pt(1)-N(14) 2.019(9) 
N(7a)-Pt(1)-N(13) 179.0(3) N(7b)-Pt(1)-N(13) 91.4(3) 
N(7a)-Pt(1)-N(14) 90.03(3) N(7b)-Pt(1)-N(14) 178.6(3) 
Pt(1)N4/9-EtGH(a) 52.6(1) Pt(1)N4/9-EtGH(b) 75.7(1) 
N(7a)-Pt(1)-N(7b) 88.4(4) N(13)-Pt(1)-N(14) 89.8(3) 
Pt(1)-N(7a)-C(5a) 122.1(7) C(5a)-N(7a)-C(8a) 106.3(8) 
Pt(1)-N(7b)-C(5b) 128.8(8) C(5b)-N(7b)-C(8b) 105.0(1) 
 
The geometry about the Pt is normal and similar to the other published 
structures. 194,195 There are no significant differences in bond lengths and angles 
within the G ligands. The differences in the relative orientation of the ethyl groups 
determine the degree of base overlap.194 The ethyl group of guanine ligand “b” is 
roughly coplanar with the endocyclic atoms of the ring, while the CH3 group of the 
ethyl group of the ligand “a” is substantially outside the plane of the rest of the 
ring and is bent towards the ring “b”. Therefore, the intermolecular base-base 
distance is too large for any stacking interactions. 
 
The hydrogen bonding takes place between O(6) of purines and NH3 groups, 
N(13)···O(6a), 2.983(9) Å, N(13)···O(6b), 2.98(1) Å and N(13)···O(6b), 2.970(9) Å. 
The exocyclic amino groups act as proton donors in hydrogen bonds with O(6) 
and N(3), the distances being 3.15(1) Å, 2.97(1) Å, for N(2b)H2···O(6) and 
N(2b)H2···N(3b)respectively. Additionally, there is extensive hydrogen bonding 
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involving O(6) of guanine, NH3 groups and oxygens of the nitrates. None of these 
contacts (2.8 – 3.3 Å) between heavy atoms is particularly short. 
 
2.5.3.2 Synthesis of trans-[(NH3)Pt(9-EtGH-N7)I2] (15) 
15 was prepared according to the method described in the literature. 186 1:4 
solution mixtures of 14 and KI were kept at 35 ˚C for 4 days. The reaction was 
done in a slightly acidic medium as in this condition high yields of the trans 
complex are obtained. 
 
2.5.4 Ethylenediamine as a Bridging Ligand 
Qu et al.196 have reported the synthesis and properties of complexes (Figure 50) 
containing bidentate coordination spheres [{cis-[(NH3)PtCl2}2-(diamine)]Cl2 and 
monodentate coordination spheres [{trans-[(NH3)2PtCl}2-(diamine)]Cl2 where 
diamine = 1,4-butanediamine or 2,5-dimethyl-2,5-hexadiamine. These complexes 
serve as novel types of intra- and interstrand crosslinks suggesting that different 
DNA binding modes may have different biological effects.196 
 
 
Figure 50  Structures of bis(platinum) complexes containing monodentate (I, II) and 
bidentate (III, IV) coordination spheres.196 
The reactions of trans-[(NH3)Pt(9-EtGH-N7)I2] with ethylenediamine in aqueous 
solution were unsuccessful due to the poor solubility of the starting materials. To 
circumvent this problem, reactions were carried out with cis-[(NH3)2Pt(9-EtGH-
N7)Cl]Cl instead of trans-[(NH3)Pt(9-EtGH-N7)I2] and followed by 1H NMR 
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spectroscopy. The 1H NMR spectra revealed the presence of a number of linkage 
isomers and proved difficult to interpret.  
 
2.5.5 Pyrazine as a Bridging Ligand 
The coordination chemistry of pyrazine (pyrz) and related ligands with Pt has 
been extensively investigated.188,197,198 The pyrazine-bridged dinuclear Pt(II) 
complexes, [{cis-(NH3)2PtCl}2-(µ-pyrz)]Cl2, and its derivatives have been reported 
to possess anticancer properties. The Pt···Pt distance is 6.82 Å188 and the 
compounds have the flexibility to cross-link with a minimal distortion of the DNA 
molecule. With pyrazine as a bridging ligand, the hydrogen bonding of the 
cationic oligonucleotides can take place only with every second nucleobase in 
DNA or RNA. 
 
The single pot aqueous reaction of trans-[(NH3)Pt(9-EtGH-N7)I2], AgNO3 and 
pyrazine in a 1:2:3 proportion at room temperature produced the complex trans-
[(NH3)Pt(9-EtGH-N7)(pyrz)2]2+ 16. Recrystallization of 16 from 1:1:1 mixture of 
acetone, MeOH and water, afforded yellow crystals suitable for X-ray 
crystallography. 16 was characterized by elemental analysis, 1H NMR 
spectroscopy and X-ray crystallography. The Raman spectrum was not obtained 
as the compound decomposed under the laser beam. 
 
ppm 8.509.009.50
H8
Pyrz
 
Figure 51  A section of 1H NMR spectrum for the reaction of 15 with AgNO3 and pyrazine 
(1:2:3, D2O, pH* 4.3). 
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A representative 1H NMR spectrum for the H8 and pyrazine protons region is 
shown in Figure 51. Chemical shifts of the individual 1H resonances of the 
compound 16 are listed and assigned in the Experimental Section. Additionally, 
there were 195Pt satellites present for the pyrazine signals. The coupling constant 
is 3JPt-H ~ 46 Hz. 
 
2.5.5.1 Solution Studies of 16 
In the course of the present work, pKa values of 16 were determined (Figure 52) 
using pH dependent 1H NMR spectroscopic measurements. pKa (H2O) for trans-
[(NH3)Pt(9-EtGH-N7)(pyrz)2]2+/trans-[(NH3)Pt(9-EtG-N7)(pyrz)2]+ is 8.13 ± 0.07. 
Contrary to the expectations, the pyrazine signals are shifted upfield, this might 
be due to the protonation of guanine. 
 
 
Figure 52  pD dependence (δ, ppm) of H8 and pyrazine protons for 16 in D2O. 
2.5.5.2 Characterization of trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O 
(16) 
The view of the molecular cation is shown in Figure 53. A selection of bond 
lengths and angles is given in Table 15. 
 91  Results and Discussions 
 
 
 
Figure 53  View of cations of trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O (16) with atom 
numbering scheme. Only one of the two positions of the disordered ethyl 
chains is shown. 
The coordination around the platinum atoms is square planar. The angles around 
the Pt atom are close to the expected values for this situation. The dihedral 
angles between the heterocycles “a” and “b” and Pt(1)N4 and Pt(2)N4 
coordination planes are 78.0(1)˚and 85.2(1)˚, respectively. 
 
Table 15  Selected distances (Å) and angles (º) for 
            trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O (16) 
trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O (16) 
Pt(1)-N(7a)  2.030(1) Pt(1)-N(11b) 2.050(1) 
Pt(1)-N(7b) 2.020(1) Pt(1)-N(1e) 2.010(1) 
Pt(1)-N(11a) 2.040(1) Pt(1)-N(1f) 2.010(1) 
Pt(2)-N(1d) 2.000(1) Pt(2)-N(1c) 2.000(1) 
    
N(1e)-Pt(1)-N(1f) 178.1(5) N(7a)-Pt(1)-N(11a) 177.0(5) 
N(1e)-Pt(1)-N(7a) 88.0(5) N(1f)-Pt(1)-N(11a) 89.8(5) 
N(1e)-Pt(1)-N(11a) 90.1(5) N(7a)-Pt(1)-N(11a) 177.0(5) 
N(1f)-Pt(1)-N(7a) 92.2(5) N(7b)-Pt(2)-N(11b) 178.1(5) 
N(1c)-Pt(2)-N(1d) 176.6(5) N(1c)-Pt(2)-N(11b) 90.2(5) 
   92 Results and Discussions
N(1c)-Pt(2)-N(7b) 89.5(4) N(1d)-Pt(2)-N(7b) 90.0(5) 
N(1d)-Pt(2)-N(11b) 90.5(5) Pt(1)-N(1e)-C(1e) 123.0(1) 
Pt(1)-N(1f)-C(1f) 125.0(1) Pt(1)-N(1e)-C(4e) 120.0(1) 
Pt(1)-N(1f)-C(5f) 120.0(1) Pt(2)-N(1c)-C(2c) 120.0(1) 
Pt(2)-N(1d)-C(1d) 122.0(1) Pt(2)-N(1c)-C(5c) 124.0(1) 
Pt(2)-N(1d)-C(5d) 122.0(1) Pt(2)-N(7b)-C(5b) 127.8(9) 
Pt(1)-N(7a)-C(5a) 126.2(8) Pt(2)-N(7b)-C(8b) 125.3(9) 
Pt(1)-N(7a)-C(8a) 128.0(1) C(5b)-N(7b)-C(8b) 107.0(1) 
C(5a)-N(7a)-C(8a) 107.0(1) C(4b)-N(9b)-C(8b) 108.0(1) 
C(2c)-N(1c)-C(5c) 117.1(1) C(1c)-N(3c)-C(4c) 119(2) 
C(2f)-N(3f)-C(4f) 114.0(1) C(2e)-N(3e)-C(5e) 117.1(1) 
C(2d)-N(3d)-C(4d) 117.0(1) C(1d)-N(1d)-C(5d) 117.1(1) 
C(1e)-N(1e)-C(4e) 118.0(1) C(1f)-N(1f)-C(5f) 117.0(1) 
 
Pt-N distances are normal. The binding of pyrazine to platinum through the 
nitrogen atom slightly increases the internal C-N-C angles, which vary from 
117.1(1)˚ to 119(2)˚. In free pyrazine, these angles are 115.1˚.199 The bond 
distances and angles in the different pyrazine rings are as expected. In the 
crystal, the stacking interactions occur between the pyrazine rings at a distance 
of ca. 3.48 Å. 
 
The cations are arranged in a form of chains and the nitrate anions are located in 
between these chains. The nitrate anions are involved in extensive intermolecular 
hydrogen bonding interactions to the N(1)H, N(2)H2 of the purine bases as well 
as to the NH3 ligands. 
 
The hydrogen bonding distances between the heavy atoms are N(1)-H···O, 
2.89(1) Å, N(11)-H···O, 3.26(1) Å, N(11)-H···O, 2.75(3) Å, N(11)-H···O, 3.15(1) Å, 
N(11)-H···O, 2.75(3) Å, N(11)-H···O, 3.16(2) Å, N(11)-H···O, 3.21(3) Å, N(11)-
H···O, 2.82(2) Å, N(11)-H···O, 3.20(3) Å, N(11)-H···O, 2.95(2) Å, N(2)-H···O, 
2.96(2) Å and N(2)-H···O, 3.26(2) Å. Additionally, the water molecules also 
participate in hydrogen bonding. 
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2.5.5.3 Reactions with cis-[(NH3)2Pt(9-EtGH-N7)Cl]Cl (14) 
The reaction between 14, AgNO3 and pyrazine at 1:1.5:1 ratio in water was 
carried out to obtain the complex cis-[(NH3)2Pt(9-EtGH-N7)(pyrz)]2+. AgNO3 was 
added to the reaction mixture slowly, in order to have constantly an excess of 14. 
The reaction was monitored by 1H NMR spectroscopy. A representative 1H NMR 
spectrum is shown in Figure 54. 
 
ppm 8.509.00
Pyrz
H8
A
B
A
A
 
Figure 54  A section of 1H NMR spectrum for the reaction of 14 with AgNO3 and pyrazine 
(1:1:1.5, D2O, pH* 5.4). Assignment of resonances (A)–(B) was made on the 
basis of their pD dependence. 
During the course of the reaction, two new sets of H8 and pyrazine peaks were 
observed. The products were identified by a 1H NMR pH titration (Figure 55) on a 
similar solution. Of these, peak B is due to the complex 14. The most intense set 
of resonances A was assigned to the desired complex cis-[(NH3)2Pt(9-EtGH-
N7)(pyrz)]2+. There are 195Pt satellites present for the pyrazine (3JPt-H ~ 43 Hz) 
and H8 protons (3JPt-H ~ 21 Hz). The integrals are consistent with this 
interpretation. 
 
The pKa values were determined from H8 1H NMR shifts. Relevant pKa values 
are 8.48 ± 0.04 and 8.36 ± 0.06 for cis-[(NH3)2Pt(9-EtGH-N7)(H2O)]2+/cis-
[(NH3)2Pt(9-EtGH-N7)(H2O)]+ and cis-[(NH3)2Pt(9-EtGH-N7)(pyrz)]2+/cis-
[(NH3)2Pt(9-EtGH-N7)(pyrz)]+, respectively. 
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Figure 55  pD dependence (δ, ppm) of H8 protons of guanine ligand in 
             cis-[(NH3)2Pt(9-EtGH-N7)(pyrz)]2+ and cis-[(NH3)2Pt(9-EtGH-N7)(H2O)]2+ 
in D2O. 
A similar reaction was performed with excess of 14, and only one species 
corresponding to the compound cis-[(NH3)2Pt(9-EtGH-N7)(pyrz)]2+ was detected 
in the 1H NMR spectrum. 
 
2.5.6 4,4’-bipyridine as a Bridging Ligand 
A number of cationic, tetranuclear, PtII- and PdII- based macrocyclic squares 
have been prepared and characterized using difunctional chelating ligands, for 
example, 4,4’-bipyridine and dicyanobenzene.189 The X-ray crystallography 
establishes the dimension of the 4,4’-bipy and related squares to be ca. 11 Å, 
based on the M···M interatomic distances.189 Using 4,4’-bipy as a bridging ligand, 
the hydrogen bonding of the cationic oligonucleotides can take place only with 
every third or fourth nucleobase in DNA or RNA. The pKa value of protonated 
4,4’-bipy is 3.87 ± 0.12. 
 
2.5.6.1 Reactions with trans-[(NH3)Pt(9-EtGH-N7)I2] (15) 
The reaction of 15 with AgNO3 and 4,4’-bipy at 1:2:3 ratio was done at room 
temperature as well as at 40 ˚C. After 3 days, AgI and insoluble 4,4’-bipy were 
filtered off and 1H NMR spectra of the products were recorded. For the reaction 
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performed at 40 ˚C, a number of linkage isomers were formed in the reaction 
mixture. The 1H NMR spectrum was complicated and hence, interpretation was 
difficult. 
 
A typical 1H NMR spectrum for the reaction carried out at room temperature is 
shown in Figure 56. As can be seen, only a single product was detected 
corresponding to the set of resonances A. This set of resonances was assigned 
to the compound trans-[(NH3)Pt(9-EtGH-N7)(bipy)2]2+. Additionally, there was 
uncoordinated or free 4,4’-bipy present. However, it was not possible to remove 
the excess bipy from the mixture. The free bipy was identified on the basis of its 
pD-dependent chemical shifts. 
 
ppm 8.008.509.00
Free bipy
Free bipy
Bipy Bipy
H8
A
A A A
A
 
Figure 56  A section of 1H NMR spectrum for the reaction of 15 with AgNO3 and 4,4’-bipy 
(1:2:3, D2O, pH* 5.8). The set of resonances A was assigned to the complex 
trans-[(NH3)Pt(9-EtGH-N7)(bipy)2]2+. 
1H NMR peak assignments are as follows: δ = 9.09 (m, bipy), 8.80 (m, bipy), 8.72 
(m, free bipy), 8.78 (s, H8), 8.04 (m, bipy), 7.90 (m, bipy), 7.82 (m, free bipy), 
4.15 (q, methylene), 1.46 (t, methyl) ppm. 
 
2.5.6.2 Reactions with cis-[(NH3)2Pt(9-EtGH-N7)Cl]Cl (14) 
The reactions of 14 with 4,4’-bipy in different proportions, viz. 1:2, 1:1 and 1:0.5 
were carried out at room temperature and monitored by 1H NMR spectroscopy. A 
typical spectrum is shown in Figure 57. 
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Four species labeled A, B, C and free bipy were detected during the time course 
of the reaction. Of these, B and free bipy are due to 14 and uncoordinated 
4,4’-bipyridine. These species were identified on the basis of their pD 
dependence. 
ppm 8.008.509.00
Free bipy H8
A A
A
A
Bipy
Bipy
Free bipy
B
C
C
C
A
 
Figure 57  A section of 1H NMR spectrum for the reaction of 14 with 4,4’-bipy (1:1, D2O, pH* 
5.6). The set of resonances A was assigned to the complex cis-[(NH3)2Pt(9-
EtGH-N7)(bipy)]2+, C to the bridged complex [{cis-(NH3)2Pt(9-EtGH-N7)}2-(µ-
bipy)]2+ and B is the complex 14. 
For the complex cis-[(NH3)2Pt(9-EtGH-N7)(bipy)]2+, four sets of resonances were 
expected for the coordinated 4,4’-bipy. Hence, the set of resonances A has been 
assigned to this complex. The two sets of resonances C for the coordinated 4,4’-
bipy are due to the bridged complex [{cis-(NH3)2Pt(9-EtGH-N7)}2-(µ-bipy)]2+. Out 
of the three H8 signals present, the most intense signal A has been assigned to 
cis-[(NH3)2Pt(9-EtGH-N7)(bipy)]2+ and C is due to the complex [{cis-(NH3)2Pt(9-
EtGH-N7)}2-(µ-bipy)]2+ based on the relative intensities and the species 
distribution in the reaction mixture. 
 
2.5.7 Synthesis of the Terminus 
Attempts to prepare and isolate Pt36+ compounds using trans-[(NH3)Pt(9-EtGH-
N7)(pyrz)]2+ and 14 at 1:2 ratio have till this date been unsuccessful. The spectra 
obtained are complicated and difficult to interpret. 
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2.5.8 Summary 
Reactions with trans-[(NH3)Pt(9-EtGH-N7)I2] have been carried out using three 
different bridging ligands, ethylenediamine, pyrazine and 4,4’-bipyridine. The 
reactions with ethylenediamine were unsuccessful. With pyrazine, initial success 
was achieved as far as the synthesis of the middle part of the artificial 
oligonucleotides is concerned. However attempts to use these blocks in order to 
synthesize Pt36+ compounds have been unsuccessful. The reactions with 4,4’-
bipyridine as a bridging ligand were also promising though the isolation of 
product has not been successful so far. The complexes trans-[(NH3)Pt(9-EtGH-
N7)(pyrz)2](NO3)2 16 and cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 19 have been 
characterized by X-ray crystallography. 
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2.6 Pt2+ Complexes of 7-Methylguanine (7-MeGH) 
2.6.1 Introduction 
Treatment of cells by alkylating agents such as alkylsulfates, 
alkylmethanesulfonates or nitrosoureas can result in cell death, mutagenesis and 
carcinogenesis.200,201 These effects are believed to be due to the alkylation of 
nucleic acids. The main DNA targets of such compounds are the N(3) of adenine, 
O(6) and N(7) sites of guanine.200,201 Guanine, methylated at the N(7) position, is 
by far the main product of DNA alkylation.202 The presence of 7-MeGH is 
necessary to optimize the activity of important functional regions of rRNA and 
tRNA.203-205 The methylation leads to a pronounced change in the hydrogen 
bonding and acid-base properties of the guanine nucleobase.206 
 
The relative degree and position of alkylation can lead to a drastic change in the 
metal binding behavior of the available heteroatoms in purine bases.207,208 
Studies of metal coordination to 7-MeGH (Chart 23) have been very limited. 
Metal complex formation with 7-MeGH has been studied by other groups,209-214 
and there are examples of X-ray structurally characterized metal compounds with 
N1,N3,N9,209 N9,209,213,214 N1,N9209 or N1209 coordination. 
 
 
Chart 23  Schematic representation of 7-methylguanine. 
 
2.6.2 Aim of the Project 
We were interested in the metal binding behavior of 7-MeGH and specifically the 
attachment of a PtII entity to the N(9) position. Therefore, we wanted to 
synthesize the 1:1 complex cis-[(NH3)2Pt(7-MeGH-N9)Cl]Cl on a preparative 
 99  Results and Discussions 
 
scale. This 1:1 complex was to be used in the synthesis of central building blocks 
in order to generate the artificial oligonucleotides (ref. section 2.5). 
 
2.6.3 Reactions with (dien)PtII 
A number of NMR scale reactions were carried out to study the metal binding 
behavior of 7-MeGH. The reaction of 7-MeGH with [(dien)Pt(D2O)]2+ was 
performed in a 1:1 proportion at pD 4.0 for a day at 40 ˚C. The reaction was 
monitored by 1H NMR spectroscopy. Only one species was detected in the 
reaction mixture. The H(8) signal was assigned to the N(9) linkage isomer by 
comparison with the spectrum of the isolated compound [(dien)Pt(7-MeGH-N9)]2+ 
18. The structure of this compound has been established by X-ray 
crystallography. Also, there were well resolved 195Pt satellites (3JPt-H ~ 15.5 Hz) 
present for the H8 signal. The pKa value for [(dien)Pt(7-MeGH-N9)]2+/[(dien)Pt(7-
MeG-N9)]+ is 8.16 ± 0.04 as determined by pD dependent (Figure 58) 1H NMR 
spectroscopic measurements. Below pD 1.0, protonation takes place either at 
N(3) or O(6). 
 
Figure 58  pD dependence (δ, ppm) of H8 proton for [(dien)Pt(7-MeGH-N9)]2+. 
 
2.6.4 Characterization of [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18) 
The view of the molecular cation is shown in Figure 59. Selected bond lengths 
and angles are listed in Table 16. As can be seen, the (dien)PtII entity is 
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coordinated to 7-MeGH via N9 position. The angle between the Pt coordination 
plane and the guanine ligand is 12.0(1)˚. The geometries of the (dien)PtII group is 
usual, including the deviations of some of the angles from ideal square-planar 
coordination geometry of the Pt due to the strain exercised by the tridentate 
ligand.106,159,160 
 
Figure 59  View of the cation of [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18) with atom numbering 
scheme. 
Carbon atoms of the ethylene group do not display a uniform pattern as far as 
positions relative to the PtN4 plane is concerned,106 deviations being -0.15(1) Å 
C(1d), 0.53(1) Å (C2d), 0.67 (1) Å (C3d) and 0.03 (1) Å (C4d). The bond lengths 
and bond angles in the 7-MeGH have normal values. 
 
Table 16  Selected distances (Å) and angles (º) for [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18) 
[(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18) 
Pt(1)-N(9a) 2.032(5) Pt(1)-N(2d) 2.005(6) 
Pt(1)-N(1d) 2.040(6) Pt(1)-N(3d) 2.042(6) 
    
Pt(1)-N(9a)-C(8a) 124.9(4) Pt(1)-N(1d)-C(1d) 107.3(4) 
N(3d)-Pt(1)-N(9a) 95.3(2) N(2d)-Pt(1)-N(9a) 179.3(2) 
N(1d)-Pt(1)-N(2d) 83.9(2) Pt(1)-N(2d)-C(2d) 108.1(4) 
N(1d)-Pt(1)-N(3d) 166.3(2) Pt(1)-N(2d)-C(3d) 106.8(4) 
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N(1d)-Pt(1)-N(9a) 96.6(2) Pt(1)-N(3d)-C(4d) 108.7(4) 
Pt(1)-N(9a)-C(4a) 129.9(4) C(4a)-N(9a)-C(8a) 105.2(5) 
N(2d)-Pt(1)-N(3d) 84.2(2) C(2a)-N(1A)-C(6a) 125.0(5) 
 
The perchlorate and nitrate anions are involved in intermolecular hydrogen 
bonding with the N(1a), N(2a), dien-NH2 and dien-NH, viz. N(1d)-H···O(12), 
3.18(1) Å, N(2d)-H···O(11), 3.16(1) Å, N(2d)-H···O(13), 3.12(1) Å, N(3d)-
H···O(21), 3.00(1) Å, N(3d)-H···O(23), 3.18(1) Å, N(3d)-H···O(22), 3.09(1) Å, 
N(3d)-H···O(22), 2.92(1) Å, N(2a)-H···O(21), 3.12(1) Å, N(2a)-H···O(12), 3.03(1) Å 
and N(1a)-H···O(21), 2.88(1) Å. Additionally, N(3a) and O(6a) also participate in 
hydrogen bonding. There is an intramolecular hydrogen bond N(1d)-H···N(3a) 
2.87(1) Å and O(6) is involved in intermolecular hydrogen bonding to N(1d)-
H···O(6a) 3.02(1) Å. The purine rings of the adjacent complexes are stacked so 
that the pyrimidine ring of one complex overlays the N(1)-C(6) bond on another at 
a mean stacking distance of 3.42 Å. 
 
2.6.5 Reactions with cis-[(NH3)2PtII] 
On the NMR scale, reaction of cis-[(NH3)2PtCl2] with 7-MeGH (1:1) gave at least 
three major products, one of which was later isolated in analytically pure form as 
a chloride salt: cis-[(NH3)2Pt(7-MeGH-N9)2]2+ 20. The second compound cis, cis-
[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]2+ was isolated as a chloride salt as well, but it 
was contaminated with 20.  
 
A typical 1H NMR spectrum is shown in Figure 60. Peak B (8.10 ppm) was 
assigned to the complex cis-[(NH3)2Pt(7-MeGH-N9)2]2+ on the basis of the pD 
dependent 1H NMR spectroscopic measurements for the isolated compound 20. 
The signal A (7.87 ppm) was due to the free ligand by comparison with the 
spectrum obtained for the ligand at a similar pH. 
 
There are well resolved 195Pt satellites present for the signals C (8.53 ppm) and 
D (8.25 ppm). The coupling constants are 3JPt-H ~ 13.8 Hz and 3JPt-H ~ 16.9 Hz for 
the signals C and D, respectively. The signal C was assigned to the compound 
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cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]2+ 21 by comparison with the spectrum of 
the isolated compound. Although the isolated compound was contaminated with 
complex 20, the peaks were well separated. Peak D is assigned to the desired 
complex cis-[(NH3)2Pt(7-MeGH-N9)Cl]+. Besides this, there were also other 
linkage isomers present in the reaction mixture. However, it was not possible to 
identify these complexes. 
 
ppm 7.508.008.509.009.50
H8
A
B
C D
 
Figure 60  Lowfield section of 1H NMR spectrum (D2O, pH* 3.0, H8 resonances only) of 
reaction mixture (1:1) cis-[(NH3)2PtCl2] and 7-MeGH after 2 days at 30 °C. The 
signal A has been assigned to the free ligand and B is due to the 2:1 complex 
(20). Peak C is assigned to N3,N9 dinuclear species and D is due to the N9 
linkage isomer. 
 
2.6.6 Characterization of cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O 
(21) 
The complex was isolated during the course of the present work to synthesize 
the N(9) linkage isomer on a preparative scale. Figure 61 provides a view of the 
cation of cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O 21. Selected bond 
lengths and angles are listed in Table 17. 
 
Two cis-[(NH3)2PtCl]+ entities are bound to 7-MeGH through N3 and N9 
positions. The coordination spheres of the Pt(1) and Pt(2) are square-planar with 
the angles near 90˚ and the normal distances to the Cl ligands.215  
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Figure 61  View of the cation of cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O (21) with 
atom numbering scheme. The water molecules and anions have been omitted 
for clarity. 
The Cl ligands are oriented in mutually opposite directions to prevent steric 
hindrance. Pt-N distances are as usual. Distances and angles within the purine 
base are likewise normal.209,214 The dihedral angles between the purine base and 
the Pt coordination planes are 86.3(2)˚ and 86.8(1)˚ for Pt(1) and Pt(2), 
respectively. 
Table 17  Selected distances (Å) and angles (º) for cis, cis-[{(NH3)2Pt}2(7-MeGH-
N3,N9)Cl2]Cl2 · 3H2O (21) 
cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O (21) 
Pt(1)···Pt(2) 3.1603(9) Pt(1)-Cl(1) 2.292(4) 
Pt(2)-N(3b) 2.06(1) Pt(1)-N(11) 2.04(1) 
Pt(2)-N(13) 2.03(1) Pt(1)-N(12) 2.05(1) 
Pt(2)-N(14) 2.05(1) Pt(1)-N(9b) 2.06(1) 
Pt(2)-Cl(2) 2.298(4)   
Pt(1)N4/7-MeGH 86.3(2) Pt(2)N4/7-MeGH 86.8(1) 
Cl(1)-Pt(1)-N(9B) 90.5(3) Pt(2)-N(3b)-C(4b) 120.6(9) 
N(13)-Pt(2)-N(14) 89.1(5) C(2b)-N(3b)-C(4b) 113.0(1) 
Cl(2)-Pt(2)-N(3b) 88.4(3) C(5b)-N(7b)-C(7b) 124.0(1) 
N(3b)-Pt(2)-N(14) 92.5(5) C(5b)-N(7b)-C(8b) 105.0(1) 
N(3b)-Pt(2)-N(13) 178.5(4) C(7b)-N(7b)-C(8b) 132.0(1) 
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Cl(1)-Pt(1)-N(12) 174.8(3) C(4b)-N(9b)-C(8b) 102.0(1) 
Pt(1)-N(9b)-C(4b) 129.7(9) N(7b)-C(8b)-N(9b) 122.0(1) 
Pt(1)-N(9b)-C(8b) 128.5(9) N(7b)-C(5b)-C(6b) 135.0(1) 
Cl(1)-Pt(1)-N(11) 88.0(3) N(1b)-C(2b)-N(3b) 132.0(1) 
N(11)-Pt(1)-N(12) 90.8(4) N(3b)-C(4b)-N(9b) 130.0(1) 
N(9b)-Pt(1)-N(11) 178.4(4) N(9b)-C(4b)-C(5b) 109.0(1) 
Cl(2)-Pt(2)-N(13) 90.1(4) N(3b)-C(4b)-C(5b) 123.0(1) 
Cl(2)-Pt(2)-N(14) 179.0(4) N(7b)-C(5b)-C(4b) 105.0(1) 
Pt(2)-N(3b)-C(2b) 128.0(1) C(4b)-C(5b)-C(6b) 122.0(1) 
  N(1b)-C(2b)-N(2b) 114.0(1) 
 
In the crystal lattice, the adjacent complexes are (Figure 62) linked via 
intermolecular hydrogen bonding between the Cl of one and the NH3 group of the 
other complex to form a zig zag ladder. The hydrogen bonding distances are 
N(12b)-H···Cl(2c), 3.43(1) Å and N(14)-H···Cl(1b), 3.39(1) Å. The chloride anions 
are involved in additional hydrogen bonding with N(1b)-H···Cl(4), 3.26(1) Å, 
N(11)-H···Cl(3), 3.32(1) Å, N(11)-H···Cl(4), 3.54(1) Å, N(11)-H···Cl(3), 3.36(1) Å, 
N(12)-H···Cl(3), 3.47(1) Å, N(13)-H···Cl(3), 3.36(1) Å, N(13)-H···Cl(3), 3.32(1) Å 
and N(13)-H···Cl(4), 3.36(1) Å. The water molecules are also participating in 
hydrogen bonding interactions. 
Cl(2c)
Cl(1c)
N(11c)
N(13c)
Pt(2a)
Pt(1a)
Pt(1d)
Pt(2d)
Pt(2b)
Pt(1b)
Pt(1c)
Pt(2c) N(9a)
Cl(2a)
Cl(2d)
Cl(2d)
Cl(2b)
Cl(1b)
N(11a)
N(14a)
N(13a)N(12a)
N(12d)
N(13d)
N(11d)
N(14d)
N(13b)
N(14c)
N(12c)
N(12b)
N(11b)
N(14b)
N(9d)
N(9b)
N(9c)
Cl(1a)
 
Figure 62  The adjacent complexes are linked via hydrogen bonding in cis, cis-
[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O (21) to form a zig zag ladder. The 
water molecules and anions have been omitted for clarity. 
 105  Results and Discussions 
 
2.6.7 Characterization of cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (n = 2, 3) (20) 
The reaction of 7-MeGH with an excess of cis-[(NH3)2PtII] at 30 ˚C led to the 
formation and isolation of the compound 20. This complex has been 
characterized by X-ray crystallography. Two crystals have been measured for 
this complex with a varying number of water molecules, i.e. two and three water 
molecules. For both the crystals, the molecular geometries of the cations are 
similar. Figure 63 gives a view of the cation and Table 18 lists selected distances 
and angles. 
 
 
Figure 63  Molecular structure of cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (20) with atom 
numbering scheme. The water molecules and anions have been omitted for 
clarity. 
Pt is bound via the N9 positions of the two purine bases which are oriented in a 
head-to-tail fashion. Pt has square-planar coordination geometry with the angles 
close to 90˚. The Pt-N distances are usual. There are no significant differences in 
bond lengths and angles within the two purine ligands except for the two internal 
angles, Pt(1)-N(9)-C(4) and Pt(1)-N(9)-C(8), at N9. For the two ligands, the 
variations in the internal angles at N9 are about 4˚. 
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Table 18  Selected distances (Å) and angles (º) for cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (20) 
cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (n = 2, 3) (20) 
Pt(1)-N(11) 2.050(7) Pt(1)-N(9b) 2.018(6) 
Pt(1)-N(12) 2.040(6) Pt(1)-N(9a) 2.013(7) 
    
Pt(1)N4/9-EtGH(a) 70.2(1) Pt(1)N4/9-EtGH(b) 74.6(1) 
N(11)-Pt(1)-N(12) 88.8(3) N(12)-Pt(1)-N(9b) 178.9(3) 
N(11)-Pt(1)-N(9a) 177.6(3) N(9a)-Pt(1)-N(9b) 90.5(3) 
N(11)-Pt(1)-N(9b) 90.1(3) Pt(1)-N(9b)-C(4b) 126.2(6) 
N(12)-Pt(1)-N(9a) 90.5(3) Pt(1)-N(9b)-C(8b) 127.8(6) 
Pt(1)-N(9a)-C(4a) 130.6(6) N(1b)-C(2b)-N(3b) 123.5(9) 
Pt(1)-N(9a)-C(8a) 123.9(7) C(4b)-N(9b)-C(8b) 106.0(7) 
N(1a)-C(2a)-N(3a) 122.8(1) C(4a)-N(9a)-C(8a) 105.5(7) 
 
The angles between the Pt coordination plane and the purine bases “a” and “b” 
are 70.2(1)˚ and 74.6(1)˚, respectively. The head-to-tail orientation permits the 
purine bases of the adjacent complexes to undergo stacking interactions to form 
a ladder like structure with a mean stacking distance of 3.5 Å. Additionally, the 
O6 carbonyl oxygen forms an intermolecular hydrogen bond to the NH3 ligand at 
a distance of 3.07(1) Å. The water molecules and chloride anions are involved in 
numerous hydrogen bonding interactions with NH3, N1(H) and N(2)H2 groups. 
None of the contacts (3.0 – 3.4 Å) between heavy atoms is particularly short. 
 
2.6.8 Solution Studies of 20 
During the course of the present work, the pKa values were determined by pH 
dependent (Figure 64) 1H NMR spectroscopic measurements. Typically, 1:1 
reaction mixtures were treated with acid and/or base over a wide pH* range and 
1H NMR spectra were recorded. For the complex cis-[(NH3)2Pt(7-MeGH-N9)2]2+, 
the pKa values (H2O) are 8.00 ± 0.08 and 1.86 ± 0.45 corresponding to the 
deprotonations and protonations occurring in two purine bases.216 At least for the 
deprotonation of the two guanine ligands, the two steps overlap. 
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Figure 64  pD dependence (δ, ppm) of H8 proton for cis-[(NH3)2Pt(7-MeGH-N9)2]2+. 
2.6.9 Summary 
Reactions with [(dien)PtII] were carried out to study the metal binding behavior of 
the ligand 7-MeGH. The crystal structure analysis of [(dien)Pt(7-MeGH-
N9)](NO3)ClO4 18 is reported. Reactions with cis-[(NH3)2PtII] were carried out in 
order to synthesize cis-[(NH3)2Pt(7-MeGH-N9)Cl]Cl on a preparative scale. 
However, attempts to isolate this compound were unsuccessful. The pKa values 
for the complex cis-[(NH3)2Pt(7-MeGH-N9)2]2+ are 8.00 ± 0.08 and 1.86 ± 0.45. 
The complexes cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (n = 2 or 3) 20 and cis, cis-
[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O 21 have been characterized by X-ray 
crystallography. 
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3. Summary 
The central idea behind the present project was the synthesis of the cationic di- 
and trinucleotide analogs with a positively charged Pt2+ backbone. The 
nucleobases can attach to the metal centers either through 
a) N1 (unsubstituted isocytosine base), via 
b) N9 (unsubstituted guanine base),  
c) N7 (9-EtGH) or 
d) N9 (7-MeGH)  
These ligands were also studied with regard to the effects of metallation on 
hydrogen bonding properties and tautomerism. 
 
Isocytosine exists in solution as two major tautomeric forms 1a and 1b with the 
N(1) position and the N(3) position carrying the acidic proton, respectively. In the 
solid state, both tautomers coexist in a 1:1 ratio. Our results reveal that it is 
possible to shift the equilibrium between 1a and 1b by adding a co-hydrogen 
bonding partner that selectively interacts with one of the two tautomers. The two 
tautomers 1a and 1b can be individually crystallized in the presence of the 
isocytosinium cation and neutral 1-MeC, respectively. In both compounds, the 
two partners are involved in triple hydrogen bond formation. 
 
 
Figure 65  Individual tautomers 1a and 1b can be cocrystallized in presence of a suitable 
hydrogen bonding partner. 
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Reactions with a series of PdII and PtII am(m)ine entities, (dien)PdII, (dien)PtII, cis-
(NH3)2PtII and trans-(NH3)2PtII have been carried out and were followed by 
1H NMR spectroscopy. It was found that these metals have an apparent 
preference for the N(3) site. The crystal structure analyses of [(dien)Pd(ICH-
N3)](NO3)2 2 and [(dienM)2(IC-N1,N3)](ClO4)3 (M = PdII, 3 and PtII, 4) are 
reported. In strongly acidic medium [(dienPt)2(IC-N1,N3)]3+ is converted to 
[(dien)Pt(ICH-N1)]2+, hence to the PtII complex of tautomer 1b. 
 
DFT calculations have been carried out for tautomer compounds of composition 
[(NH3)3Pt(ICH)]2+, cis- and trans-[(NH3)2PtCl(ICH)]+, trans-[(NH3)2Pt(ICH)2]2+, as 
well as (dien)PdII, (dien)PtII and (tmeda)PtII linkage isomers. Without exception, 
N(3) linkage isomers are more stable. The experimental results are in agreement 
with the theoretical calculations. The calculations suggest that the intramolecular 
hydrogen bonding between the ICH tautomers and the co-ligands at M play an 
important role. However, it is the inherently stronger M-N3 bond which is the 
determining factor for the preferential complexation of 1a. The calculations 
furthermore show a marked pyramidalization of the NH2 group of ICH in the 
complex once the heterocycle forms a dihedral angle < 90˚ with the metal 
coordination plane.  
 
Figure 66 Optimized computed structures of N(1) and N(3) linkage isomers of 
[(NH3)3Pt(ICH)]2+ and trans-[(NH3)2PtCl(ICH)]+. 
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The low abundance of PtII and PdII complexes of isocytosine with N(1) 
coordination in solution reflects the enormous influence metal coordination can 
have on the tautomer equilibria. The efforts to coordinate isocytosine at N(1) 
position by changing the co-ligands at PtII have likewise not been successful. 
These findings are in qualitative agreement with the results obtained from the 
computational studies. 
 
In order to synthesize the metal complexes of guanine with the PtII entity 
attached to the N(9) position, at first, it was important to unequivocally establish 
the metal binding site(s) of guanine. Therefore, (dien)PtII complexes of 
unsubstituted guanine were synthesized and individual species have been 
identified by the pD dependence of the guanine resonances. With (dien)PtII, the 
coordination occurs preferentially at the N9 position. The complexes, 
[(dien)Pt(GH2-N9)]Cl(ClO4) 12a, 2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} 12b and 
[(dienPt)2(GH-N7,N9)](ClO4)3 13 have been characterized by X-ray 
crystallography.  
 
DFT calculations have been carried out for [(dien)Pt(GH2-N7)]2+, [(dien)Pt(GH2-
N9)]2+ and [(dienPt)2(GH-N7,N9)]3+. The calculations show that the N(7) linkage 
isomer is more stable than the N(9) linkage isomer by ΔE = 8.4 kcal/mol. This 
observation is not in accordance with the experimental results where the 
preferential coordination site is N9. The reason for the preference of the N(7) 
linkage isomer might be the intramolecular hydrogen bonding between O(6) and 
the NH2(dien) ligand. 
 
Using 9-EtGH as a ligand, the complex trans-[(NH3)Pt(9-EtGH-N7)I2] was 
synthesized according to the known literature methods. Starting out from trans-
[(NH3)Pt(9-EtGH-N7)I2], a number of reactions have been carried out using three 
different bridging ligands, ethylenediamine, pyrazine and 4,4’-bipyridine.  
 
The reactions with ethylenediamine were not successful. The reactions with 
pyrazine were successful as far as the synthesis of the middle part of the artificial 
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oligonucleotides is concerned. Attempts to prepare and isolate [(NH3)5Pt3(9-
EtGH)3(pyrz)2]6+ compounds using these middle blocks have till date been 
unsuccessful. The reactions carried out with 4,4’-bipyridine as a bridging ligand 
led to the synthesis of the desired product in solution although the isolation of 
product has not been possible. The complexes trans-[(NH3)Pt(9-EtGH-
N7)(pyrz)2](NO3)2 16 and cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 19 have been 
characterized by X-ray crystallography. 
 
The metal binding behavior of 7-MeGH has been studied using (dien)PtII and cis-
[(NH3)2PtII]. Attempts have been made to obtain the 1:1 cis-[(NH3)2Pt(7-MeGH-
N9)Cl]Cl on a preparative scale. However, it has not been possible to isolate this 
compound. The crystal structure analyses of [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) 
18, cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 · nH2O (n = 2 or 3) 20 and cis, cis-
[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2 · 3H2O 21 are reported. 
 
The (dien)MII (M = Pd and Pt) complexes of 1-MeIC were also synthesized and it 
was found that under alkaline conditions, [(dien)Pt(1-MeIC-N3)]2+ undergoes 
deamination to give the corresponding complex [(dien)Pt(1-MeU-N3)]2+. The 1-
MeICH+ 9, [(dien)Pd(1-MeIC-N3)](ClO4)2 10 and [(dien)Pt(1-MeIC-N3)](ClO4)2 11 
were characterized by X-ray crystallography. 
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4. Zusammenfassung 
Die zentrale Idee hinter dem aktuellen Projekt war die Synthese kationischer Di- 
und Trinukleotik-Analoga mit einem positiv geladenen Pt2+-Rückgrat. Die 
Nukleobasen können hierbei entweder über 
a) N1 (unsubstituiertes Isocytosin), 
b) N9 (unsubstituiertes Guanin), 
c) N7 (9-EtGH) oder über 
d) N9 (7-MeGH)  
an das Metall koordinieren. Diese Liganden wurden auch mit Hinblick auf die 
Einflüsse ihrer Metallierung auf ihre Wasserstoffbrückenbindungseigenschaften 
sowie ihre Tautomerisierung untersucht. 
 
Isocytosin existiert in Lösung in zwei tautomeren Formen 1a und 1b, in denen 
N(1) oder N(3) das saure Proton trägt. Im Festkörper liegen beide Tautomere im 
Verhältnis 1:1 vor. Unsere Ergebnisse zeigen, dass es möglich ist, das 
Gleichgewicht zwischen den Tautomeren durch Zufügen selektiv 
wechselwirkender Wasserstoffbrückenbindungspartner zu verschieben. Die 
beiden Tautomere 1a und 1b können mit Isocytosinium und 1-MeC getrennt 
voneinander kokristallisiert werden. In beiden Festkörperstrukturen liegen 
zwischen den beiden beteiligten Molekülen jeweils drei Wasserstoffbrücken vor. 
 
Abbildung 1  Die zwei Tautomere 1a und 1b können einzeln in Gegenwart eines geeigneten 
Wasserstoff-brückenbindungs partners kokristallisiert werden.  
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Reaktionen dieser Liganden mit einer Reihe von PdII und PtII Am(m)in-
Komplexen, (dien)PdII, (dien)PtII, cis-(NH3)2PtII und trans-(NH3)2PtII wurden 
1H-NMR-spektroskopisch untersucht. Es zeigte sich, dass diese Metalle eine 
Koordination an N(3) bevorzugen. Die Kristallstrukturen von [(dien)Pd(ICH-
N3)](NO3)2 2 und [(dienM)2(IC-N1,N3)](ClO4)3 (M = PdII, 3 und PtII, 4) werden 
beschrieben. In stark saurem Medium reagiert [(dienPt)2(IC-N1,N3)]3+ zu 
[(dien)Pt(ICH-N1)]2+, also zum PtII Komplex des Tautomers 1b. 
 
DFT-Berechnungen wurden für [(NH3)3Pt(ICH)]2+, cis- und trans-
[(NH3)2PtCl(ICH)]+, trans-[(NH3)2Pt(ICH)2]2+ und für bindungsisomeren ICH-
komplexe mit, (dien)PdII, (dien)PtII und (tmeda)PtII ausgeführt. In allen Fällen war 
die Koordination an N(3) gegenüber N(1) energetisch bevorzugt. Die 
experimentellen Ergebnisse unterstützen die theoretischen Befunde. Die 
Berechnungen legen nahe, dass dieser Befund vor allem durch die energetische 
Bevorzugung der Metall-N3-Bindung gegenüber der Metall-N1-Bindung 
hervorgerufen wird. Intramolekulare Wasserstoffbrücken zwischen den 
Coliganden am Metall und dem ICH-Tautomer unterstützen diesen Effekt 
zusätzlich. Die Berechnungen zeigen außerdem eine deutliche Pyramidalisierung 
der exozyklischen NH2-Gruppe an, sobald die Nukleobase einen Diederwinkel 
 < 90˚ zur Koordinationsebene des Metalls einnimmt. 
 
Abbildung 2  Optimierte berechnete Strukturende N(1) und N(3)-Bindungsisomere von 
[(NH3)3Pt(ICH)]2+ und trans-[(NH3)2PtCl(ICH)]+. 
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Das geringe Vorkommen der PtII und PdII Komplexe des Isocytosins mit einer 
koordinativen Bindung über N(1) in Lösung belegt den enormen Einfluss, den 
Metallkoordination auf Tautomeren-Gleichgewichte haben kann. Demgemäß 
waren die Bemühungen, durch Variation der Coliganden am PtII das Isocytosin 
über N(1) zu koordinieren, nicht erfolgreich. Dies kann als Bestätigung der 
theoretischen Berechnungen aufgefasst werden. 
 
Um Metallkomplexe des PtII mit Guanin über dessen N(9) Position zu 
synthetisieren, war es zunächst erforderlich, die bevorzugte Koordination des 
Guanins zu ermitteln. Dazu wurden (dien)PtII Komplexe des unsubstituierten 
Guanins dargestellt und einzelne Spezies dann über die pH-Abhängigkeit ihrer 
1H-NMR-Resonanzen identifiziert. (dien)PtII koordiniert bevorzugt an N(9) des 
Guanins. Die Komplexe [(dien)Pt(GH2-N9)]Cl(ClO4) 12a, 2{[(dien)Pt(GH2-
N9)](ClO4)2 · 2H2O} 12b und [(dienPt)2(GH-N7,N9)](ClO4)3 13 wurden 
kristallographisch charakterisiert. 
 
DFT-Berechnungen wurden fϋr [(dien)Pt(GH2-N7)]2+, [(dien)Pt(GH2-N9)]2+ und 
[(dienPt)2(GH-N7,N9)]3+ durchgeführt. Die Rechnungen zeigen, dass der über 
N(7)-koordinierende Komplex um ΔE = 8,4 kcal/mol stabiler ist als das N(9)-
Bindungsisomer. Dieser Befund steht nicht im Einklang mit den experimentellen 
Befunden, wonach das N(9)-Bindungsisomer bevorzugt ist. Als Grund für die 
Bevorzugung der N(7)-Position in der Gasphase ist die intramolekulare 
Wasserstoffbrücke zwischen O(6) und der NH2(dien)-Gruppe des Coliganden zu 
betrachten. 
 
Mit 9-EtGH als Ligand wurde der Komplex trans-[(NH3)Pt(9-EtGH-N7)I2] 
entsprechend der in der Literatur bekannten Methoden dargestellt. Ausgehend 
von trans-[(NH3)Pt(9-EtGH-N7)I2] wurden drei verschiedene verbrückende 
Liganden untersucht: Ethylendiamin, Pyrazin und 4,4’-Bipyridin. 
 
Die Umsetzungen mit Ethylendiamin waren nicht erfolgreich; mit Pyrazin waren 
sie nur im Hinblick auf die Synthese des Mittelstücks der künstlichen 
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Oligonukleotide erfolgreich. Versuche, [(NH3)5Pt3(9-EtGH)3(pyrz)2]6+ mit diesem 
„Mittelteil“ zu synthetisieren und zu isolieren, sind bis heute fehlgeschlagen. Die 
Umsetzungen mit 4,4’-Bipyridin als verbrückendem Liganden führten zur 
Synthese des Zielproduktes in Lösung, aber dessen Isolierung gelang bis heute 
nicht erfolgreich. Die Komplexe trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 16 und 
cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 19 konnten kristallographisch charakterisiert 
werden. 
 
Das Metallbindungsverhalten von 7-MeGH wurde an (dien)PtII und cis-[(NH3)2PtII] 
untersucht. Dabei wurde versucht, den 1:1 Komplex cis-[(NH3)2Pt(7-MeGH-
N9)Cl]Cl im präparativen Maßstab zu isolieren. Dies gelang allerdings nicht. Die 
Kristallstrukturen von [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) 18, cis-[(NH3)2Pt(7-
MeGH-N9)2]Cl2 · nH2O (n = 2 oder 3) 20 und cis, cis-[{(NH3)2Pt}2(7-MeGH-
N3,N9)Cl2]Cl2 · 3H2O 21 werden beschrieben. 
 
(dien)MII (M = Pd und Pt) Komplexe von 1-MeIC wurden synthetisiert und es 
wurde gefunden, dass [(dien)Pt(1-MeIC-N3)]2+ unter alkalischen Bedingungen 
desaminiert wird und [(dien)Pt(1-MeU-N3)]2+ bildet. 1-MeICH+ 9, [(dien)Pd(1-
MeIC-N3)](ClO4)2 10 und [(dien)Pt(1-MeIC-N3)](ClO4)2 11 konnten  
kristallographisch charakterisiert werden. 
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5. Experimental Section 
5.1 Materials 
Isocytosine (ICH), pyrazine and 4,4’-bipyridine were purchased from Sigma; 
K2PtCl4 and K2PdCl4 from Heraeus; guanosine from Sigma-Aldrich; guanine from 
Merck; 9-MeGH, 9-EtGH and 7-MeGH from Prof. W. Pfleiderer, Fa. Chemogen, 
Konstanz; [(dien)PtI]I217, [(dien)PdI]I105, trans-[(NH3)2PtCl2]218, cis-
[(NH3)2PtCl2]218, 1-methylcytosine (1-MeC)150, 1-methylthymine (1-MeT)219 and 
the complexes, trans-[(NH3)2Pt(9-EtGH-N7)Cl]Cl187,220, trans-[(NH3)2Pt(1-
MeC)Cl]Cl221, cis-[(NH3)2Pt(1-MeC)Cl]Cl222 and trans-[(NH3)2Pt(1-MeT)Cl]223 
were prepared according to the methods given in the literature; [(dien)PdBr]Br105 
was prepared in an analogous manner as [(dien)PdI]I. Deuterated solvents 
DMSO-d6, D2O were obtained from Deutero GmbH, Kastellaun (Germany). 
 
5.2 Instrumentation and Measurements 
5.2.1 NMR-Spectroscopy 
1H NMR Spectra were recorded on Varian FT-NMR Mercury 200 (200.13 MHz), 
and DRX 400 (400.13 MHz) instruments at 23 ˚C. In D2O, spectra were 
measured with presaturation of the water resonance using sodium-3-
(trimethylsilyl)propanesulfonate (TSP, δ = 0 ppm) as internal reference.  
 
Spectra in DMSO-d6 were recorded without the presaturation of the water signal 
using the resonance of DMSO-d5 (δ = 2.50 ppm relative to tetramethylsilane 
(TMS)) as reference. DMSO-d6 was dried over 4-Å-molecular sieves for a week 
before use or a freshly opened bottle was used. 
 
5.2.2 Vibrational Spectra 
Infrared spectra (KBr pellets) were recorded on a Bruker IFS 28 FT spectrometer 
in the region between 4000 cm-1 to 250 cm-1.  
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Raman spectra were recorded on a Coderg T800 with Ar+-Laser (514.5 nm) or 
Kr+-Laser (647.1 nm) excitation. 
 
5.2.3 Elemental Analysis 
Elemental analysis (C H N) was performed with a Leco Elemental Analyzer 
CHNS-932. 
 
5.2.4 pKa values 
pH* values refer to uncorrected pH meter readings (Metrohm 6321; combination 
glass electrode) in D2O solutions. pH* values were adjusted by addition of DNO3 
or NaOD solutions; pD values were obtained by adding 0.4 to the uncorrected pH 
meter reading. The pKa values were determined using pH dependent 1H NMR 
spectroscopic measurements in D2O. pKa values were evaluated with a Newton-
Gauss224 non-linear least-squares fit method that deals with the changes in 
chemical shifts of all non-exchangeable protons with the change in pD of the 
solution. The obtained acidity constants were then transformed to the values 
valid for H2O according to the literature.225 
 
5.2.5 Computational Details 
The ab initio molecular orbital calculations were performed using the Gaussian 
98 package.226 A combination of Becke’s three-parameter hybrid functional101 
with Lee-Yang-Parr’s exchange functional102,103 was applied for all structures. 
The structures of the two tautomers were optimized using two different basis sets 
LANL2DZ and 6-31+G*. The metals in the Pd and Pt complexes have been 
described with the LANL2DZ basis set, including effective core potentials, while 
the 6-31G* basis set has been used for C, N, O, and H atoms. Additionally, the 
wave functions were analyzed by the natural bond orbital (NBO) method,116 a 
standard option of Gaussian 98. The NBO analysis explains the strength of 
hydrogen bonds in terms of donor-acceptor interactions between doubly 
occupied lone pair orbitals and unoccupied antibond orbitals. The total energy 
was calculated as the sum of the electronic energy and the zero-point vibrational 
 119  Experimental Section 
energy. Vibrational frequency calculations were carried out to ensure that the 
stationary points located on the potential energy surfaces by geometry 
optimization were minima. 
 
5.2.6 X-ray Crystallography 
X-ray intensity data were collected at room temperature or at 120 K for 
compounds on an Enraf-Nonius-KappaCCD diffractometer227 using graphite-
monochromated Mo Kα radiation (λ = 0.7107 Å). None of the crystals showed 
evidence of crystal decay during data collection. For data reduction and cell 
refinement, the programs DENZO and SCALEPACK (Nonius, 2000)228 were 
used. Corrections for incident and diffracted beam absorption effects were 
applied using SADABS. The structures were solved by either conventional direct 
or Patterson methods and subsequent Fourier syntheses and refined by full-
matrix least squares on F2 using the SHELXTL 5.1 program.229 Hydrogen atoms 
were either located in a difference Fourier map and refined isotropically or were 
fixed in idealized positions and allowed to ride on the atom to which they were 
attached. Hydrogen atom thermal parameters were tied to those of the atom to 
which they were attached. Except for the disordered atoms, all non-hydrogen 
atoms in the structures were refined anisotropically. Crystallographic data and 
details of refinement are reported in X-ray Tables (ref. Appendix). 
 
5.3 Syntheses of Complexes 
5.3.1 [(dien)PdBr]Br (1) 
A reaction mixture containing 5.0 g (28 mmol) of PdCl2, 5.0 g (24 mmol) of 
dien·3HCl in 100 ml of water was refluxed for 8 h. An orange solution formed and 
some deposition of metallic palladium was observed. The solution was filtered 
and the filtrate was concentrated to a volume of 30 ml. LiBr (4.3 g, 50 mmol) was 
added to the concentrated solution to isolate [(dien)PdBr]Br. Yellow crystals of 
[(dien)PdBr]Br were isolated and characterized by X-ray crystallography. Yield 
65%. 
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Elemental analysis (%) for C4N3H13Br2Pd (369.4): C 13.0, H 3.5, N 11.4; found: C 
13.1, H 3.5, N 11.4. IR ( ~ν cm-1): 3204 (s), 3127 (s), 3056 (s), 1591 (s), 1448 (m), 
1384 (m), 1144 (s), 1084 (s), 1050 (s), 991 (w), 926 (w). 1H NMR (200 MHz, 
D2O): δ = 3.35 – 2.90 ppm (m; dien). 
 
5.3.2 [(dien)Pd(ICH-N3)](NO3)2 (2) 
A suspension of [(dien)PdBr]Br (79.8 mg, 0.22 mmol) in water (10 ml) was 
treated with AgNO3 (73.4 mg, 0.43 mmol) for 5 h at 40 ˚C with the exclusion of 
daylight. The solution was then cooled to room temperature, AgI was filtered off, 
and isocytosine (314.0 mg, 0.22 mmol) was added. The mixture was again stirred 
for 5 h at 40 ˚C and kept for crystallization. Yellow crystals appeared after few 
weeks, which were later dried in air. A single crystal was picked and 
characterized by X-ray crystallography. Yield 20%. 
 
Elemental analysis (%) for C8H18N8O7Pd · H2O (462.7): C 20.7, H 4.4, N 24.2; 
found: C 20.2, H 4.2, N 24.0. No water was detected in the X-ray crystal 
structure, however. 1H NMR spectra were recorded in D2O and it was found that 
there was an immediate equilibration of the compound in solution to give four 
sets of resonances. 1H NMR (200 MHz, D2O, pD = 4.4): δ = 7.84 (d; 3J = 7.6 Hz; 
H6), 7.69 (d; 3J = 7.0 Hz; H6), 7.61 (d; 3J = 7.8 Hz; H6), 7.48 (d; 3J = 7.4 Hz; H6), 
5.93 (d; 3J = 7.8 Hz; H5), 5.91 (d; 3J = 7.6 Hz; H5), 5.87 (d; 3J = 7.4 Hz; H5), 5.73 
(d; 3J = 7.0 Hz; H5), 3.30 – 2.90 ppm (m; dien). IR ( ~ν cm-1): 3407 (s), 3135 (br), 
1664 (s), 1606 (s, sh), 1381 (w, sh), 824 (s). Raman ( ~ν cm-1): 1230(3), 1045(10), 
1039(8), 798(7), 612(4), 572(1), 546(2). 
 
5.3.3 [(dienPt)2(IC-N1,N3)](ClO4)3 · 2H2O (3) 
A suspension of [(dien)PtI]I (155.1 mg, 0.14 mmol) in D2O (3 ml) was treated with 
AgClO4 (95.5 mg, 0.28 mmol) for 5 h at 40 ˚C with the exclusion of daylight. The 
solution was then cooled to room temperature, AgI filtered off, and divided into 
two parts. Isocytosine (7.7 mg, 0.22 mmol) was added to the first part of the 
solution. The mixture was again stirred for 5 h at 40 ˚C. pD of the solution was 
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later adjusted to 5.6 and 100 μL of [(dien)Pt(D2O)]2+ solution was added to the 
mixture solution. The progress of the reaction was monitored by 1H NMR 
spectroscopy. This procedure was repeated until only a single set of signals due 
to [(dienPt)2(IC-N1,N3)](ClO4)3 was present. Colorless crystals were formed in 
the reaction mixture within 2 days at 3 ˚C. A single crystal was picked and 
characterized by X-ray crystallography. Yield 40%. 
 
Elemental analysis (%) for C12H30N9O13Pt2Cl3 · 2H2O (1040.97): C 13.9, H 3.3, N 
12.1; found: C 13.7, H 3.2, N 12.1. 1H NMR (200 MHz, D2O, pD = 6.24): δ = 7.73 
(d; 3J = 7.0 Hz; H6), 5.77 (d; 3J = 7.0 Hz; H5), 3.30 – 2.90 ppm (m; dien). 
IR ( ~ν cm-1): 3410 (s, br), 3271 (m, sh), 1633 (s, sh), 1563 (m), 1458 (s), 1409 (s), 
1304 (s), 843 (m). Raman ( ~ν cm-1): 1496(3), 1409(1), 1235(8), 934(10), 801(7). 
 
5.3.4 [(dienPd)2(IC-N1,N3)](ClO4)3 (4) 
A suspension of [(dien)PdBr]Br (50.0 mg, 0.14 mmol) in D2O (1.0 ml) was treated 
with AgClO4 (55.7 mg, 0.27 mmol) for 5 h at 40 ˚C with the exclusion of daylight. 
The solution was then cooled to room temperature, AgBr filtered off, and divided 
into two parts. Isocytosine (7.5 mg, 0.07 mmol) was added to the first part of the 
solution. The mixture was again stirred for 5 h at 40 ˚C. pD of the solution was 
later adjusted to 7.6 and 150 µL of [(dien)Pd(D2O)]2+ solution was added to the 
mixture. The progress of the reaction was monitored by 1H NMR spectroscopy. 
This procedure was repeated until only a single set of signals due to 
[(dienPd)2(IC-N1,N3)](ClO4)3 was present. Yellow crystals were formed in the 
reaction mixture within 1 day at 3 ˚C. A single crystal was picked and 
characterized by X-ray crystallography. Yield 45%. 
 
Elemental analysis (%) for C12H30N9O13Pd2Cl3 (827.62): C 17.4, H 3.7, N 15.2; 
found: C 17.4, H 3.5, N 15.1. Two molecules of water were detected in the X-ray 
crystal structure, however. 1H NMR (200 MHz, D2O, pD = 6.42): δ = 7.70 (d; 
3J = 7.0 Hz; H6), 5.73 (d; 3J = 7.0 Hz; H5), 3.35 – 2.90 ppm (m; dien). IR ( ~ν cm-1): 
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3400 (s, br), 3266 (m, sh), 1620 (s, sh), 1563 (s), 1450 (m), 1400 (m), 1300 (s), 
840(w). Raman ( ~ν cm-1): 1409(2), 1237(8), 955(2), 936(10), 801(5), 455(7). 
 
5.3.5 [(dien)Pt(ICH-N1)]2+ (5a) and [(dien)PtCl]ClO4 (5b) 
[(dienPt)2(IC-N1, N3)](ClO4)3 was dissolved in D2O and the pD of the solution was 
adjusted to 1.2 by addition of DCl. The progress of the reaction was monitored by 
1H NMR spectroscopy. A new set of resonances started to appear immediately 
after addition of DCl. The solution was then heated at 40 ˚C for four hours. With 
time, the signals for the dinuclear complex disappeared and a single set of 
resonances was present. This set of resonances was assigned to the N(1) 
linkage isomer on the basis of a pD-dependence. Furthermore, 195Pt satellites are 
present for the H6 proton of the ICH ligand. Till date, it has not been possible to 
isolate the compound from solution. From the reaction mixture, colorless crystals 
were picked but X-ray crystallography revealed that the crystals were the 
compound [(dien)PtCl]ClO4 5b. 
 
1H NMR for 5a (200 MHz, D2O, pD = 1.41): δ = 7.87 (d; 3J = 7.6 Hz; H6), 5.90 (d; 
3J = 7.6 Hz; H5), 3.33 – 2.90 ppm (m; dien). 
 
Elemental analysis (%) for 5b C4H13N3O4PtCl2 · H2O (451.17): C 10.6, H 3.4, N 
9.3; found: C 10.9, H 3.7, N 9.8.  No water molecule was detected in the crystal 
structure, however. 
 
5.3.6 ICH · (1-MeC) · 2H2O (6) 
1-MeC (50.0 mg, 0.40 mmol) and ICH (44.4 mg, 0.40 mmol) were dissolved in a 
minimum amount of water. The solution was warmed at 30 ˚C until a clear 
solution was obtained. The solution was concentrated on a water bath and kept 
for crystallization in air. Colorless crystals appeared after one week. A single 
crystal was picked and characterized by X-ray crystallography. 
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Elemental analysis (%) for C9H12N6O2 (anhydrous sample): C 45.7, H 5.1, N 
35.6; found: C 45.5, H 5.0, N 35.2. Raman ( ~ν cm-1): 1263(8), 1216(2), 781(6), 
774(10), 629(6). 
 
5.3.7 [ICH · ICH2]NO3 (7) 
ICH (50.0 mg, 0.45 mmol) was dissolved in water and pH* of the solution was 
adjusted to 4.3 with the addition of HNO3. Colorless crystals were isolated and 
characterized by X-ray crystallography. 
 
Elemental analysis (%) for C8H11N7O5 (285.24): C 33.7, H 3.8, N 34.7; found: C 
34.0, H 3.8, N 35.0. Raman ( ~ν cm-1): 1231(5), 1209(5), 1046(4), 1038(3), 
796(10), 790(5). 
 
5.3.8 1-MeIC (8) 
4.0 g (0.04 mol) of isocytosine, 70.0 ml of hexamethyldisilazane (HMDS) and 5.8 
ml of trimethylchlorosilane (TMCS) were added to a 250 ml round-bottom flask. 
The mixture was stirred and refluxed at 140 ˚C with until the solution became 
transparent. The reaction mixture was cooled to 40 ˚C and 28 ml of methyliodide 
(CH3I) was slowly added to the flask. The solution was again heated to reflux at 
80 ˚C, with stirring, overnight. The reaction mixture was treated with 230 ml of 6N 
acetic acid at room temperature to hydrolyze the trimethylsilyl protecting group. 
The solution was evaporated to dryness under reduced pressure to yield a crude 
slightly yellow product. The crude product was washed with a large amount of 
water and redissolved in ethanol, kept at 4 ˚C for a day. White crystalline product 
precipitated out of the solution which was later purified over the sephadex G25 
column. Yield 60%. 
 
Elemental analysis (%) for C5H7N3O (125.10): C 48.0, H 5.6, N 33.6; found: C 
47.5, H 5.7, N 33.6. 1H NMR (200 MHz, D2O, pD = 4.0): δ = 7.56 (d; H6), 5.98 (d; 
H5), 3.53 ppm (s; CH3). Raman ( ~ν cm-1): 1451(1), 1408(1), 1289(8), 982(1), 
972(1), 796(10), 615(2), 552(1). 
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5.3.9 [1-MeICH](NO3)3(ClO4) (9) 
20.2 mg (0.16 mmol) of 1-methylisocytosine was dissolved in 2 ml of H2O and pH 
of the solution was adjusted with the help of HNO3, HClO4 and NaOH to 4.5 (pKa 
value of 1-methylisocytoine). Colorless crystals appeared after a few days which 
were characterized by X-ray crystallography. 
 
Elemental analysis (%) for C20H32N15O17Cl (790.01): C 30.4, H 4.1, N 26.6; 
found: C 30.0, H 4.0, N 27.0. Raman ( ~ν cm-1): 1508(9), 1473(1), 1290(1), 
1272(6), 1249(6), 1207(1), 1047(10), 798(5), 790(8), 772(7), 719(1), 623(1), 
607(3), 555(3), 547(4). 
 
5.3.10 [(dien)Pd(1-MeIC-N3)](ClO4)2 (10) 
To a suspension of 1 (25.0 mg, 0.07 mol) in 1 ml of water, AgClO4 was added. 
The reaction mixture was stirred at 40 ˚C with the exclusion of daylight for 4 h 
and AgBr was filtered off. To the clear solution, 1-methylisocytosine (4.2 mg, 0.03 
mmol) was added and the reaction mixture was stirred at 40 ˚C for few hours. 
The solution was rotary-evaporated to near dryness. The residue was 
redissolved in a minimum quantity of water. Pale yellow crystals appeared at 4 ˚C 
after one day, which were later dried under vacuum. A single crystal was picked 
and characterized by X-ray crystallography. Yield 75%. 
 
Elemental analysis (%) for C9H20N6O9PdCl2 (533.6): C 20.3, H 3.8, N 15.7; found: 
C 20.0, H 3.5, N 15.5. 1H NMR (200 MHz, D2O, pD = 2.0): δ = 7.49 (d; 3J = 7.6 
Hz; H6), 5.90 (d; 3J = 7.6 Hz; H5), 3.52 (s, CH3), 3.35 – 2.90 ppm (m; dien). 
Raman ( ~ν cm-1): 1464(1), 1273(1), 935(10), 840(1), 791(3), 633(2), 576(4). 
 
5.3.11 [(dien)Pt(1-MeIC-N3)](ClO4)2 (11) 
Addition of AgClO4 (71.6 mg, 0.36 mmol) to a suspension of [(dien)PtI]I (100.4 
mg, 0.180 mmol) in 5 ml of water resulted in the immediate precipitation of AgI. 
The mixture was stirred at 40 ˚C with the exclusion of daylight for 4 h and AgI 
was filtered off. To the clear solution, 1-methylisocytosine (22.0 mg, 0.18 mmol) 
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was added and the reaction mixture was stirred at 40 ˚C for 2 days. The solution 
was evaporated at room temperature to a volume of 2.0 ml. Colorless crystals 
appeared at 4 ˚C after a few days, which were later dried under vacuum. A single 
crystal was picked and characterized by X-ray crystallography. Yield 65%. 
 
Elemental analysis (%) for C9H20N6O9PtCl2 (622.3): C 17.4, H 3.2, N 13.5; found: 
C 17.0, H 3.2, N 13.1. 1H NMR (200 MHz, D2O, pD = 6.2): δ = 7.73 (d; 3J = 7.6 
Hz; H6), 5.77 (d; 3J = 7.6 Hz; H5), 3.59 (s, CH3), 3.35 – 2.90 ppm (m; dien). 
Raman ( ~ν cm-1): 1464(1), 1408(1), 1264(8), 933(10), 811(2), 790(3), 634(2), 
546(4). 
 
5.3.12 [(dien)Pt(GH2-N9)](Cl)ClO4 (12a) and 2{[(dien)Pt(GH2-
N9)](ClO4)2 · 2H2O} (12b) 
A suspension of [(dien)PtI]I (276.0 mg, 0.50 mmol) in H2O (13 ml) was treated 
with AgClO4 (221.0 mg, 0.98 mmol) for 5 h at 40 ˚C with the exclusion of daylight. 
The mixture was then cooled to room temperature and AgI was filtered off. pH of 
the solution was adjusted to 4.1 with the addition of 0.1 M NaOH or 0.01 M HCl 
and 72.0 mg (0.48 mmol) guanine was added. The reaction mixture was stirred at 
40 ˚C for 8 h. Excess guanine was removed by filtration. The solution was rotary-
evaporated to dryness. The residue was dissolved in 1:1 solution of CH3OH:H2O. 
Very fine, colorless crystals appeared after 2 days at 3 ˚C. A single crystal was 
picked and characterized by X-ray crystallography. Yield 15%. 
 
Elemental analysis (%) for 12b C9H18N8O9Cl2Pt (648.28): C 16.7, H 2.8, N 17.3; 
found: C 16.6, H 2.7, N 17.3. Four water molecules were detected in the crystal 
structure, however. 1H NMR (200 MHz, D2O, pD = 3.3): δ = 8.15 (s; H8), 
3.35 - 2.90 ppm (m; dien). 
 
5.3.13 [(dienPt)2(GH-N7,N9)](ClO4)3 (13) 
A suspension of [(dien)PtI]I (845.0 mg, 1.53 mmol) in H2O (20 ml) was treated 
with AgClO4 (671.0 mg, 2.98 mmol) for 5 h at 40 ˚C with the exclusion of daylight. 
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The reaction mixture was then cooled to room temperature and AgI was filtered 
off. 116.0 mg (0.77 mmol) guanine was added and pH of the solution was 
adjusted to 10.0 with the addition of 0.1 M NaOH. The solution was stirred at 
40 ˚C for 8 h. Excess guanine was removed by filtration. The solution was rotary-
evaporated to a volume of 10.0 ml. Yield 250 mg. Colorless crystals appeared 
within 2 days at 3 ˚C, which were later air dried. A single crystal was picked and 
characterized by X-ray crystallography.  
 
Elemental analysis (%) for C13H30N11OPt2 · 2.5ClO4 (995.24): C 15.7, H 3.0, N 
15.5; found: C 15.7, H 3.0, N 15.4. The compound was isolated at basic pH 
hence, deprotonation at N(1) position might have led to formation of an 
associated structure. 1H NMR (200 MHz, D2O, pD = 10.4): δ = 7.47 (s; H8), 
3.35 – 2.90 ppm (m; dien). 1H NMR (200 MHz, DMSO-d6): δ = 11.18 (s, N(1)H), 
7.67 (s; H8), 7.21 (s, dien(NH)), 6.45 (s, NH2), 5.89 (s, dien-NH2), 3.11 – 2.78 (m, 
dien). 
 
5.3.14 cis-[(NH3)2Pt(9-EtGH-N7)Cl]Cl (14)  
A solution of cis-[(NH3)2PtCl2] (900.0 mg, 3.0 mmol) and 9-EtGH (537.0 mg, 3.0 
mmol) in 45 ml of water was stirred at 40 ˚C for 48 h. The reaction mixture was 
cooled to room temperature and a yellow-white precipitate was filtered. The 
precipitate was washed with 3 ml of DMF to remove the yellow component. The 
white residue was dried in air. Yield 65%. 
 
Elemental analysis (%) for C7H15N7OPtCl2 (479.2): C 17.7, H 3.3, N 20.3; found: 
C 17.3, H 3.2, N 20.3. 1H NMR (200 MHz, D2O, pD = 6.6): δ = 8.24 (s; H8), 4.14 
(q; methylene), 1.43 ppm (t, CH3). 1H NMR (200 MHz, DMSO-d6): δ = 10.90 (s, 
N(1)H), 8.37 (s; H8), 6.92 (s, NH2), 4.59 (s, Pt-NH3), 4.27 (s, Pt-NH3), 4.10 (q, 
methylene), 1.33 ppm (t, CH3). IR ( ~ν cm-1): 349 [ν(Pt-Cl)]. 
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5.3.15 trans-[(NH3)Pt(9-EtGH-N7)I2] (15)  
To a suspension of 14 (150.0 mg, 0.31 mmol) in 150 ml of water was added KI 
(208.0 mg, 1.25 mmol) which was dissolved in 10 ml of water. The pH of the 
reaction mixture was adjusted to 2.0 by the addition of 1 M HNO3. The mixture 
was stirred at 35 ˚C for 4 days. The solution was then rotary-evaporated to near 
dryness, and a brown precipitate was filtered off, washed with water to remove 
NH4Cl and dried. Yield 45%. 
 
Elemental analysis (%) for C7H12N6OPtI2 (645.1): C 12.5, H 2.0, N 12.7; found: C 
12.4, H 1.9, N 12.6. 1H NMR (200 MHz, DMSO-d6): δ = 11.20 (s, N(1)H), 8.57 (s; 
H8), 6.86 (s, NH2), 4.59 (s, Pt-NH3), 4.03 (q, CH2), 1.35 ppm (t, CH3). 
 
5.3.16 trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O (16) 
A suspension of 150.0 mg of 15 (0.23 mmol), AgNO3 (79.2 mg, 0.47 mmol) and 
pyrazine (56.0 mg, 0.70 mmol) in 200 ml of water was stirred at room 
temperature for 6 days with the exclusion of daylight. After that, AgI was filtered 
off and the solution was rotary-evaporated to dryness. The yellow residue was 
dissolved in 1:1:1 solution of CHCl3:CH3OH:H2O. Yellow crystals appeared within 
2 days at 3 ˚C, which were later air dried. A single crystal was picked and 
characterized by X-ray crystallography. Yield 35%. 
 
Elemental analysis (%) for C15H20N12O7Pt · H2O (693.50): C 25.8, H 3.2, N 24.2; 
found: C 25.7, H 3.2, N 24.0. 1H NMR (200 MHz, D2O, pD = 4.3): δ = 8.47 (s; 
H8), 8.79 (m, pyrz), 8.97 (m, pyrz), 4.05 (q; CH2), 1.35 ppm (t, CH3). A Raman 
spectrum was not obtained as the compound decomposed under the laser light. 
 
5.3.17 trans-[(NH3)Pt(9-EtGH-N7)(4,4’-bipyridine)2](NO3)2 (17)  
15 (100 mg, 0.155 mmol), AgNO3 (52.7 mg, 0.36 mmol) and 4,4’-bipyridine (72.6 
mg, 0.46 mmol) were dissolved in 50 ml of water. The reaction mixture was 
stirred at room temperature with the exclusion of daylight for four days. AgI was 
filtered off and the solution was rotary-evaporated to dryness. 1H NMR of the 
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yellow solid in DMSO-d6 confirmed the presence of the desired compound along 
with free 4,4’-bipyridine. The compound was dissolved in a number of solvents 
(methanol, acetone, chloroform) in order to get rid of unreacted 4,4’-bipyridine. 
However, these attempts were unsuccessful.  
 
1H NMR (200 MHz, DMSO-d6) of 17: δ = 11.29 (s, N(1)H), 8.92 (d; bipy), 8.78 (m, 
bipy) 8.16 (d, bipy), 7.89 (m, bipy), 6.91 (s, NH2), 5.10 (s, Pt-NH3), 3.95 (q, CH2), 
1.29 (t, CH3). 
 
5.3.18 [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18)  
A suspension of [(dien)PtI]I (50 mg, 0.05 mmol) in D2O (1 ml) was treated with 
AgClO4 (18.8 mg, 0.09 mmol) for 5 h at 40 ˚C with the exclusion of daylight. The 
solution was then cooled to room temperature, AgI was filtered off, and to this 
solution 7.5 mg (0.05 mmol) of 7-methylguanine (7-MeGH) was added. The 
mixture was stirred at 40 ˚C for one day. Colorless crystals were isolated from the 
reaction mixture within 2 days at 3 ˚C. A single crystal was picked and 
characterized by X-ray crystallography. 
 
Elemental analysis (%) for C10H20N9O8ClPt·2H2O (660.89): C 18.2, H 3.7, N 19.1; 
found: C 18.1, H 3.7, N 19.0. No water molecules were detected in the X-ray 
structure, however. 1H NMR (200 MHz, D2O, pD = 2.4): δ = 8.10 (s; H8), 3.97 (s; 
CH3), 3.35, 3.29, 3.12, 3.09, 2.93, 2.90 ppm (m; dien). A Raman spectrum was 
not obtained as the compound decomposed under the laser light. 
 
5.3.19 cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2 (20) 
A solution of cis-[(NH3)2PtCl2] (150.0 mg, 0.5 mmol) and 7-MeGH (165.2 mg, 1.0 
mmol) in 45 ml of water was stirred at 40 ˚C for 48 h. The reaction mixture was 
cooled to room temperature and a white precipitate was filtered off. The 
precipitate was dried in air. Yield 85%. 
 
Elemental analysis (%) for C12H20N12O2PtCl2 (630.36): C 22.7, H 3.2, N 26.7; 
found: C 22.4, H 3.2, N 26.5. 1H NMR (200 MHz, D2O, pD = 2.3): δ = 8.12 (s; 
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H8), 3.98 (s, CH3). IR ( ~ν cm-1): 3440 (m, br), 3141 (w), 1701 (s), 1630 (s, sh), 
1384 (s). Raman ( ~ν cm-1): 1579(4), 1559(3), 1516(4), 1363(10), 1275(4), 
1049(6), 719(2), 689(1), 650(4), 563(1). 
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6. Appendix 
6.1 Theoretical and Computational Aspects of ab initio 
Procedures 
The ab initio molecular orbital calculations done in this thesis dealt mainly with 
the geometry optimizations to locate the lowest energy molecular structure in 
close proximity to the specified starting structures. Additionally, vibrational 
frequency calculations were carried out to ensure that the stationary points 
located on the potential energy surfaces by geometry optimization were minima. 
Calculations were done using the Gaussian 98 suite of programs.226  
 
6.1.1 Geometry Optimizations 
Geometry optimizations230 strive to locate a minimum on the potential energy 
surface in order to predict equilibrium structures of molecular systems. This can 
be understood in terms of the values of potential energy surfaces. These 
surfaces indicate the way in which the energy of a molecular system varies with 
small changes in its structure. Hence, a potential energy surface is a 
mathematical relationship linking the molecular structure and the resultant 
energy. In Figure 67, the potential energy surface considers only two of the 
degrees of freedom within the molecule, and plots the energy above the plane 
defined by them, creating a surface. Each point corresponds to a particular 
molecular structure, with the height of the surface at that point representing the 
energy of that structure.  
 
 
Figure 67  The potential energy surface.230 
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All the minima on a potential energy surface of a molecule correspond to stable 
stationary points where the forces on atoms are zero. The global minimum is the 
most stable conformation; the local minima, less stable conformations; and the 
saddle points are transition conformations between minima. 
 
At both minima and saddle points, the first derivative of the energy is zero. Since 
the gradient is the negative of the forces, the forces are also zero at such points. 
A point on the potential energy surface where the forces are zero is called a 
stationary point. All successful optimizations locate a stationary point, although 
not always the one that was anticipated. Geometry optimizations usually locate 
the stationary point closest to the starting geometry. 
 
Geometry optimizations are iterative and begin at some starting geometry. First, 
the single point energy calculation is performed on the starting geometry. Then 
the coordinates for some subset of atoms are changed and another single point 
energy calculation is performed to determine the energy of the new conformation. 
The first or second derivative of the energy (depending on the method) with 
respect to the atomic coordinates then determines how large and in what 
direction the next increment of geometry change should be. Then the change is 
made. Following the incremental change, the energy and energy derivatives are 
again determined and the process continues until convergence is achieved, at 
which point the minimization process terminates. A successive search for 
minimum finds a local minimum but not necessarily the lowest. A geometry 
optimization alone is not adequate to tell the nature of the stationary point that it 
finds. In order to characterize a stationary point, it is essential to perform a 
frequency calculation on the optimized geometry.  
 
6.1.2 Vibrational Frequency Calculations 
Energy calculations and geometry optimizations ignore the vibrations in 
molecular systems. In this way, these computations use an idealized view of 
nuclear position. In reality, the nuclei in molecules are constantly in motion. In 
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equilibrium states, these vibrations are regular and predictable, and molecules 
can be identified by their characteristic spectra.230  
 
Gaussian can calculate the vibrational spectra of molecules in their ground state. 
Additionally, it can also describe the displacements a system undergoes in its 
normal modes. Molecular frequencies depend on the second derivative of the 
energy with respect to the nuclear positions. 
 
The completed frequency calculation comprises of frequencies, intensities, the 
associated normal modes, the structure’s zero point energy, and various 
thermochemical properties. The nature of the computations is such that the 
frequency calculations are valid only at stationary points on the potential energy 
surface. Therefore, frequency calculations should be performed only on the 
optimized structures. A frequency job should use the same theoretical model and 
basis set as the optimized geometry. Frequencies computed with a different 
basis sets or methods have no validity. 
 
The frequency values which are less than zero are known as imaginary 
frequencies. The number of imaginary frequencies represents the sort of 
stationary point to which the given molecular structure corresponds. By definition, 
a structure which has n imaginary frequencies is an nth order saddle point. Thus, 
the minimum will have zero imaginary frequencies, and an ordinary transition 
structure will have one imaginary frequency since it is a first order saddle point. 
 
6.2 Determination of pKa values 
NMR methods are widely used for the determination of pKa values of 
nucleobases lying in the pH range of aqueous solutions (pH 0 – 14). For a single 
protonation-deprotonation step, the chemical shifts, δ, plotted against pD gives a 
sigmoidal curve. The resultant pD profile is then analysed by the equation224: 
 
( )
( )
δ δδ
−
−
+ ⋅=
a
a
p pH
A B
exp p pH
10
1+10
K
K   (1) 
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where δA and δB represent the chemical shifts for the deprotonated and neutral 
species, respectively. For a molecule with two deprotonation sites, pD profile is 
analysed by the equation:  
 
( ) ( )
( ) ( )
NbH NbHNbH 2
NbH NbHNbH 2
p p 2pHp pH
Nb NbH NbH2
obs p p 2pHp pH
10 10
1 10 10
K KK
K KK
δ δ δδ
+ −−
+ −−
+ ⋅ + ⋅= + +  (2) 
 
where, δNbH2, δNbH and δNb represent the chemical shifts for the species which can 
be deprotonated twice (δNbH2), once (δNbH) and not any further (δNb).The values 
pKNbH and pKNbH2 are the negative logarithms of the acidity constants, NbH2 and 
NbH, respectively. 
 
The pKa values obtained in this way can be transformed into pKa values valid for 
H2O solutions using the relationship225:  
 
( ) ( ) −= 22 p D O 0.45p H O 1.015aa
K
K  (3) 
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6.3 X-Ray Tables 
X-ray Table 1.  [(dien)PdBr]Br (1) 
formula C4H13N3Br2Pd  
fw 369.39   
space group 1P   
unit cell dimensions a = 14.242(3) Å  
 b = 4.9350(10) Å  
 c = 13.551(3) Å  
V (Å3) 952.4(3)  
Z 4  
Dcalc, (Mg/m3) 2.576  
μ (mm-1) 0.0022(3)  
Reflns. collected 3048  
Unique reflns. with |Fo| ≥ 4σ|Fo| 1563  
2θ range 8.26-50.0  
R1, wR2 [I > 2σ(I)] 0.0195, 0.0336  
GOF 0.964  
 
 
 
X-ray Table 2.  [(dien)Pd(ICH-N3)](NO3)2 (2) 
formula C8H18N8O7Pd  
fw 444.72  
space group 1P   
unit cell dimensions a = 6.6310(13) Å α = 65.80(3)˚ 
 b = 10.651(2) Å β = 87.08(3)˚ 
 c = 12.214(3) Å γ = 74.07(3)˚ 
V (Å3) 754.7(3)  
Z 2  
Dcalc, (Mg/m3) 1.957  
μ (mm-1) 1.285  
Reflns. collected 3463  
Unique reflns. with |Fo| ≥ 4σ|Fo| 2824  
2θ range 6.4-55.06  
R1, wR2 [I > 2σ(I)] 0.0345, 0.0863  
GOF 1.081  
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X-ray Table 3.  [(dienPt)2(IC-N1,N3)](ClO4)3 · 2H2O (3) 
formula C12H34N9O15Cl3Pt2  
fw 1040.97  
space group P21/c  
unit cell dimensions a = 14.598(3) Å  
 b = 11.601(2) Å β = 129.54(1)˚ 
 c = 21.769(7) Å  
V (Å3) 2843.0(14)  
Z 4  
Dcalc, (Mg/m3) 2.423  
μ (mm-1) 1.109  
Reflns. collected 63424  
Unique reflns. with |Fo| ≥ 4σ|Fo| 6508  
2θ range 6.6-55.0  
R1, wR2 [I > 2σ(I)] 0.0306, 0.0712  
GOF 1.63  
 
 
 
X-ray Table 4.  [(dienPd)2(IC-N1,N3)](ClO4)3 · 2H2O (4) 
formula C12H34N9O15Cl3Pd2  
fw 863.65  
space group P21/c  
unit cell dimensions a = 14.659(3) Å  
 b = 11.504(2) Å β = 129.583(19)˚ 
 c = 21.760(7) Å  
V (Å3) 2828.1(14)  
Z 4  
Dcalc, (Mg/m3) 2.019  
μ (mm-1) 1.637  
Reflns. collected 49155  
Unique reflns. with |Fo| ≥ 4σ|Fo| 6471  
2θ range 6.0-55.0  
R1, wR2 [I > 2σ(I)] 0.0327, 0.0686  
GOF 1.15  
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X-ray Table 5.  [(dien)PtCl]ClO4 (5b) 
formula C4H13N3O4Cl2Pt  
fw 433.15  
space group 1P   
unit cell dimensions a = 8.1414(16) Å α = 69.15(3)˚ 
 b = 11.217(2) Å β = 86.27(3)˚ 
 c = 13.247(3) Å γ = 78.88(3)˚ 
V (Å3) 1109.3(5)  
Z 4  
Dcalc, (Mg/m3) 2.594  
μ (mm-1) 13.125  
Reflns. collected 9720  
Unique reflns. with |Fo| ≥ 4σ|Fo| 4956  
2θ range 6.0-55.0  
R1, wR2 [I > 2σ(I)] 0.0628, 0.1278  
GOF 1.17  
 
 
 
X-ray Table 6.  ICH · (1-MeC) · 2H2O (6) 
formula C9H16N6O4  
fw 272.28  
space group C2/c  
unit cell dimensions a = 23.541(5) Å  
 b = 7.4360(15) Å β = 93.88(3)˚ 
 c = 14.529(3) Å  
V (Å3) 2537.5(9)  
Z 8  
Dcalc, (Mg/m3) 1.425  
μ (mm-1) 0.114  
Reflns. collected 4562  
Unique reflns. with |Fo| ≥ 4σ|Fo| 2697  
2θ range 5.6-55.8  
R1, wR2 [I > 2σ(I)] 0.0335, 0.0629  
GOF 0.627  
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X-ray Table 7.  [ICH · ICH2]NO3 (7) 
formula C8H11N7O5  
fw 285.24  
space group C2/c  
unit cell dimensions a = 20.617(5) Å  
 b = 5.1570(10) Å β = 97.79(3)˚ 
 c = 22.684(4) Å  
V (Å3) 2389.5(9)  
Z 8  
Dcalc, (Mg/m3) 1.586  
μ (mm-1) 0.133  
Reflns. collected 4327  
Unique reflns. with |Fo| ≥ 4σ|Fo| 2637  
2θ range 5.0-56.6  
R1, wR2 [I > 2σ(I)] 0.0361, 0.0818  
GOF 0.77  
 
 
 
X-ray Table 8.  [1-MeICH](NO3)3(ClO4) (9) 
formula C20H32N15O17Cl  
fw 790.06  
space group 1P   
unit cell dimensions a = 9.6476(19) Å α = 88.29(3)˚ 
 b = 9.941(2) Å β = 86.06(3)˚ 
 c = 18.783(4) Å γ = 64.63(3)˚ 
V (Å3) 1623.9(6)  
Z 2  
Dcalc, (Mg/m3) 1.616  
μ (mm-1) 0.219  
Reflns. collected 4327  
Unique reflns. with |Fo| ≥ 4σ|Fo| 2637  
2θ range 6.18-55.0  
R1, wR2 [I > 2σ(I)] 0.0603, 0.1447  
GOF 1.023  
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X-ray Table 9.  [(dien)Pd(1-MeIC-N3)](ClO4)2 (10) 
formula C9H20N6O9Cl2Pd  
fw 533.63  
space group 1P   
unit cell dimensions a = 6.5670(13) Å α = 75.77(3)˚ 
 b = 10.614(2) Å β = 87.05(3)˚ 
 c = 14.099(3) Å γ = 77.42(3)˚ 
V (Å3) 929.7(4)  
Z 2  
Dcalc, (Mg/m3) 1.906  
μ (mm-1) 1.343  
Reflns. collected 4288  
Unique reflns. with |Fo| ≥ 4σ|Fo| 2937  
2θ range 6.4-55.0   
R1, wR2 [I > 2σ(I)] 0.0720, 0.2116  
GOF 1.34  
 
 
 
X-ray Table 10.  [(dien)Pt(1-MeIC-N3)](ClO4)2 (11)  
formula C9H20N6O9Cl2Pt  
fw 622.30  
space group 1P   
unit cell dimensions a = 6.5270(13) Å α = 75.93(3)˚ 
 b = 10.663(2) Å β = 87.52(3)˚ 
 c = 14.104(3) Å γ = 77.01(3)˚ 
V (Å3) 927.7(4)  
Z 2  
Dcalc, (Mg/m3) 2.228  
μ (mm-1) 7.908  
Reflns. collected 21612  
Unique reflns. with |Fo| ≥ 4σ|Fo| 4263  
2θ range 6.4-55.0  
R1, wR2 [I > 2σ(I)] 0.0671, 0.1622  
GOF 1.41  
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X-ray Table 11.  [(dienPt)2(GH-N7,N9)](ClO4)3 (13) 
formula C13H30N11O13Cl3Pt2  
fw 1045.01  
space group P21/c  
unit cell dimensions a = 7.9690(16) Å  
 b = 14.986(3) Å β = 106.90(3)˚ 
 c = 25.261(6) Å  
V (Å3) 2886.5(12)  
Z 4  
Dcalc, (Mg/m3) 2.405  
μ (mm-1) 10.038  
Reflns. collected 3990  
Unique reflns. with |Fo| ≥ 4σ|Fo| 3990  
2θ range 4.4-46.8  
R1, wR2 [I > 2σ(I)] 0.0462, 0.1001  
GOF 0.89  
 
 
 
X-ray Table 12.  [(dien)Pt(GH2-N9)](Cl)(ClO4) (12a) 
formula C9H18N8O5Cl2Pt  
fw 584.29  
space group P21/c  
unit cell dimensions a = 8.1800(16) Å  
 b = 19.454(4) Å β = 111.79(2)˚ 
 c = 11.411(2) Å  
V (Å3) 1707.0(8)  
Z 4  
Dcalc, (Mg/m3) 2.274  
μ (mm-1) 8.574  
Reflns. collected 27195  
Unique reflns. with |Fo| ≥ 4σ|Fo| 3913  
2θ range 6.8-55.0  
R1, wR2 [I > 2σ(I)] 0.0376, 0.0636  
GOF 1.05  
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X-ray Table 13.  2{[(dien)Pt(GH2-N9)](ClO4)2 · 2H2O} (12b) 
formula C18H36N16O22Cl4Pt2  
fw 1368.61  
space group C2/c  
unit cell dimensions a = 38.466(8) Å  
 b = 11.210(2) Å β = 133.49(3)˚ 
 c = 27.134(5) Å  
V (Å3) 8489(5)  
Z 2  
Dcalc, (Mg/m3) 2.129  
μ (mm-1) 6.933  
Reflns. collected 27635  
Unique reflns. with |Fo| ≥ 4σ|Fo| 9515  
2θ range 6.0-55.0  
R1, wR2 [I > 2σ(I)] 0.0586, 0.1485  
GOF 1.04  
 
 
 
X-ray Table 14.  trans-[(NH3)Pt(9-EtGH-N7)(pyrz)2](NO3)2 · H2O(16) 
formula C15H22N12O8Pt  
fw 693.51  
space group 1P   
unit cell dimensions a = 12.770(3) Å α = 104.56(3)˚ 
 b = 14.437(3) Å β = 108.13(3)˚ 
 c = 15.161(3) Å γ = 103.90(3)˚ 
V (Å3) 2412.0(13)  
Z 4  
Dcalc, (Mg/m3) 1.904  
μ (mm-1) 5.884  
Reflns. collected 21402  
Unique reflns. with |Fo| ≥ 4σ|Fo| 10749  
2θ range 6.0-55.0  
R1, wR2 [I > 2σ(I)] 0.0728, 0.1842  
GOF 1.32  
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X-ray Table 15.  [(dien)Pt(7-MeGH-N9)](NO3)(ClO4) (18)  
formula C10H20N9O8ClPt  
fw 624.88  
space group 1P   
unit cell dimensions a = 6.9590(14) Å α = 97.76(3)˚ 
 b = 11.946(2) Å β = 96.47(3)˚ 
 c = 11.964(2) Å γ = 92.56(3)˚ 
V (Å3) 977.4(3)  
Z 2  
Dcalc, (Mg/m3) 2.123  
μ (mm-1) 7.375  
Reflns. collected 7550  
Unique reflns. with |Fo| ≥ 4σ|Fo| 4347  
2θ range 6.4-55.0  
R1, wR2 [I > 2σ(I)] 0.0386, 0.0958  
GOF 1.15  
 
 
 
X-ray Table 16.  cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2·3H2O (20a) 
formula C12H26N12O5Cl2Pt  
fw 684.40  
space group C2/c  
unit cell dimensions a = 18.201(6) Å  
 b = 21.417(6) Å β = 121.69(4)˚ 
 c = 14.822(3) Å  
V (Å3) 4916(3)  
Z 2  
Dcalc, (Mg/m3) 1.833  
μ (mm-1) 5.973  
Reflns. collected 26925  
Unique reflns. with |Fo| ≥ 4σ|Fo| 5636  
2θ range 6.2-55.0  
R1, wR2 [I > 2σ(I)] 0.0510, 0.1084   
GOF 1.01  
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X-ray Table 17.  cis-[(NH3)2Pt(7-MeGH-N9)2]Cl2·2H2O (20b) 
formula C12H24N12O4Cl2Pt  
fw 666.39  
space group 1P   
unit cell dimensions a = 7.8340(16) Å α = 102.69(3)˚ 
 b = 11.100(2) Å β = 100.49(3)˚ 
 c = 13.252(3) Å γ = 90.02(3)˚ 
V (Å3) 1104.4(4)  
Z 2  
Dcalc, (Mg/m3) 1.992  
μ (mm-1) 1.795  
Reflns. collected 9818   
Unique reflns. with |Fo| ≥ 4σ|Fo| 5011  
2θ range 6.4-55.0  
R1, wR2 [I > 2σ(I)] 0.0307, 0.0610  
GOF 1.14  
 
 
 
X-ray Table 18.  cis, cis-[{(NH3)2Pt}2(7-MeGH-N3,N9)Cl2]Cl2·3H2O (21) 
formula C6H25N9O4Cl4Pt2  
fw 819.29  
space group C2/c  
unit cell dimensions a = 13.525(3) Å  
 b = 17.095(3) Å β = 110.15(3)˚ 
 c = 19.292(4) Å  
V (Å3) 4187.5(17)  
Z 8  
Dcalc, (Mg/m3) 2.580  
μ (mm-1) 13.889  
Reflns. collected 16033  
Unique reflns. with |Fo| ≥ 4σ|Fo| 4802  
2θ range 6.4-55.0  
R1, wR2 [I > 2σ(I)] 0.0631, 0.1262  
GOF 1.14  
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X-ray Table 19.  cis-[(NH3)2Pt(9-EtGH-N7)2](NO3)2 (19) 
formula C14H24N14O8Pt  
fw 711.56  
space group 1P   
unit cell dimensions a = 10.779(2) Å α = 64.08(3)˚ 
 b = 11.926(2) Å β = 66.48(3)˚ 
 c = 12.640(3) Å γ = 67.66(3)˚ 
V (Å3) 1297.7(4)  
Z 2  
Dcalc, (Mg/m3) 1.821  
μ (mm-1) 5.473  
Reflns. collected 4644  
Unique reflns. with |Fo| ≥ 4σ|Fo| 4644  
2θ range 4.6-55.0  
R1, wR2 [I > 2σ(I)] 0.062, 0.147  
GOF 1.46  
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